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Stem cells have exploded onto the scene of regenerative medicine in the past two 
decades and have been touted as a sort of medical panacea with uses ranging from modeling 
early developmental processes to enabling better in vitro platforms for drug testing. 
However, the majority of applications initially focused on exploiting the differentiation 
capacity of stem cells for the replacement of damaged tissues. Despite the continued 
excitement surrounding cell replacement therapies, the results of initial in vivo 
transplantation studies have indicated that many of the observed functional improvements 
were due to the transient paracrine actions of the transplanted stem cells, rather than the 
stem cells permanently engrafting and replacing the damaged cellular material. Thus, 
research on the identity and potency of paracrine factors secreted by stem cells has become 
an increased area of focus in the regenerative medicine field. However, the secretory 
properties of pluripotent stem cells, including embryonic stem cells (ESCs), have been 
largely neglected in favor of research on the paracrine actions of multipotent adult stem 
cells. Due to the mitogenic and morphogenic roles of ESCs during the early stages of 
development, they are an underexplored cell population with a unique and potent 
secretome. 
A potential application for the milieu of mitogens and morphogens produced by 
pluripotent stem cells is the restoration of the proliferative and regenerative capacity of 
adult stem cell populations. While the self-renewal capacities of adult stem cell populations 
in vivo are well-documented, similar success has not been achieved in attempts to expand 
the cell populations ex vivo. For example, hematopoietic stem cells (HSCs) cultured ex vivo 
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exhibit extremely limited expansion potential and rapidly lose the capacity for self-
renewal, while muscle satellite cell populations demonstrate a decreased capacity for re-
engraftment and regeneration following expansion ex vivo. Due to insufficient and 
unreliable expansion with traditional cytokines, increased emphasis is being placed on the 
use of developmental factors, such as Wnt proteins, Notch ligand, bone morphogenetic 
proteins (BMPs), and fibroblast growth factors (FGFs), to expand adult stem cell 
populations ex vivo. Additionally, the regulation of adult stem cell populations in vivo is 
critically dependent on the surrounding microenvironment, and the loss of stem cell 
function in response in disease or aging has been attributed to a failure of the niche to 
adequately support cell function. For example, systemic factors from young animals restore 
the regenerative capacity of aged animals, indicating that the diminished function of aged 
stem cell populations arises more from the aged microenvironment than from cell intrinsic 
changes. Therefore, identifying and applying signals capable of restoring functionality to 
deteriorated stem cell niches would be a significant development for the translation of 
regenerative therapies. 
To take advantage of the stimulatory potential of pluripotent cell-derived signals, 
the goal of this project was to develop a controlled means of harnessing and delivering 
soluble factors derived from pluripotent stem cells. The traditional use of conditioned 
media is limited by the need for a bolus delivery, likely product degradation, and the 
relatively dilute concentrations of cell-secreted factors. Therefore, a novel upstream 
bioreactor for ESC culture was developed that can be continuously perfused to deliver 
secreted factors to downstream cell populations. In order to facilitate densely packed 
cultures, prevent agglomeration of stem cell aggregates, and protect cells from damage by 
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hydrodynamic forces, a microencapsulation-based approach was investigated for ESC 
culture (Chapter 3). A number of microencapsulation configurations were examined, but 
ultimately the encapsulation of pre-formed ESC aggregates led to the highest cell viability 
and degree of reproducibility. ESC aggregates encapsulated in alginate microbeads 
exhibited diminished cell growth and a delayed loss of pluripotency in comparison to 
unencapsulated aggregates, though similar levels of viability were observed. Altering the 
composition of alginate from a stiffer, more highly crosslinked composition (“High G”) to 
a softer, less crosslinked structure (“High M”) promoted greater concentrations of growth 
factors in the conditioned media and induced the enclosed ESC aggregates to differentiate 
toward a mesendodermal lineage. Given the establishment of the microencapsulation 
method, a bioreactor was then designed to extract secreted factors from a high density 
culture of microencapsulated ESCs (Chapter 4). The development of a packed bed 
configuration allowed for continuous perfusion of medium, which both enables direct one-
way delivery to downstream cell populations and leads to increased concentration of ESC-
secreted growth factors in comparison to density-matched static controls, perhaps through 
the removal of a system of negative feedback inhibition. Depending on the flow rate of 
perfusion through the reactor, a peak yield of growth factor could be achieved. 
The development the efficient and tightly engineered bioreactor system to deliver 
trophic factors from pluripotent stem cells enabled a number of downstream investigations. 
Because many of the morphogens and growth factors produced by ESCs are generally 
present in low concentrations, previous attempts to characterize the composition of ESC 
conditioned media have encountered technical challenges. However, the concentration of 
factors obtained through perfusion culture enabled thorough characterization of ESC 
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secreted factors at the gene and protein levels (Chapter 5). Using antibody arrays 
containing 96 cytokines and growth factors, many mitogenic and morphogenic proteins 
were detected in media conditioned by ESCs, and the quantity of secreted factors was 
increased with perfusion culture (in comparison to static culture) for essentially all detected 
species. To determine the influence of perfusion culture on ESC phenotype, a custom gene 
expression array of 96 proteins was designed. Dramatic differences in gene expression 
profile were observed between ESCs, mouse embryonic fibroblasts, and mesenchymal 
stem cells, emphasizing that pluripotent stem cells are a unique source of factors even in 
comparison to other traditional supportive cell populations. In addition, a global increase 
in gene expression was observed in ESCs cultured in the perfusion bioreactor, suggesting 
that the culture platform may be affecting protein expression at the level of transcriptional 
regulation. 
Finally, the impact of ESC secreted factors on adult stem cell populations ex vivo 
was established using three different cell populations that were studied in both co-culture 
with ESCs and with ESC conditioned media (Chapter 6). Cultures of bone marrow-
derived mesenchymal stem cells (MSCs) were examined in addition to more heterogeneous 
primary cells isolated from murine bone marrow and skeletal muscle. Conditioned media 
collected from ESCs at different stages of differentiation and ESCs cultured under different 
environmental settings were also directly compared to determine the impact of a shifting 
composition of paracrine factors. Mesenchymal stem cell populations and hematopoietic 
progenitors exhibited increased growth in response to ESC conditioned media, and the 
hematopoietic progenitors also demonstrated increased differentiation capacity, 
particularly to lymphoid populations. The presence of ESC conditioned medium in 
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heterogeneous cultures of primary skeletal muscle cells led to enrichment of myocytes over 
fibroblasts and reduced the differentiation of myocytes to multinucleated myotubes. 
Overall, the studies demonstrated the potent mitogenic nature of pluripotent stem cell-
derived factors across multiple adult stem cell niches. 
The development of platforms which efficiently harness stem cell paracrine factors 
will be essential for the translation of future therapies in regenerative medicine, whether 
through delivery the of regenerative factors to a dysfunctional location in vivo or by 
enabling expansion of multipotent stem cell populations for cell therapy applications. 
Through the integration of concepts in biomaterials and bioprocess engineering with stem 
cell biology and regenerative medicine, this project incorporated technology development 
with critical biological questions regarding the identity and performance of embryonic 
morphogens for expanding adult stem cell populations ex vivo. Ultimately, this project 
established pluripotent stem cells as a unique source of potent growth factors and cytokines 
which can be regulated and concentrated using engineering design parameters to enable 







A reduced capacity for regeneration often accompanies illness, injury, or aging, a 
decline that is associated with the diminished function of adult stem cell populations. 
Increasing evidence indicates that the decreased ability of adult stem cell populations to 
properly maintain and repair deteriorating tissues reflects a failure of the surrounding 
microenvironment to provide adequate support. For example, systemic factors from young 
animals restore the regenerative capacity of aged animals, indicating that the diminished 
function stems more from the aged microenvironment than from cell intrinsic changes. 
Therefore, identifying and applying signals capable of restoring functionality to 
dysfunctional stem cell niches would be a significant development for the translation of 
regenerative therapies. In addition, knowledge regarding mitogenic cues can enable the 
development of ex vivo expansion protocols to generate adequate cell numbers of adult 
stem cells for allogeneic or autologous cell therapies.  
Pluripotent embryonic stem cells (ESCs), the “youngest” cellular state, stimulate 
tissue specification and morphogenesis by secreting growth factors, cytokines, 
chemokines, and mitogens. The regenerative capacity of fetal tissue, such as its ability for 
scarless wound-healing, can be related to endogenous secreted signals during the growth 
and maturation of developing mammals. Developmental morphogenic factors involved in 
multipotent stem cell ontogeny—such as members of the wingless-type (Wnt), sonic 
hedgehog, Notch, fibroblast growth factor, bone morphogenetic protein, and insulin-like 
growth factor pathways—may enhance the function of adult stem cells. In addition, initial 
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studies transplanting stem cells in vivo suggest that many of the observed functional 
improvements were due to the transient paracrine actions of the transplanted stem cells, 
rather than the stem cells actively engrafting and replacing the damaged cellular material. 
Thus, in combination, embryonic signals may recapitulate the supportive in vivo 
environment. Therefore, the paracrine actions of ESC trophic factors are an unexplored 
source of paracrine cues to stimulate adult stem cells to regain a more “youthful” 
proliferative and/or regenerative capability. However, ESC-based therapies present 
significant challenges, such as the difficulty of controlling ESC differentiation and the 
potential for teratoma formation by transplanted ESCs. Therefore, an engineered platform 
that provides a defined environment to control ESC morphogen secretion and subsequently 
delivers ESC-derived trophic factors without cell transplantation would be a truly 
transformative regenerative therapy. 
The long term goal that motivated the work of this dissertation is to engineer 
strategies for the delivery of trophic factors derived from pluripotent stem cells as a means 
to regenerate aged, diseased, or injured tissue. The overall objective of this project was to 
develop an engineered platform for the delivery of pluripotent factors to enable factor 
identification and to stimulate adult stem cell populations ex vivo. The general hypothesis 
was that providing a defined environment via encapsulation and bioreactor parameters will 
allow the trophic secretion of ESCs to be controlled and concentrated such that exposure 
of adult stem cell populations to soluble factors derived from pluripotent 
microenvironments will promote cell survival, proliferation, and function. The rationale 
for this hypothesis was based upon the morphogenic role of ESCs during development 
which suggests that they are a potent source of secreted factors capable of providing 
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powerful rejuvenative signals to stimulate adult stem cell populations. The primary 
objective was completed and the central hypothesis investigated through the following 
specific aims: 
 
Specific Aim 1. Develop a microencapsulation-based platform for ESC culture. The 
working hypothesis was that varying encapsulation parameters, such as the configuration 
of cells and the composition of alginate beads, would lead to defined environments for ESC 
culture. The impact of alginate composition on encapsulated single ESCs and ESC 
aggregates was assessed via cell viability, cell proliferation, aggregate morphology, and 
gene/protein expression for pluripotent and lineage-specific markers. The outcome of this 
aim was the establishment of a robust culture platform which enabled well-defined, high 
density cultures of encapsulated ESC aggregates. 
 
Specific Aim 2. Investigate strategies for high density ESC culture to facilitate 
concentration and delivery of paracrine factors. The working hypothesis was that ESC 
factor secretion could be controlled via environmental conditions while trophic factors 
were concentrated through culture in a high density bioreactor. A packed bed perfusion 
bioreactor was designed, fabricated, and validated for culture of encapsulated ESCs and 
trophic factor concentration. The impact of external influences, including alginate 
composition, hypoxic culture, directed mesoderm differentiation, and perfusion culture, on 
encapsulated ESC secretion profiles was assessed via gene and protein expression. The 
outcomes of this aim were the development and validation of a novel culture platform to 
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enable delivery of a morphogen-riche perfusate and the characterization of a unique 
secretory milieu that is distinct from other supportive cell populations. 
 
Specific Aim 3. Explore the effects of ESC trophic factors on adult stem populations 
ex vivo. The working hypothesis is that delivery of pluripotent stem cell-derived 
morphogens will improve the survival, proliferation, and function of adult stem cell 
populations, including mesenchymal stem cells, hematopoietic progenitors, and skeletal 
muscle myoblasts, in an ex vivo setting. Following exposure to ESC-derived factors, 
mesenchymal stem cells were assessed for growth and morphology, hematopoietic 
progenitors were evaluated for proliferation, lineage commitment, and differentiation 
potential, and myoblasts were examined for growth and differentiation. The outcome of 
this aim is the establishment of pluripotent cell-derived factors as a novel mitogenic source 
for the ex vivo culture of adult stem cell populations. 
 
This project is innovative because the delivery of the complex potent milieu of 
concentrated trophic factors produced by pluripotent stem cells using a novel high-density 
perfusion reactor is a novel method to stimulate the growth and enhance the function of 
adult stem cells. Additionally, the development of the microencapsulation-based bioreactor 
platform for stem cell culture and trophic factor concentration is an original approach that 
can be used to study heterotypic paracrine cell interactions. The results of this project have 
a direct translational impact for expansion and transplantation of bone marrow and skeletal 
muscle-derived multipotent stem cell populations and yield novel scientific insights that 
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could lead to a more mechanistic understanding of the influence of embryonic-derived 





2.1 Pluripotent stem cells 
2.1.1 Origin and characteristics 
 Stem cells are now known to be found in nearly all tissues throughout the body and 
are defined by the signature characteristics of self-renewal and differentiation capacity. 
Pluripotent stem cells (PSCs) include embryonic stem cells (ESCs), derived from the inner 
cell mass of the pre-implantation blastocyst [1–3], and induced pluripotent stem cells 
(iPSCs), obtained by reprogramming somatic cells to a pluripotent state [4,5]. Both ESCs 
and iPSCs can expand indefinitely in vitro and differentiate into all three germ lineages 
(endoderm, mesoderm and ectoderm), consequently giving rise to cells from all tissue 
types. Pluripotent cells differ functionally from multipotent stem cells that are more 
restricted in their differentiation capacity. Common multipotent stem cells include 
mesenchymal stem cells (MSCs), which can be derived from multiple sources including 
bone marrow [6] and adipose tissue [7], and hematopoietic stem cells (HSCs), found in 
bone marrow [8] and cord blood [9]. Because most multipotent stem cells can be readily 
                                                 
 
 
1Modified from: Wilson JL, McDevitt TC. Stem cell microencapsulation for phenotypic control, 
bioprocessing, and transplantation. Biotechnol Bioeng 2013;110:667-82.  
 
2Modified from: Wilson JL, McDevitt TC. Biofunctional Hydrogels for Three-Dimensional Stem Cell 
Culture. Biology and Engineering of Stem Cell Niches (eds. Ajaykumar Vishwakarma and Jeffrey Karp, 
Designing Smart Biomaterials to Mimic & Control Stem Cell Niche section), Elsevier Press. 
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obtained from adults, autologous and allogeneic cell therapies are feasible for several 
clinical applications; however, ex vivo expansion of multipotent stem cells is limited when 
compared to the capacity for indefinite self-renewal that defines pluripotent stem cells. 
Thus, ESCs and iPSCs may represent a more practical solution for large-scale production 
of a broader range of cell therapy products. 
2.1.2 Three-dimensional stem cell culture 
 There are significant differences between the native environment of stem cell 
populations and the artificial in vitro culture platforms used by the majority of scientists 
today. For example, pluripotent stem cells exist transiently in the pre-implantation 
blastocyst constituting the inner cell mass, a tightly packed cluster of cells which is encased 
in a layer of epithelial trophoblast and surrounded by the fluid of the blastocoel cavity [2]. 
In contrast, bone marrow mesenchymal stem/stromal cells are encompassed in a semi-solid 
matrix consisting of various collagens, proteoglycans, and glycosaminoglycans [10,11]. 
Despite these distinct yet similarly complex microenvironments, in vitro studies of ESCs 
and MSCs are generally conducted in the same manner: as two-dimensional (2D) cell 
monolayers on plastic surfaces. 
In typical 2D culture, cells are specifically polarized by attachment to a plastic 
surface on one side and contact with liquid culture medium on the other. Interactions 
between neighboring cells occur laterally within a single plane, if at all, and the three-
dimensional physical cues presented by interstitial extracellular matrices are absent 
entirely. Since cell-matrix and cell-cell interactions dictate much of a cell’s behavior, it is 
logical that the attenuation of these cues can lead to cell dysfunction, and this has been 
observed in cell types ranging from liver hepatocytes to ovarian and colorectal cancer cells 
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[12–14]. Therefore, a greater emphasis on three-dimensional (3D) culture platforms for 
stem cell culture may provide more accurate insights into in vivo cell physiological function 
as well as enable more advanced applications, such as tissue-engineered constructs, 
biomanufacturing approaches, and platforms for drug discovery and toxicity testing. 
 There are several standard approaches for 3D culture of stem cells, including 
seeding of cells onto porous scaffolds or decellularized ECM from native tissues [15] and 
culture of cells within hydrogel scaffolds [16]. Additionally, material-free approaches 
exist, including the formation of scaffold-free microtissues, often in the form of spheroids 
or aggregates. Spherical aggregates are used in pluripotent stem cell cultures to promote 
spontaneous differentiation through recapitulation of developmental processes. Embryoid 
bodies (EBs), pluripotent stem cell aggregates, play pivotal roles in many differentiation 
protocols and can be used as a platform for directed differentiation [17]. Traditional 
methods for embryoid body formation include hanging drop, static and stirred suspension 
formation, methylcellulose culture, and microwell forced aggregation [18,19]. Once 
formed, aggregates can be cultured in suspension, allowing for straightforward translation 
to scalable bioreactors. In the last five years, three-dimensional aggregates of pluripotent 
stem cells have been gently coaxed to self-organize into organoid structures resembling a 
number of functional tissues, including optic cup [20,21], anterior pituitary [21], intestine 
[22], thyroid [23], and cerebral brain [24], among others. Therefore, three-dimensional 
culture of pluripotent stem cells can instigate complex morphogenic processes which likely 
coincide with the production of relevant morphogenic cues. 
2.1.3 Paracrine actions 
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Early studies in delivering stem cells to sites of injury have exhibited improved 
tissue function, which was originally attributed to differentiation of the stem cells and 
replacement of the damaged tissue. However, a recent paradigm shift has emerged 
suggesting that the beneficial effects observed following stem cell transplantation may be 
due to the cells’ transient paracrine actions more so than their engraftment and subsequent 
differentiation [25–29] (Figure 2.1). Injection of ESCs into embryos with multiple cardiac 
defects has improved the embryonic cardiac phenotype, a finding attributed to secretion of 
insulin-like growth factor 1 (IGF-1) and Wnt5a [30]. ESC transplantation has also reduced 
myocardial dysfunction in a rat model of surgically induced global ischemia, presumably 
by increasing the secretion of VEGF and interleukin-10 [31]. Additionally, in vitro studies 
have utilized ESC co-culture for expanding cardiomyocytes and corneal epithelial cells 
[32–34], observing improved proliferation and function in both cases. Conditioned media 
from ESCs was also found to improve proliferation of aged satellite cells and myoblasts 
while inhibiting differentiation [35] as well as improve survival of hematopoietic 
progenitors [36]. In addition to stem cell-derived factors, evidence suggests that systemic 
molecules present in younger animals can improve function in aged animals, as has been 
observed using the parabiotic mouse model for enhanced wound healing [37,38], 
improvement in muscle satellite cell function [39–41], rejuvenation of neural cells and 
cognitive function [42–45], and reversal of cardiac hypertrophy [46]. As pluripotent ESCs 
represent the ultimate “young” state, similar effects may be observed with the delivery of 
pluripotent stem cell-derived factors. Therefore, ESCs represent a comprehensive cell 
source capable of stimulating adult stem cell populations though the secretion of a complex 




Figure 2.1. Applications of pluripotent stem cells. Pluripotent stem cells enable many 
downstream applications, including advanced drug screening platforms, differentiation into cell 
types from all three germ lineages (endoderm, mesoderm, and ectoderm), and secretion of paracrine 
trophic factors. The translation of all applications is dependent on the development of robust 
processes for expanding pluripotent stem cells and harnessing their unique abilities. 
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2.2 Stem cell bioprocessing 
2.2.1 Microencapsulation 
 In the early 1960s, Thomas M. S. Chang drew inspiration from naturally-occurring 
aqueous partitions, such as cells and organelles, to develop a method for 
microencapsulation of biological material in natural polymers [47]. Since that time, cell 
microencapsulation has been widely researched, particularly in the field of cell 
transplantation for the treatment of endocrine disorders, such as diabetes, in which a 
continual regulation and response to physiologic stimuli is required. Encapsulation 
facilitates allogeneic and xenogeneic cell transplantation because the semi-permeable 
membrane of the capsule protects the enclosed cells from the host immune system. In 
addition to the benefits of microencapsulation for transplantation, the technology offers 
several potential advantages for stem cell expansion and differentiation. The modification 
of encapsulation material properties, such as the polymer species, type of coating, 
mechanics, and permeability, can be used to control the stem cell microenvironment, 
allowing for either the maintenance of potency or directed differentiation toward a desired 
lineage. In addition, encapsulated stem cells can be expanded in scalable suspension 
bioreactor systems without being damaged by the presence of hydrodynamic shear forces. 
Consequently, microencapsulation can play an important role throughout the pipeline of 
production and delivery of stem cell therapies (Figure 1.2). 
 The general encapsulation process involves the formation of cell-containing 
droplets, the crosslinking of droplets, and often the coating of droplets with a stabilizing 
membrane. Hydrogels are the most common material used in encapsulation for several 




Figure 2.2. Stem cell microencapsulation approaches. Microencapsulation of stem cells permits 
mass transport of nutrients and secretory products while restricting the passage of immune 
molecules and cells and shielding from physical forces. Modification of various capsule parameters 
can modulate stem cell response(s) while simultaneously enabling expansion in scalable suspension 
bioreactors for bioprocessing and transplantation in vivo. 
 
minimal mass transfer limitations. Second, hydrogel materials tend to be soft and flexible, 
reducing mechanical friction on adjacent tissues upon transplantation. Third, the high water 
content leads to hydrophilic interactions, which reduce interfacial tension, protein 
adsorption, and cellular adhesion while enhancing biocompatibility. Natural polymeric 
materials are used more often than synthetic polymers because they are more 
biocompatible and require milder crosslinking processes (i.e. those that take place under 
aqueous and physiological conditions without the presence of reactive species). However, 
a reduction in the stability of the microcapsule can occur using natural polymers when 
compared to results obtained with synthetic polymers [48]. 
The general formulations of microcapsules include solid matrix beads, solid matrix 
beads with an external coating, liquid core capsules, and direct conformal coating. Liquid 
core capsules are fashioned by liquefying the center of a solid matrix bead as the outer 
membrane is stabilized by a thin polyion coating [49]. Conformal coated microcapsules are 
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formed by constructing a thin membrane surrounding individual cells or pre-formed cell 
aggregates, thereby minimizing the empty capsule volume [50]. In some cases, 
encapsulated single cells will aggregate into spheroids within a capsule. The fashion in 
which cells form aggregates within microcapsules is based on the mechanical restriction of 
the hydrogel [51]. In solid matrix beads, encapsulated cells are more physically constrained 
and therefore proliferate to form smaller spheroids with multiple foci. In liquid core 
capsules, cell movement and proliferation are less restricted, and the cells can therefore 
aggregate and proliferate as a single large spheroid [52]. As cells proliferate in liquid core 
capsules, the capsules tend to swell, but excessive swelling can be restricted with the 
addition of a polymeric surface coating [53]. 
2.2.2 Alginate as a biomaterial for microencapsulation 
Alginate, a natural polymer purified from brown seaweed, is the most common 
material used for microencapsulation due to its abundance, biocompatibility, and gentle 
cross-linking procedure. Alginate is made up of two anionic monomers, α-L-guluronic acid 
(G) and β-D-mannuronic acid (M), which are arranged in both homopolymeric regions 
(GG blocks and MM blocks) and mixed monomeric regions (MG blocks) [54]. Alginate 
can be cross-linked by several different divalent cations, including calcium and barium. 
Calcium (Ca2+) crosslinks only G residues, therefore, alginates with higher G content and 
longer GG blocks produce stiffer, more durable capsules when crosslinked with Ca2+ than 
alginates with greater M content. Alternatively, barium crosslinks alginate by binding to 
both G and M residues, thus yielding stronger and more uniform crosslinking than Ca2+ 
alone can provide [55]. The molecular weight of alginate also impacts its physical 
properties, with higher molecular weight alginate leading to capsules with greater 
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mechanical stability than lower molecular weight alginate [48]. However, the relative 
impact on the mechanical stability with increasing molecular weight is not as profound as 
increasing either the G content or concentration of alginate [52]. The stability of alginate 
capsules generally weakens over time due to exposure to certain species in the cell culture 
medium or in vivo, including chelating agents (e.g. sodium citrate, EDTA, phosphate) or 
monovalent ions (e.g. sodium), which can displace the ionic interactions created by the 
divalent cross-linkers [56]. Although alginate has many favorable properties for cell 
encapsulation, native isoforms are not able to directly interact with cells since alginate 
lacks adhesive moieties. Therefore, it is primarily the mechanical properties of native 
alginate that impact its relationship with cells. The mechanical properties (e.g. elastic 
modulus, viscosity, osmotic tolerance/swelling) are generally based on the chemical 
properties of the alginate (e.g. G vs. M composition, molecular weight, concentration). 
Thus, when deciding on an alginate for microencapsulation, the physiochemical properties 
should be carefully considered depending on the intended function(s) of the system. 
Alginate encapsulation alone is usually insufficient to completely shield cells from 
the immune system in vivo because of mechanical and chemical instability in addition to 
poor resistance to osmotic swelling, which often results in cell escape. Therefore, coating 
the exterior of alginate capsules to reduce the permeability to immune cells and proteins 
material while simultaneously increasing the mechanical stability and biocompatibility of 
the capsule is often performed by polyelectrolyte complexation, where two oppositely 
charged polymers are complexed to form a thin membrane layer with a thickness on the 
order of 10-100 μm [57]. Since alginate is a polyanion, the coating materials are usually 
polycations, with poly-L-lysine (PLL) being the most common since Lim and Sun 
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introduced the alginate-PLL system in 1980 [58]. PLL binds to both the M and G blocks 
through ionic interactions, though it typically binds more tightly to alginate with higher M 
content as there are more alginate moieties available for binding, creating a coating that is 
thicker and less permeable [59]. To improve biocompatibility, the positive PLL charges on 
the exterior of the capsule are sometimes neutralized through incubation with additional 
alginate, forming “APA” (alginate-PLL-alginate) beads. Chitosan, polyethylene glycol 
(PEG), and other polycations are sometimes used as alternatives to PLL; however PLL 
remains the most commonly used polymer due to its historical prevalence and creation of 
mechanically resistant capsules [60]. 
The two most common methods for hydrogel bead formation are emulsification and 
extrusion. The emulsification process involves creating a dispersion of a polymeric 
aqueous phase in an immiscible phase (often oil), followed by gelation through addition of 
a cross-linking agent or cooling of the mixture. There are several challenges with this 
approach, including the presence of shear forces during mixing that may harm cells and the 
insolubility of some gelling agents (e.g. CaCl2) in the immiscible phase. The extrusion 
process involves forcing a cell-polymer solution through a small aperture, such as a needle 
or an area of small-diameter tubing, into a solution containing the cross-linker to stabilize 
bead formation. Solely adding droplets to a cross-linking bath generates large particles (on 
the order of millimeters) and is feasible only for low viscosity solutions. In order to form 
smaller, more uniform beads with higher viscosity solutions, a voltage gradient between 
the needle and cross-linking solution can be applied to overcome droplet surface tension 
and therefore produce large quantities of smaller beads [61]. Alternatively, a constant 
vibration can be applied to a laminar liquid jet to produce small, uniform capsules [62,63]. 
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A coaxial gas flow can also be used to form beads by shearing droplets with compressed 
gas that flows around the needle exit. An additional extrusion approach is the co-flowing 
of two immiscible liquid streams in a coaxial tube, one in the aqueous phase containing the 
cells/polymer and the other a liquid paraffin solution [64]. The paraffin solution, present in 
the outer coaxial tube, shears the polymer drops as they are extruded through a nozzle. 
Recently, microfluidics and microlithography have been introduced as systematic 
processes for more homogeneous and controlled capsule formation, though they currently 
have lower throughput than the aforementioned macro-scale methods [49]. 
2.2.3 Microencapsulation of pluripotent stem cells 
Microencapsulation approaches have been explored as an approach to maintain the 
viability and pluripotency of microencapsulated ESCs. Agarose microencapsulation 
prevents embryoid body (EB) agglomeration in culture, allowing for higher density 
cultures without the formation of aggregates with large necrotic cores [65]. Murine ESCs 
(mESCs) were observed to retain >90% viability after 20 days in alginate-PLL capsules 
[66], with liquid core capsules leading to enhanced proliferation and viability compared to 
unliquefied capsules [67]. An altered liquid core configuration in which smaller alginate 
microcapsules containing mESCs were encapsulated in larger agarose capsules, followed 
by liquefaction of the alginate core, found that the enclosed mESCs formed EB-like 
spheroids and stained heterogeneously for alkaline phosphatase, suggesting a mixture of 
undifferentiated cells and differentiated progeny [68]. An additional study found that 
expression of the pluripotency markers OCT-4, SSEA-1, and alkaline phosphatase were 
maintained by mESCs for two weeks in vitro in APA liquid core capsules, though a 
decrease in pluripotency marker expression was observed once the capsules were 
 17 
implanted in vivo [67]. Human ESCs (hESCs) have also been maintained in alginate-
gelatin microcapsules for up to 260 days without experiencing significant decreases in 
viability or pluripotency [69] or as aggregates [70], thereby supporting future endeavors in 
the large-scale production of hESCs. 
2.2.4 Bioreactor platforms 
 Several bioreactor systems have been employed for experimental studies of 
microencapsulated stem cells, including spinner flasks, which simulate larger-volume 
stirred tank bioreactors. Ex vivo expansion of APA encapsulated bone marrow HSCs using 
spinner flasks with continuous media exchange yielded a 12-24 fold multilineage 
expansion within 19 days [71]. In addition to ex vivo expansion of HSCs, the differentiation 
of mESCs to hematopoietic progenitors while encapsulated in agarose microcapsules was 
also performed in spinner flasks [65]. Cardiac differentiation protocols, which usually 
require an EB suspension culture step, have likewise been developed for 
microencapsulated mESCs in spinner flasks [72,73]. Spinner flask culture of 
microencapsulated hESCs found that while encapsulation of single hESCs led to poor 
viability, encapsulation of hESC aggregates and hESCs on microcarriers allowed for 
maintenance of viability and pluripotency for up to two weeks in suspension culture [70]. 
In addition to stirred tank bioreactors, other reactor configurations have been investigated, 
including the high aspect ratio vessel (HARV), a rotary microgravity reactor that operates 
under the laminar flow regime to lessen the impact of mechanical forces, which was used 
with mESC-containing alginate microcapsules to create mineralized constructs for bone 
tissue engineering [74]. A fixed bed reactor in which CellBeads, a commercially available 
product consisting of hMSC aggregates in alginate microcapsules, were packed and 
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perfused with culture medium was able to maintain viability and induce adipogenic 
differentiation with similar results to stirred suspension controls [75]. Other bioreactor 
configurations have been developed for the direct assembly of tissue engineered constructs, 
including a tubular perfusion system of aggregated alginate beads containing hMSCs 
[76,77]. The initial results obtained from bioreactor studies suggest that the development 
of novel bioreactor systems may lead to improved bioprocess efficiency through better 
maintenance of viability or more efficient directed differentiation than can be obtained with 
static cultures. 
2.3 Adult stem cell niche regulation 
2.3.1 Function of stem cell niches 
 Multipotent stem cell populations, including hematopoietic stem cells, 
mesenchymal stem cells, satellite cells, and neural stem cells, exist throughout life and act 
to maintain and repair many tissue types. Almost 40 years ago, the concept of a stem cell 
niche was proposed as a fixed region responsible for maintaining the self-renewal capacity 
of the resident stem cell pool [78]. While the standard description and purpose of the stem 
cell niche has not changed considerably since its initial definition, the complexity and 
number of components seems to be ceaselessly increasing as our understanding of stem 
cell anatomy and behavior improve. In general, the niche consists of specific soluble 
molecules, a particular extracellular matrix composition, and direct or indirect interactions 
with other cell types that all function at the structural, topographical, environmental, and 
chemical level [79–81]. 
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 Hematopoietic stem cells, which were the first stem cells to be identified and 
transplanted, give rise to all blood and immune cells and are responsible for continually 
replenishing these cell populations for functions ranging from oxygen transport throughout 
the body (via erythrocytes) to adaptive immune responses (via T cells and B cells). Though 
the mature cells derived from HSCs through the process of hematopoiesis are found 
throughout circulation in the body, the HSCs themselves are housed primarily along the 
endosteal surface of trabecular bone. This anatomical location permits easy access to 
circulation for both the HSCs themselves and their differentiated progeny [82,83]. The 
bone marrow niche exists as a semi-solid matrix consisting of various collagens, 
proteoglycans, glycosaminoglycans, and calcium minerals to house the resident HSCs 
[10,11,84,85]. Many other cell types also reside within the bone marrow niche, including 
mesenchymal stem/stromal cells (MSCs), endothelial progenitor cells, osteoblasts, 
adipocytes, nerve cells, and Cxcl12-abundant reticular (CAR) cells [86]. High levels of 
regulatory cytokines (e.g. SDF-1, SCF, interleukins, TPO) are present within the niche in 
addition to ligands of the Notch and Wnt signaling pathways [82,84,87–89]. It is worth 
noting that though the bone marrow is the anatomical location for post-natal adult HSCs, 
the HSC niche during development shifts between multiple tissue regions, including the 
aorta-gonad-meonephros region, the yolk sac, the placenta, the fetal liver, and the spleen 
[90]. Therefore, recapitulating cues found in these early transient environments might be a 
novel approach to rejuvenate HSC function.  
Similar to HSCs and other adult stem cell populations, skeletal muscle satellite cells 
do not act autonomously and require structural and biochemical signals along with support 
from their niche. Satellite cells are generally located along myofibers underneath the 
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surrounding basal lamina and outside the plasma membrane of the myofiber [91]. Many 
soluble cues, including Wnts, FGFs, IGFs, HGF, EGFs, SDF-1α, and Notch ligand, are 
exchanged between satellite cells and the surrounding myofibers, interstitial cells, and 
endothelial cells, and the identities and concentrations of the paracrine factors are 
responsible for maintaining quiescence, prompting self-renewal, and instigating 
differentiation [92–97]. In addition to the niches of HSCs and satellite cells, stem cell 
niches have also been identified for a number of tissue specific stem cells, including those 
of the intestine [98,99], skin [100], and nervous system [101].  
2.3.2 Targeting dysregulated stem cell niches 
 The elegant and specified functionalities of stem cell niches are perhaps most 
appreciated when compared to systems in which the niche function has gone awry. In fact, 
there is mounting evidence linking dysregulated stem cell niches with many pathological 
occurrences, including aging [40,102–104], tissue degeneration [105], and tumor 
formation [106–108]. Certain diseases are also associated with improper niche function, 
such as is the case with the skin disorder epidermolysis bullosa in which the extracellular 
matrix composition of the basement membrane does not support the resident epidermal 
stem cells [109,110]. Therefore, targeting stem cell niches in order to promote endogenous 
regeneration is a promising strategy for a number of distinct applications.  
 There have been several clinical therapeutics based on the concept of targeting the 
stem cell niche, with many in particularly focusing on the bone marrow compartment [111]. 
The co-delivery of parathyroid hormone with transplanted umbilical cord blood was 
hypothesized to stimulate the resident osteoblasts in order to increase the number of HSCs, 
as activated osteoblasts have increased expression of Notch ligand which can in turn 
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stimulate HSC proliferation. Despite promising results observed in mice, no significant 
human patient outcomes were observed [112]. Several parallel approaches have been 
investigated for treating bone marrow failure due to severe aplastic anemia. Treatment with 
eltrombopag, a mimic of the stimulatory cytokine thrombopoietin, was recently observed 
to improve hematopoiesis in patients with refractory aplastic anemia [113], while 
immunosuppression with agents including antithymocyte globulin and cyclosporine are 
currently approved to target the immune cells in the niche [114]. To induce mobilization 
of HSCs from the niche for isolation and subsequent transplantation, the cytokines G-CSF 
and GM-CSF, or the small molecule inhibitor AMD3100, are used to inhibit the 
CXCR4/CXCL12 chemotaxis pathway normally active in the bone marrow niche [115]. 
These clinical examples of targeting different aspects of the bone marrow niche in order to 
induce a given response are not successful in every patient, which may be due to patient-
to-patient variability in the niche composition and response.   
2.3.3 Ex vivo expansion of adult stem cells 
 Unlike pluripotent stem cells, multipotent stem cells are not capable of extensive 
self-renewal in vitro. There is tremendous need for expansion protocols for multipotent 
adult stem cell populations, either for autologous cell therapies in which a patient’s own 
stem cell pool must be expanded, or for allogeneic cell therapies in which large banks of 
cells are desired.  
For example, while HSCs are by far the most common stem cells to be clinically 
transplanted, HSC transplants are primarily dependent on the availability of allogeneic 
donors with matching HLA types. Umbilical cord blood represents an additional source of 
HSCs, but there are not enough cells in a single cord for an adult patient, necessitating the 
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pooling of the cells from multiple cords. The ability to expand HSCs ex vivo would 
therefore reduce the dependence on finding a donor match and improve availability of cells 
to patients. Unfortunately, attempts at expansion of HSCs, even with the addition of 
purified growth factors known to regulate HSCs, have had limited success [116–118], as 
HSCs must be expanded quickly or risk losing their proliferative and blood lineage 
potential. Expansion of ST-HSCs rather than the desired LT-HSCs is a common issue, as 
is favoring expansion of lymphoid over myeloid progenitors [119,120]. Some success has 
been observed when HSCs are co-cultured with MSCs [121–124], since MSCs are stromal 
cells that are a natural part of the HSC microenvironment. However, compared with 
pluripotent stem cells, MSCs are not as amenable to scalable culture due to their reduced 
capacity for growth in vitro and significant donor-to-donor variability [125,126]. Classical 
cytokines, such as stem cell factor (SCF), thrombopoietin (TPO), interleukins (ILs), and 
Flt3-ligand (Flt3L), have been used previously to stimulate expansion. However, due to 
insufficient and unreliable HSC expansion with traditional cytokines, new emphasis is 
being placed on the use of developmental factors, such as Wnt proteins, Notch ligand, bone 
morphogenetic proteins (BMPs), and fibroblast growth factors (FGFs) [117,120,127,128]. 
 Similar challenges with ex vivo expansion are observed with primary muscle 
populations, with a decreased capacity for re-engraftment and regeneration observed in 
satellite cell-derived myoblasts following expansion ex vivo [129–132]. Current strategies 
to expand mouse myoblasts cultured in vitro include the presentation of Notch-ligand [133] 
and the use of hydrogel culture substrates with a low elastic modulus that better mimics 
the native physiological environment [134], while recent advances in expanding human 
muscle stem cells has been achieved through inhibition of p38 MAPK [135]. To overcome 
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the current limitations, an increased understanding of the components and interactions in 
the stem cell niche will likely translate to more effective protocols for the maintenance and 
expansion of adult stem cell populations ex vivo.   
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CHAPTER 3 
ALGINATE ENCAPSULATION PARAMETERS INFLUENCE 
MICROENCAPSULATED EMBRYONIC STEM CELL 
PHENOTYPE3 
3.1 Introduction 
Stem cells, including pluripotent embryonic stem cells (ESCs), have tremendous 
potential as tools for regenerative medicine and drug discovery. However, there are many 
challenges to overcome before stem cell-derived therapies can be made broadly available, 
including the lack of processes to manufacture viable and homogenous cell populations of 
sufficient numbers [136]. Currently, the large scale production of mammalian cells 
typically occurs in suspension bioreactors, which impart hydrodynamic forces that can 
adversely affect stem cell viability and influence their phenotype [137–140]. Stem cells are 
very sensitive to environmental stimuli, as external signals in the culture environment 
provide cues that determine whether stem cells continue to self-renew or differentiate into 
specific cell types. Because most current bioprocesses are designed around suspension 
culture systems, investigation into systems to culture anchorage-dependent stem cells in 
suspension is critical for translating process technology and for achieving the high cell 
densities required for therapeutic doses [141,142]. In addition, the ability to culture stem 
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cells at high density would enable concentration of cell secreted factors to support 
paracrine-based therapies. 
One approach to the challenge of scalable bioprocessing is to encapsulate stem cells 
in hydrogels, such as alginate, to better control microenvironmental cues and enable 
suspension culture. Microencapsulation has been used for decades to protect enclosed cells 
from the host immune system upon transplantation, but it can also shield cells from 
hydrodynamic shear forces found in bioreactor environments and prevent agglomeration 
of stem cell aggregates while permitting diffusion of nutrients and oxygen through the 
encapsulation material [143]. Several investigations of ESC microencapsulation, mostly 
with single cells, have been previously performed with alginate capsule formulations 
[67,69,70], and directed differentiation has been achieved, in most cases through soluble 
factor addition, toward osteogenic [74,144], cardiac [72,73], hematopoietic [145,146], 
neural [147], pancreatic [148,149], and hepatocytic lineages [66,150]. Although most 
previous studies have examined the encapsulation of single ESCs, aggregates of ESCs are 
important to investigate in addition to single cells for a number of reasons. First, using pre-
formed aggregates provides a consistent initial size that can be compared directly to 
unencapsulated controls, which can also be cultured in suspension. Though 
microencapsulation-based protocols have been developed to form multicellular aggregates 
[67,68,151], using microwell formation [19] may provide more consistency so that the 
impact of encapsulation parameters on cell phenotype is not confounded by the additional 
parameters of aggregate size or the aggregation kinetics [152]. Furthermore, 
microencapsulation of aggregates has been previously determined to improve cell viability 
[70], as ESCs generally require maintenance of intercellular adhesions for optimal survival 
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[153]. Finally, culture as 3D aggregates can initiate differentiation of ESCs as embryoid 
bodies (EBs) [17,154], providing a platform to study the impact of microencapsulation 
parameters on differentiation trajectory.  
While encapsulation has been explored as a tool for stem cell expansion and 
directed differentiation, the impact of alginate encapsulation parameters on stem cell 
phenotype has not been systematically examined. Alginate is a biocompatible polymer 
purified from brown seaweed that is commonly used to encapsulate mammalian cells due 
to its relative abundance and mild cross-linking requirements. Alginate is composed of two 
anionic monomers, α-L-guluronic acid (G) and β-D-mannuronic acid (M), which are 
arranged in both homopolymeric regions (GG blocks and MM blocks) and mixed 
monomeric regions (MG blocks) [54]. Cross-linking occurs at G residues through binding 
of divalent cations such as calcium, therefore alginates with higher G content and longer 
GG blocks produce stiffer, more porous beads due to greater cross-linking than alginates 
with higher M content. Because native alginate is non-adhesive and therefore cannot 
interact directly with cells, the physical and chemical properties of the polymer dictate the 
interactions with the enclosed cells. A handful of studies have examined the impact of G 
and M content on cell proliferation, metabolism, and secretion. Experiments with murine 
insulinoma βTC3 cells found that alginates with high G content inhibited cell growth, 
leading to decreased metabolic and secretory activity [155]. Alternatively, studies of 
encapsulated neural stem cells observed improved secretion of neurotrophic factors when 
the cells were cultured in alginate with high G content, citing poor capsule stability in 
alginate with high M content [156]. Despite such examples of reported differences based 
on G and M content, most studies do not specify the composition of alginate species used, 
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thus provoking questions about the potential influence of the encapsulation material 
utilized on the phenotype of the enclosed cells.  
An additional microencapsulation property that can be varied is the presence of a 
coating surrounding the capsule, typically with a polycation like poly-L-lysine (PLL), 
which has historically served as an added barrier to the host immune system upon 
transplantation by decreasing the permeability of larger molecules, such as antibodies, into 
and out of the bead [58]. However, coating with PLL also confers additional mechanical 
stability [57,60,157,158] which can be beneficial for maintaining capsule integrity over 
time. Many studies have described problems with single cells escaping or leaking out of 
the capsules [53,73,159,160], an issue which may be ameliorated through PLL coating. 
However, the issue of cell escape may be increased when encapsulating pre-formed 
aggregates due to their large size and potential proximity to the bead edge, and it has yet 
to be determined whether addition of PLL is sufficient to prevent escape in this context, a 
question also relevant for the encapsulation of other aggregated cells. 
Overall, the inconsistency in the composition of alginate and use of a coating layer 
in previous studies with microencapsulated cells raises questions about whether disparate 
results ensue from differing material compositions. The potential impacts of 
microencapsulation material on cell phenotype are particularly relevant for the culture of 
ESCs due to their increased sensitivities to the surrounding physical microenvironment 
[161]. Thus, the objective of this study was to systematically examine the impact of varying 
alginate compositions on microencapsulated ESC expansion and phenotype. Single cells 
and pre-formed aggregates of murine ESCs were encapsulated in alginate microbeads 
composed of a high or low ratio of G to M residues, with and without a PLL coating. 
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Characterization of the mass transport and mechanical properties of each bead composition 
was performed, as well as analysis of encapsulated cell viability, morphology, and 
phenotype via gene and protein expression. The results of this study revealed distinctions 
in the growth rate, morphology, differentiation trajectories, and secretion activities of ESCs 
in each of the encapsulated formats over 14 days of culture, suggesting that alginate bead 
composition is an important parameter to consider when designing microencapsulation-
based expansion and directed differentiation protocols. 
3.2 Materials and methods 
3.2.1 Microbead and microcapsule formation 
Two different medium viscosity alginates were used: ultrapure MVG (Pronova) 
which contains greater than 60% G residues (High G) and ultrapure MVM (Pronova) which 
contains greater than 50% M residues (High M). Alginate solutions were prepared at 1.5 
wt% in calcium-free DMEM (Gibco) and autoclaved for sterilization no more than one day 
before use. An electrostatic bead generator (Nisco) was utilized for encapsulation. The 
alginate solution was extruded through a 400 μm nozzle using a syringe pump at a flow 
rate of 6 mL/hour and a voltage of 10 kV to produce beads that were dropped into a stirred 
bath of 100 mM calcium chloride (EMD) to crosslink the polymer droplet solution. The 
beads were washed three times with serum-free media (5 mL per mL of alginate beads) 
prior to downstream culture. To add a poly-L-lysine (PLL) coating, the beads were coated 
with variable concentrations of PLL (MW 15,000-30,000; Sigma) (1 mL per mL of alginate 
beads) for 2 minutes prior to three additional media rinses. This low concentration and 
short incubation time facilitated dissolution of the beads at a later time point, whereas 
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longer incubation times or higher concentrations prevented the retrieval of encapsulated 
cells. Non-coated beads were dissolved with a 5 minute incubation with 55 mM sodium 
citrate, while the PLL-coated beads required a 10 minute incubation with TrypLETM 
(Invitrogen) prior to the 5 minute incubation with 55 mM sodium citrate. To form solid-
core PLL-coated beads, the beads were incubated with 0.1% PLL for 10 minutes followed 
by incubation with 0.15% alginate for 10 minutes. To form liquid-core PLL-coated beads, 
the solid-core beads were additionally incubated with 55 mM sodium citrate for five 
minutes to liquefy the center. The solid-core and liquid-core beads could not be easily 
dissolved post-formation. An additional technique to form liquid-core beads was also 
examined, was adapted from Zhao et al in which a “shell” of 2% alginate with 250 mM 
mannitol in PBS was pushed through the outer region (21 gauge) of a coxial nozzle, while 
a 1% carboxymethyl cellulose with 0.25 M mannitol in PBS was simultaneously pushed 
through the inner region (28 gauge) of the coaxial nozzle [162].  
3.2.2 Embryonic stem cell culture 
Murine ESCs (D3 cell line) were cultured on tissue culture treated polystyrene 
dishes (Corning) adsorbed with 0.1% gelatin (EmbryoMax). Undifferentiated ESC culture 
media consisted of Dulbecco’s modified Eagle’s medium (DMEM) (Mediatech) 
supplemented with 15% fetal bovine serum (Hyclone), 100 U/mL penicillin, 100 μg/mL 
streptomycin, and 0.25 μg/mL amphotericin (Mediatech), 2 mM L-glutamine (Mediatech), 
1x MEM non-essential amino acid solution (Mediatech), 0.1 mM 2-mercaptoethanol 
(Fisher Scientific), and 103 U/mL of leukemia inhibitory factor (LIF) (ESGRO). Cultures 
were replenished with fresh media every other day (complete media exchance) and 
passaged prior to reaching 70% confluence. 
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3.2.3 ESC aggregate formation and culture 
A single cell suspension of undifferentiated ESCs was obtained through 
dissociation of monolayer cultures with 0.05% trypsin-EDTA (Mediatech). Defined, 
serum-free N2B27 media [163] was used for all aggregate cultures and consisted of 
DMEM/F12 (50/50) medium (Gibco) supplemented with N2 (Gibco), 25 μg/L bovine 
serum albumin (BSA), 100 U/mL penicillin, 100 μg/mL streptomycin, and 0.25 μg/mL 
amphotericin (Mediatech), 2 mM L-glutamine (Mediatech), all combined 1:1 with 
Neurobasal medium (Gibco) supplemented with B27 (Gibco). N2B27 basal media has been 
widely used by several groups for a number of different applications, including 
undifferentiated ESC culture [164], differentiation of ESCs to insulin-producing cells 
[149], and hematopoietic differentiation of ESCs [146]. Additionally, neural ectoderm 
differentiation is considered the “default” pathway for ESC differentiation [165] in the 
absence of any exogenous factors, thus N2B27 media is an appropriate choice for basal 
media to examine ESC differentiation. Aggregation of ESCs was achieved by 
centrifugation (200 rcf) of ESCs into 400 μm square polydimethylsiloxane (PDMS) micro-
wells (AggrewellTM, Stem Cell Technologies) as previously reported [19,152]. The cell 
seeding density yielded approximately 500 cells per individual well. The ESCs were 
incubated in the wells for approximately 20 hours in serum-free N2B27 culture media to 
allow for aggregate formation. The resulting aggregate population was either immediately 
transferred to suspension culture (approximately 1500 aggregates in 10 mL of serum-free 
culture media) for the unencapsulated condition or transferred after subsequent 
encapsulation. Aggregates were cultured in sterile 100 x 15 mm bacteriological grade 
polystyrene Petri dishes (BD) and maintained on rotary orbital shakers [166] at ~45 rpm. 
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A 90% media exchange was performed every three days following gravity-induced 
sedimentation of the aggregates in 15 mL conical tubes. Suspension cultures were 
maintained for up to 14 days of differentiation. 
3.2.4 Single cell and aggregate microencapsulation 
Single cells were resuspended in 1.5% sterile alginate warmed to 37° at a density 
of 5 x 106 cell/mL of alginate, while aggregates were re-suspended at a density of 12,000 
aggregates per mL (approximately 6 x 106 cells/mL), as this density balanced the number 
of empty beads with beads containing multiple aggregates. Alginate beads were formed 
using the electrostatic bead generator and processed as described in section 3.2.1. All 
encapsulated cells were cultured in serum-free N2B27 media on a rotary orbital shaker as 
previously described in section 3.2.3. 
3.2.5 Mass transport characterization 
 To assess the diffusion of molecules out of the alginate beads, fluorescent dextran 
molecules of 3 kDa, 10 kDa, and 70 kDa (Life Technologies) were utilized. Alginate beads 
of varying compositions were incubated with 100 µM dextran solutions for 2 hours. After 
the 2 hour incubation, the beads were removed from the dextran solution using a cell 
strainer and added to a volume of fresh PBS. Samples of the PBS solution were taken every 
30 seconds for 20 minutes in addition to 25 minute, 30 minute, and 40 minute time points. 
The collected samples were read on a Synergy H4 plate reader (Biotek) at the appropriate 
excitation and emission wavelengths and related to concentration based on standard curves 
created from known concentrations of fluorescent dextran. 
3.2.6 Mechanical characterization 
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Alginate beads of both High G and High M were formed (without cells) and coated with 
PLL as described in section 3.2.1. The beads were maintained in serum-free (N2B27) 
media on a rotary orbital shaker to simulate conditions experienced during culture. At days 
1, 7, and 14 following formation, the mechanical properties were assessed through micron-
scale parallel-plate compression using a CellScale MicroSquisher and the associated 
SquisherJoy software [167]. The upper compression plate of a 302.8 μm cantilever 
compressed the samples at 40% strain over a period of 40 seconds, held at constant 
deformation for 10 seconds, and released over a period of 40 seconds to document the 
magnitude of hysteresis. To determine the Young’s modulus, Hertzian theory for non-
adhesive elastic contact was used to fit a linear regression line to 30 data points above and 
below the 20% strain data point on the plot of force (F) vs. deformation2/3 (d). The resultant 
slope in addition to the initial radius (R) of the bead was used to calculate the Young’s 
modulus of the sample (E), as described by the following standard expression:  
 
During testing, all samples were held in a PBS fluid bath (pH 7.4 with 0.1 g/L Ca2+ and 0.1 
g/L Mg2+). 
3.2.7 Cell viability staining and imaging 
Cell viability was assessed using a LIVE/DEAD kit (Molecular Probes Inc., 
Eugene, OR). Samples were incubated in PBS containing 0.1 μM calcein AM and 8 μM 
ethidium homodimer-1 at 4°C for 1 hour. The samples were washed with PBS, transferred 
to a glass-bottomed 24-well plate, and immediately imaged using a Zeiss LSM 700-405 






3.2.8 Cell number quantification 
Samples were collected from each group at days 4, 7, 10, and 14 of differentiation. 
Encapsulated aggregates were released from beads through 10 minute incubation with 
TrypLETM (Invitrogen) for PLL-coated beads only, trituration, and 5 minute incubation 
with 55 mM sodium citrate (Sigma) for all beads, as previously described [73]. The cells 
were centrifuged at 200 rcf for 5 minutes and rinsed 3x with PBS. Cells from all conditions 
were pelleted at 375 rcf for 4 minutes followed by supernatant removal and storage at -
20°C. A CyQUANT Cell Proliferation Assay Kit (Molecular Probes Inc., Eugene, OR) was 
used to determine cell number, with a standard curve created using undifferentiated ESCs 
that were counted using a hemocytometer. The fluorescence (480 nm excitation, 520 nm 
emission) indicating DNA content was read using a Synergy H4 plate reader (Biotek). The 
net growth rate (μnet) was determined by examining change in cell density (X) over given 
periods of time (t) using the following standard expression:  
 
3.2.9 Histological analysis 
Encapsulated and unencapsulated aggregates were sampled at days 4, 7, and 14 of 
differentiation, rinsed with PBS, fixed in 4% paraformaldehyde for 30 minutes with 
rotation at room temperature, rinsed with PBS, and stored at 4°C. Fixed aggregates were 
embedded in Histogel (Richard-Allen Scientific, Kalamazoo, MI), processed via a series 
of graded ethanol and xylene rinses, and embedded in paraffin. Paraffin-embedded samples 
were sectioned at a thickness of 5 μm using a rotary microtome (Microtom HM310). For 






ethanol concentrations, followed by staining with hematoxylin and eosin (H&E). Stained 
sections were imaged using a Nikon Eclipse 80i equipped with a SpotFlex digital camera 
(Diagnostic Instruments). 
3.2.10 Quantitative real time PCR 
Encapsulated aggregates were released from beads through 10 minute incubation 
with TrypLETM (Invitrogen) for PLL-coated capsules only, trituration, and 5 minute 
incubation with 55 mM sodium citrate (Sigma) for all beads. The cells were centrifuged at 
200 rcf and rinsed 3x with PBS to remove residual PLL. RNA was extracted from the 
aggregates with the RNeasy Mini kit (Qiagen Inc, Valencia, CA). The RNA (300 
ng/sample) was converted to complementary DNA using the iScript cDNA synthesis kit 
(Bio-Rad, Hercules, CA) and analyzed using real time PCR (MyIQ cycler, Bio-Rad). 
Forward and reverse primers for 18s, Oct4, Nanog, Pax6, AFP, MLC-2v, and Flk1 were 
designed with Beacon Designer software (sequences and conditions are given in Table 3.1) 
and purchased from Invitrogen. Oct4 and Nanog gene expression were calculated with 
respect to undifferentiated ESC expression levels as previously described [168]. Pax6, 
AFP, MLC-2v, and Flk1 concentrations were determined using a standard curve and 
normalized to 18s expression levels. 
Table 3.1. Primer sequences for quantitative real-time PCR analysis 
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3.2.11 Immunofluorescent staining 
Encapsulated and unencapsulated aggregates were sampled at days 4, 7, and 14 of 
differentiation, rinsed with PBS, fixed in 4% paraformaldehyde for 30 minutes with 
rotation at room temperature, rinsed with PBS, and stored at 4°C. For whole mount 
imaging, the fixed aggregates were washed 3x with block buffer (2% donkey serum, 0.1% 
Tween-20 in PBS) prior to permeabilization in 1.5% Triton-X 100 for 30 minutes. The 
aggregates were then re-fixed in 4% paraformaldehyde for 15 minutes, blocked for 1-3 
hours at room temperature, and incubated with primary antibodies against OCT-4 (Santa 
Cruz Biotechnology sc-8628; goat polyclonal; 1:100) and SSEA-1 (Santa Cruz 
Biotechnology sc-21702; mouse monoclonal; 1:100) overnight at 4°C. The following day, 
the aggregates were washed 3x with block buffer and incubated with secondary antibodies 
(1:200 Alexa Fluor 555 donkey anti-goat, 1:200 Alexa Fluor 488 donkey anti-mouse) and 
Hoechst (Life Technologies; 1:100) for 4 hours at room temperature prior to 3x washes in 
block buffer and imaging. For histological sectioning, fixed aggregates were embedded in 
Histogel (Richard-Allen Scientific, Kalamazoo, MI) and subject to graded sucrose and 
OCT infiltration prior to rapid freezing in a dry ice-ethanol bath and storage at -80°C. OCT-
embedded samples were sectioned at a thickness of 10 μm using a CryoStar NX70 cryostat 
and allowed to dry at room temperature. Each section was surrounded using a PAP 
hydrophobic barrier pen and rinsed with PBS 3x for 5 minutes. The slides were blocked 
and permeabilized with 3% donkey serum and 0.05% Triton X-100 for 45 minutes at room 
temperature. After rinsing with PBS 2x for 5 minutes, primary antibody solution diluted in 
blocking buffer (3% donkey serum in PBS) was added and incubated overnight at 4°C. 
Primary antibodies against OCT-4 (Santa Cruz Biotechnology sc-8628; goat polyclonal; 
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1:100), AFP (Dako A000829-2; rabbit polyclonal; 1:100), and α-SMA (Dako M0851; 
mouse monoclonal; 1:100) were used. Following overnight incubation, slides were rinsed 
with PBS 3x for 5 minutes and incubated with secondary solutions diluted in blocking 
buffer (1:1000 AlexaFluor®488 donkey anti-goat, 1:1000 Alexa Fluor 488 donkey anti-
rabbit, and 1:1000 Alexa Fluor 488 donkey anti-mouse) for 1 hour at room temperature. 
Slides were rinsed with PBS 3x for 5 minutes and incubated with Hoechst dye (1:100) for 
10 minutes at room temperature. Following a final PBS rinse, coverslips were mounted 
with Fluoromount-G (SouthernBiotch) and sealed with clear nail polish. The slides were 
imaged using a Zeiss LSM 700-405 confocal microscope (Carl Zeiss Inc.). 
3.2.12 Conditioned media analysis 
 Spent media was collected from unencapsulated and encapsulated ESC aggregates 
cultured in hypoxia (3% oxygen) after 72 hours of culture between day 4 and day 7 of 
differentiation. The conditioned media was centrifuged at 3000 rcf for 5 minutes to remove 
cellular debris, and the supernatant was transferred to a new 15 mL conical tube for storage 
at -20°C. Enzyme-linked immunosorbent assay (ELISA) kits (DuoSet, R&D) were used to 
quantify the amount of VEGF and BMP-4 present in the conditioned media. Capture 
antibody was adsorbed onto 96 well MaxiSorp Immunoplates (Nunc), blocked with 1% 
BSA in PBS, incubated with standards and samples, and bound with detection antibody. 
The concentration of protein was determined using a colorimetric reaction of peroxidase 
and tetramethylbenxidine and a plate reader to measure the absorbance at 450 nm. The 
absorbance values for the conditioned media samples were compared to a standard curve 
to determine the protein concentration, which was normalized to cell number (as described 
in 3.2.8) and reported as pg of protein per mL or pg of protein per one million cells. 
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3.2.13 Statistics 
All experiments were performed with replicate samples from independent 
conditions. The data is represented as the mean of the independent replicates, and the error 
bars represent the standard error of the mean. Before performing statistical analysis, data 
were normalized using a Box–Cox power transformation to normalize data variance. One-
way and two-way ANOVAs were calculated between different conditions and time points 
as appropriate, followed by post hoc Tukey analysis to determine significant differences (p 
< 0.05). All statistical analyses were performed using MatLab and SYSTAT software.  
3.3 Results 
3.3.1 Characterization of microcapsule properties 
A variety of alginate microbead and microcapsule configurations were initially 
examined as platforms for ESC culture. The concentration (i.e. wt%) and composition (i.e. 
higher or lower ratios of guluronic acid – High M and High G) of alginate were varied 
along with the presence or absence of a poly-L-lysine (PLL) coating (Figure 3.1). In 
addition to uncoated beads (Figure 3.1d), three different configurations of PLL-coated 
beads were explored: (1) coating with 0.05% PLL for 2 min, providing a thin barrier; (2) 
coating with 0.1% PLL for 10 minutes and 0.15% alginate for 10 minutes, providing a 
thicker barrier (termed “solid core”) (Figure 3.1e); and (3) coating with 0.1% PLL for 10 
minutes and 0.15% alginate for 10 minutes, followed by liquefaction of the center through 
5 minute incubation with the chelating agent sodium citrate (termed “liquid core”) (Figure 
3.1f). An additional liquid core arrangement was investigated in which a shell of alginate 




Figure 3.1. Configurations of alginate beads. ESCs were encapsulated as either single cells or as 
pre-formed 500 cell aggregates (A) in alginate composed of either a higher ratio of guluronic acid 
(G) residues or a higher ratios of mannuronic acid (M) residues (C). The beads were maintained in 
a non-coated state or coated with poly-L-lysine to promote mechanical stability (B) and allow for 
liquefaction of the center core. Phase images of non-coated (D), PLL-coated (E-F), and coaxial-
formed (G) beads display the general size and form. Scale bar = 200 µm. 
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beads in this manner was inconsistent, with only a fraction (~10%) of the capsules 
containing a single aggregate. 
Because the ultimate goal of the alginate encapsulation system requires diffusion 
of stem cell secreted molecules out of the beads, assessment of mass transport properties 
of different bead compositions was performed. To perform the experiments, alginate beads 
were incubated with dextran solutions (3 kDa, 10 kDa, 70 kDa) for two hours, assumed to 
be sufficient time for the dextran molecules to diffuse into the alginate and reach a steady 
state. Fairly instantaneous diffusion was observed with 3 kDa and 10 kDa dextran 
molecules in uncoated beads, while a more gradual diffusion profile was observed with the 
70 kDa dextran, thus the larger size was used for future evaluations (Figure 3.2a-c). 
Alginate beads composed of High G and High M were formed at two different 
concentrations (1.5 and 2.5% by weight) and with or without the presence of a PLL coating 
(with 1.5% alginate only). The PLL coating appeared to block initial transport of the 70 
kDa dextran molecules into the beads, thus preventing the ability to measure dextran 
diffusion from the alginate. The absence of dextran uptake indicated that coating the beads 
with PLL prevents transport molecules greater than 70 kDa (Figure 3.2d, 3.2f). In general, 
diffusion of the dextran out of the the alginate beads with a higher percentage of alginate 
(2.5%) took a longer time than in the beads with a lower percentage of alginate (1.5%) for 
both alginate compositions (Figure 3.2e, 3.2g). In addition, the beads composed of 1.5% 
High M alginate also exhibited slower diffusion than beads composed of 1.5% High G 
alginate (Figure 3.2h), consistent with reports that though High G alginate is capable of 
greater crosslinking, it is also more porous overall [169]. No difference in diffusion was 




Figure 3.2. Mass transport in alginate beads. Dextran molecules of 3kDa (A) and 10 kDa (B) 
diffused freely through non-coated High M beads, while 70 kDa dextran (C) diffused more 
slowly. The 70 kDa dextran was used to assess a number of capsule properties (D-I), with the 
PLL coating prohibiting diffusion (D,F), the increased alginate concentration slowing diffusion 
(E,G), and the High G alginate appearing more permeable than the High M alginate only when at 
the lower concentration (H-I).  
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though there was less overall dextran released implying that less may have been originally 
loaded into the beads.  
The bulk mechanical properties of each bead type were determined by parallel plate 
compression testing in which stress-strain curves were obtained for individual beads 
(Figure 3.3a). The Young’s modulus, estimated using Hertzian theory, ranged from 4-18 
kPa and was consistently greater in the PLL-coated beads, likely due to the increased 
mechanical stability provided by the external polyelectrolyte layer, though the liquefaction 
of the alginate core did not result in a change of overall mechanical stiffness (Figure 3.3b, 
3.3d), which may indicate that poor liquefaction was achieved or that the presence of the 
coating dominates the mechanical profile. To determine whether the mechanical properties 
or stability changed with time in culture, alginate beads composed of High G or High M 
alginate with or without a thin PLL coating were kept in culture conditions (in media at 
37°C in a humidified incubator) for up to two weeks. The uncoated High G alginate was 
significantly stiffer than the uncoated High M alginate at days 1 (p = 0.011) and 7 (p < 
0.001) following formation (Figure 3.3d), consistent with previous literature reports that 
alginate containing a higher proportion of guluronic acid residues enhances the mechanical 
strength of the hydrogels [48]. The modulus remained constant over the course of the 
culture period for each composition tested, indicating that the beads were physically stable 
for at least two weeks when cultured dynamically without enclosed cells in standard culture 
media (Figure 3.3d). The average bead diameter (~734 μm) was relatively uniform for all 




Figure 3.3. Mechanical properties of alginate beads. Stress-strain curves were recorded during 
parallel plate compression testing (A) of alginate beads immediately following formation (B), and 
the derived elastic moduli of the PLL-coated beads were found to be significantly stiffer than the 
non-coated beads, though a decrease was not observed with those beads with a liquid core (LC). 
The mechanical stability was assessed over time in culture, during which there were no substantial 
changes in capsule size (C). The High G alginate was initially stiffer than the High M alginate, with 
the PLL-coated beads exhibiting additional increases in elastic modulus (D).  Significant (p < 0.05) 




3.3.2 Encapsulation of single embryonic stem cells 
ESCs were encapsulated as single cells in High G alginate at a density of 5 x 106 
cells/mL alginate and were cultured for seven days in uncoated or PLL-coated alginate 
with the center liquefied through chelation with sodium citrate (Figure 3.4a). While the 
majority of cells appeared viable directly after encapsulation, a decrease in cell viability 
was observed in cells within the uncoated alginate beads over time (Figure 3.4b-c). The 
observed cell death is likely a result of insufficient cell-cell contacts due to the solid matrix, 
as the majority of cells remained as single cells and did not appear to increase in number 
over time. In contrast, the cells cultured in the PLL-coated liquid core beads began to form 
small aggregates as early as three days post-encapsulation (Figure 3.4l), though some 
capsule breakage was also observed (Figure 3.4j-k). In some cases, several smaller 
aggregates were established within a single beads, and in other instances, a single large 
aggregate was formed. By day 7 of culture, some of the large aggregates were observed to 
be bursting out of the capsule due to their large size (Figure 3.4m). The formation of these 
aggregates led to a substantial improvement in cell viability (Figure 3.4d-e). Though the 
culture of ESCs in liquid core beads promoted aggregate formation and cell survival, the 
size of aggregates was not uniform or well-controlled. In addition, the thicker PLL coating 
required for liquid core formation did not facilitate retrieval of the cells for further 
application or analysis due to difficulties enzymatically degrading the PLL. Thus, future 
encapsulation studies relied entirely on pre-formed ESC aggregates. 
3.3.3 Encapsulation of embryonic stem cell aggregates 
Embryonic stem cell spheroids were encapsulated in alginate with a high (High G) 




Figure 3.4. Encapsulation of single, dissociated ESCs. Single cells encapsulated in uncoated 
High G alginate (A) exhibited high initial cell viability (B) but were primarily non-viable by day 7 
of culture (C). Single cells encapsulated in PLL-coated High G alginate with the center liquefied 
(A,D) displayed higher cell viability after 7 days (E). Phase images of the two conditioned over the 
7 day culture period (F-M) demonstrate the formation of aggregates in the liquid core group and 
the relative lack of cell growth in the uncoated group. 
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beads were coated with poly-L-lysine (PLL), creating High G + PLL and High M + PLL 
beads in addition to uncoated beads (Figure 3.5). The seeding density of spheroids in 
alginate gave rise to a small number (<15%) of empty beads, with the majority of beads 
(>71%) containing one to three spheroids, consistent with the expected Poisson distribution 
assuming an average rate of two aggregates per capsule (Figure 3.5k). Although the beads 
appeared similar after one week, unencapsulated spheroids (Figure 3.5a, 3.5f) and 
aggregates within each bead type (Figure 3.5b-e, 3.5g-j) exhibited distinct morphologies 
depending on the type of alginate used. All of the encapsulated spheroids appeared smaller 
than unencapsulated spheroids, with those in High G and High G + PLL remaining 
spherical (Figure 3.5b-c, 3.5g-h), whereas those in High M and High M + PLL appeared 
more ovoid (Figure 3.5j). 
Aggregate escape from the alginate beads was observed as early as four days post-
encapsulation for aggregates within the High M alginate (Figure 3.5l). After 14 days in 
culture, aggregate escape was more frequent, with many of the initially encapsulated 
aggregates no longer residing within the alginate beads (Figure 3.5g, 3.5i). In general, the 
High G alginate contained the aggregates more effectively than the High M alginate, with 
the addition of the PLL coating improving retention. The High G + PLL formulation 
maintained all spheroids within beads (Figure 3.5h), while the uncoated High M only 
retained ~4% of the aggregates within beads after 14 days of culture.  
Cell viability was assessed following 14 days in culture for each of the 
encapsulation conditions for both encapsulated and escaped aggregates due to the incidence 
of spheroid escape. Viable cells were more prevalent when the aggregates were not 
contained within the beads (Figure 3.6a), with non-viable cells present more frequently in  
 46 
 
Figure 3.5. Encapsulation and escape of ESC aggregates. Pre-formed ESC aggregates were 
encapsulated and cultured for 14 days in four different alginate configurations in parallel with 
unencapsulated aggregates (A-J). Initially, there was a distribution of aggregates per bead, with an 
overall average of two aggregates per bead (K), though the aggregates began to escape from the 
capsules as early as four days in culture (L). The High G+PLL condition was the only alginate bead 
configuration in which no aggregates escaped in the full 14 days of culture. 
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the encapsulated aggregates. The non-viable cells tended to be localized to the more 
rounded aggregates, with more viable cells present in the elongated region of aggregates 
when present. In addition, more viable cells were observed in the beads coated with PLL 
than in the non-coated beads.  
The proliferation rates of the ESCs cultured in different configurations (Figure 
3.6b) diverged, with the unencapsulated spheroids having the highest initial net growth rate 
(0.38 day-1 versus 0.12 day-1 for High G, 0.32 day-1 for High G + PLL, 0.24 day-1 for High 
M, and 0.22 day-1 for High M + PLL). After 14 days of culture, the number of cells in the 
unencapsulated aggregates was significantly greater than in the High G (p = 0.016), High 
G + PLL (p < 0.001), and High M + PLL (p = 0.035) conditions. Cell growth appeared 
most stunted in the cells within the stiffer High G and High G + PLL beads, though the 
beads coated with PLL exhibited overall similar growth trends to each other after day 4. A 
marked increase in cell number was observed after the majority of encapsulated aggregates 
escaped from the beads (day 7 for High M and day 10 for High G), indicating that the cells 
proliferated more robustly when not encapsulated. Cell growth plateaued at a cell density 
of ~1.8 x 106 cells/mL, likely due to the volumetric capacity of the culture system and 
exhaustion of nutrients from the culture media.  
 The elongated morphology that was observed in some groups prompted further 
examination into the morphological differences observed based on encapsulation 
conditions. At day 4, the ESC aggregates were generally small and fairly round (Figure 
3.7a-c), although some elongated protrusions were observed in the High M and High M + 
PLL groups (Figure 3.7d-e). The aggregates were densely packed without any 
morphogenic structures, suggesting that a primarily undifferentiated phenotype persisted.  
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Figure 3.6. Cell viability and proliferation within alginate beads. Viability was assessed 
following 14 days in culture for each of the encapsulation conditions using a LIVE/DEAD assay, 
and projection images were obtained via confocal microscopy (A). Due to the incidence of spheroid 
escape, both escaped and encapsulated aggregates were examined (when present). Viable cells, 
indicated in green, were more frequently observed when the aggregates were not within the beads, 
with non-viable cells, indicated in red, present at a higher frequency in the encapsulated aggregates. 
Cell viability appeared to be better maintained in the beads coated with PLL when compared to the 
non-coated counterparts. The proliferation rates for the ESCs cultured in the different 
configurations diverged (B), with the cell density in the unencapsulated condition significantly 
higher than the cell density in the High G, High G + PLL, and High M + PLL conditions. Scale bar 
= 500 μm. Significant (p < 0.05) increases over unencapsulated (*), High G (#), High G + PLL ($), 




Figure 3.7. Histological analysis of aggregate morphology. Hematoxylin and eosin (H&E) 
staining of encapsulated and unencapsulated spheroids were examined at days 4, 7, and 14 of 
differentiation. At day 4, the aggregates were generally small, densely packed, and fairly circular 
(A-C), though some elongated protrusions were observed in the High M and High M + PLL groups 
(D-E). By day 7 of differentiation, some cavitation was observed in the unencapsulated (F) and 
High M (I) conditions. The aggregates in the High G (G) and High G + PLL (H) alginates appeared 
relatively spherical, whereas more elongated aggregates were observed in the High M + PLL (J) 
condition. By day 14, more organized structures were formed in the unencapsulated (K) and High 
M (N) groups, including epithelial arrangement, small neural rosettes, and continued cavitation, 
while elongated protrusions began to appear in the High G and High G + PLL groups (L-M) and 
continued to exist in the High M + PLL group (O). White arrows indicate distinct morphological 
organization. Scale bar = 100 μm.  
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By day 7 of differentiation, some cavitation was observed in the unencapsulated (Figure 
3.7f) and High M (Figure 3.7i) conditions (which by day 7 contained only half of the 
spheroids within beads), suggesting that differentiation was progressing more rapidly in 
the unencapsulated condition and the High M alginate beads. While the aggregates in the 
High G (Figure 3.7g) and High G + PLL (Figure 4H) alginate beads still appeared 
relatively round, more distinguished extension of the ovoid geometry occurred in the High 
M + PLL (Figure 3.7j) condition. After two weeks in culture, more differentiated 
structures were formed in the unencapsulated (Figure 3.7k) and High M (Figure 3.7n) 
groups, including epithelial layer arrangement, small neural rosettes, and cavitation. The 
unencapsulated and High M conditioned aggregates appeared larger, consistent with the 
cell proliferation data (Figure 3.7b) previously described. In contrast, aggregates 
encapsulated in the High G (Figure 3.7l) and High G + PLL (Figure 3.7m) beads 
continued to exhibit a smaller cross-sectional area, though more multicellular protrusions 
were observed than at earlier time points. The significantly elongated morphology in the 
High M + PLL condition at day 14 (Figure 3.7o) was present at similar levels to the High 
M + PLL at day 7 and at greater frequency than any of the other experimental groups.  
3.3.4 Impact of encapsulation parameters on ESC aggregate phenotype 
 To determine what, if any, impact encapsulation in alginate with varying 
compositions had on stem cell differentiation, gene and protein expression were examined 
over the course of two weeks. Relative to the undifferentiated ESC starting population, 
most conditions exhibited decreased gene expression of the pluripotency markers Oct4 
(Figure 3.8a) and Nanog (Figure 3.8b) over time. However, different temporal trajectories 
were observed, with the cells encapsulated in the High G and High G + PLL beads 
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exhibiting significantly higher Oct4 levels at day 7 compared to cells in unencapsulated (p 
< 0.001 and p < 0.001, respectively), High M (p < 0.001 and p < 0.001), and High M + 
PLL (p < 0.001 and p = 0.006,) conditions. Furthermore, the cells within the High M and 
High M + PLL had expressed higher levels of Oct4 when compared to the unencapsulated 
spheroids (p < 0.001 and p < 0.001, respectively), signifying that residence within the 
alginate beads, even temporarily, may delay or impede differentiation. By day 14, cells in 
the High G and High G + PLL beads continued to express higher levels of Oct4 compared 
to the unencapsulated, High M, and High M + PLL conditions. A similar trend was 
observed in the expression of Nanog, with cells in the High G alginate exhibiting higher 
levels compared to unencapsulated cells at day 4 and aggregates in the High G and High G 
+ PLL conditions expressing higher levels than the unencapsulated aggregates at day 7. 
After 14 days, the cells in the High G + PLL beads maintained significantly increased 
expression over the unencapsulated and High M groups. The steady Nanog levels observed 
in the High G + PLL group, as opposed to the decrease observed in all other groups, was 
noteworthy since High G + PLL was the only condition to retain 100% of the spheroids 
over the entire two week period of culture.  
 Genes representative of the three germ lineages were also examined to determine 
if encapsulation conditions could impact differentiated phenotype(s), since culture as 
aggregates can lead to spontaneous differentiation as embryoid bodies (EBs). Pax6, an 
early ectodermal marker, was elevated in the unencapsulated, High M, and High M + PLL 
conditions compared to the High G and High G + PLL conditions at day 7 (Figure 3.8c) 
and increased in all groups by day 14, with the High G + PLL and High M + PLL groups 




Figure 3.8. Gene expression analysis of encapsulated aggregates. Relative to the 
undifferentiated ESC starting population, most conditions exhibited decreased gene expression of 
the pluripotency markers Oct4 (A) and Nanog (B) over time, however different temporal 
trajectories were observed, with encapsulated cells, particularly those in the High G and High G + 
PLL groups, maintaining Oct4 and Nanog expression longer than the unencapsulated aggregates. 
Pax6 was elevated in the unencapsulated, High M, and High M + PLL conditions over the High G 
and High G + PLL conditions at day 7 (C) and increased in all groups by day 14, with the High G 
+ PLL and High M + PLL expressing Pax6 at higher levels than the High M and unencapsulated 
groups. Expression of alpha-fetoprotein (AFP) was increased in the High M and High M + PLL 
groups (D), with significantly higher expression compared to other groups observed both at day 7 
and 14 of differentiation. Expression of MLC-2v was elevated in High M and High M + PLL 
conditions at day 7 (E). Flk1 was more highly expressed in the unencapsulated, High M, and High 
M + PLL conditions at day 7 (F). Significant (p < 0.05) increases over unencapsulated (*), High G 
(#), High G + PLL ($), High M (+), and High M + PLL (‡) are denoted.  
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Investigation of alpha-fetoprotein (AFP) expression, an endodermal marker, revealed 
dramatic increases in the High M and High M + PLL groups (Figure 3.8d), with 
significantly higher expression compared to all other groups observed both at day 7 and 14 
of differentiation. 
 Spontaneous contractile beating was observed in approximately half of the 
unencapsulated aggregates and approximately one-third of the High M aggregates at days 
10 and 14, motivating further examination into mesodermal cardiac differentiation. 
Expression of MLC-2v, an isoform of myosin light chain-2, was elevated in High M and 
High M + PLL conditions at day 7 (Figure 3.8e). Furthermore, increased MLC-2v 
expression was observed in the unencapsulated and High M groups at day 14, consistent 
with the visually observed beating activity. In addition, expression of Flk1, which encodes 
for VEGF receptor-2 and is a common marker of primitive mesoderm differentiation, was 
increased in the unencapsulated, High M, and High M + PLL conditions at day 7 (Figure 
3.8f), though only transient expression was observed, as levels were decreased in all groups 
by day 14 compared to day 7. 
 To determine spatial patterns of phenotype expression within encapsulated 
aggregates, whole mount staining of unencapsulated and encapsulated aggregates was 
performed at day 10 of differentiation (Figure 3.9a). While the cell viability dyes were 
easily able to penetrate the PLL barrier (Figure 3.9b), antibodies were unable to diffuse 
into the PLL-coated beads (Figure 3.9c). The ESCs within the non-coated High G beads 
exhibited higher expression of the pluripotent transcription factor OCT4 and carbohydrate 





Figure 3.9. Whole mount immunostaining of encapsulated aggregates. Unencapsulated 
aggregates and aggregates encapsulated in uncoated and PLL-coated High G alginate were imaged 
after 10 days of culture. Phase contrast images indicate that less cell growth is observed in cells 
within the uncoated alginate (D) in comparison to unencapsulated (A) and PLL-coated alginate (G) 
and that cell viability was maintained in all conditions (B,E,H). Whole mount immunostaining for 
the pluripotency markers OCT-4 and SSEA-1 indicates higher expression in the cells encapsulated 
in uncoated High G alginate (F) in comparison to unencapsulated cells (C). The antibody was 
unable to penetrate the PLL barrier in the PLL-coated beads. Scale bar = 100 μm.  
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expression data indicating that encapsulation in High G alginate delayed differentiation in 
comparison to unencapsulated aggregates. 
 To assess protein expression for all groups (including the PLL-coated conditions), 
the aggregates were sectioned and immunostained for OCT-4, AFP, and alpha smooth 
muscle actin (α-SMA). Similar to what was observed in the gene expression and whole 
mount staining data, the relative intensity of OCT-4 expression in the encapsulated groups 
(Figure 3.10b-e) was elevated compared to the unencapsulated group (Figure 3.10a) at 
day 7. AFP was expressed most frequently in cells from the High M condition (Figure 
3.10i) at day 14, with little to no expression detected in the other groups (Figure 3.10g-h, 
3.10j-k). In the High M conditions, AFP was commonly observed throughout the 
aggregates or in central localized regions surrounded by an epithelial layer, as displayed in 
Figure 6I. Expression of α-SMA was observed frequently at localized regions near the 
aggregate exterior in the unencapsulated (Figure 3.10k) and High M (Figure 3.10n) 
groups at day 14, the same conditions in which spontaneous beating was observed. More 
diffuse expression of α-SMA was observed in the High G (Figure 3.10l), High G + PLL 
(Figure 3.10m), and High M + PLL groups (Figure 3.10o), none of which exhibited 
spontaneous beating in culture.  
 To determine whether encapsulation in High G or High M alginate impacted the 
secretion of growth factors produced by ESCs, conditioned media from unencapsulated 
and encapsulated ESC aggregates after 72 hours of culture between day 4 and day 7 of 
differentiation was assessed for the concentration of vascular endothelial growth factor 
(VEGF) (Figure 3.11a) and bone morphogenetic protein-4 (BMP-4) (Figure 3.11b). There 
was no significant difference observed between media collected from unencapsulated 
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Figure 3.10. Cryosection immunostaining analysis. Frozen sections from each group were 
stained for OCT-4, AFP, and alpha smooth muscle actin (α-SMA) and counterstained for cell 
nuclei. The extent of OCT-4 expression was higher in the encapsulated groups (B-E) compared to 
the unencapsulated group (A) at day 7. AFP was observed frequently in the High M condition (I) 
at day 14, with little to no expression detected in the other groups (G-H, J-K). Expression of α-
SMAwas observed at localized regions in the unencapsulated (K) and High M (N) groups at day 
14. More diffuse expression of α-SMA of a lower relative intensity was observed in the High G 




Figure 3.11. Growth factor concentrations in conditioned media. Spent media that was 
conditioned between days 4 and 7 of differentiation was collected and analyzed using ELISAs for 
the growth factors vascular endothelial growth factor (VEGF) (A) and bone morphogenetic protein-
4 (BMP-4) (B). No differences were observed between unencapsulated cells or cells encapsulated 
in High G alginate, though culture in High M alginate led to a significant increase in concentration. 
* = p < 0.05 from all other groups. 
  
aggregates and aggregates cultured in High G alginate, however a significant increase in 
concentration for both growth factors was observed in media collected from aggregates 
cultured in High M alginate (for VEGF, p = 0.021 and p = 0.009 for unencapsulated and 
High G, respectively; for BMP-4, p = 0.004 and p = 0.003 for unencapsulated and High G, 
respectively).  
3.4 Discussion 
The findings of this study indicate that the composition of alginate beads can have 
a dramatic impact on the expansion and phenotype of microencapsulated ESCs. 
Examination of four different bead compositions (High G, High G + PLL, High M, and 
High M + PLL) yielded divergent phenotypes of the enclosed ESC aggregates. The 
addition of a PLL coating to alginate beads dramatically reduced the rate of cell escape 
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from the microbeads, completely preventing escape in the case of the High G + PLL 
condition. Encapsulation generally retarded cell growth while also inhibiting the loss of 
pluripotency, particularly for cells cultured in the stiffer High G alginate than cells in the 
more flexible High M alginate. These results demonstrate that encapsulation material 
properties and format impact pluripotent stem cell expansion and differentiation. 
Though there have been several reports of encapsulating single ESCs in alginate 
beads [66,67], very low cell viability was observed when using single, dissociated cells in 
this study, likely a result of the lack of cell-cell and cell-ECM contacts. Native alginate 
does not contain adhesive moieties necessary for cell attachment, thus it is unsurprising 
that cells lacking these cues did not survive. Previous studies have overcome the issue of 
cell attachment through the incorporation of adhesive cues into the alginate material, either 
by mixing it with a second polymer such as collagen [69,170] or by modifying the alginate 
polymer with the addition of adhesive peptides like arginine-glycine-aspartic acid (RGD) 
[171]. Another approach to improve cell survival has been to permit cell aggregation within 
the beads through liquefaction of the center, though this method leads to uncontrolled 
formation kinetics and less regulated aggregate size. While some success was observed 
using the PLL-coated liquid core beads to form aggregates, the number and dimensions of 
the aggregates were quite variable (3.4e, 3.4l-m). In addition, the thick PLL coating 
required for subsequent liquefaction was not compatible with later retrieval of the 
encapsulated cells for analysis, particularly because the positively charged PLL molecule 
can interfere with RNA extraction methods. Due to these complications, the remainder of 
the studies employed pre-formed aggregates rather than single cell suspensions. 
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 To define the physical microenvironment experienced by the encapsulated ESCs, 
the mass transport and mechanical characteristics of the alginate beads were evaluated. 
Coating the beads with PLL prevented the diffusion of 70 kDa dextran molecules into 
and/or out of the beads, indicating that the molecular weight cut-off was below 70 kDa 
(Figure 3.2d, 3.2f). This finding is consistent with later observations that antibody 
molecules were unable to penetrate the capsule barrier (Figure 3.9) in addition to previous 
reports indicating that immune molecules are unable to penetrate PLL-coated alginate 
beads [172]. While 3 kDa and 10 kDa dextran molecules did not appeared to be at all 
hindered in their transport, the 70 kDa dextran took approximately 20 minutes to achieve 
a steady state concentration in the High M alginate, though the transport appeared more 
instantaneous in the more porous High G alginate (Figure 3.2h). Increasing the 
concentration of alginate from 1.5% by weight to 2.5% also impeded diffusion, as it 
appeared that the incubation time was insufficient to allow full transport of the 70 kDa 
dextran molecules (Figure 3.2e, 3.2g). The secretion of ESC-produced proteins (VEGF 
and BMP-4 are 38 kDa and 47 kDa, respectively) did not appear to be impeded by the non-
PLL-coated alginate beads given sufficient time for diffusion (Figure 3.11).  
The elastic modulus for the different bead composition was also determined, and 
the values of the different alginate beads (4-18 kPa) were similar to previously reported 
literature values [74,77,170,173,174]. PLL-coated alginate beads were stiffer than the non-
coated beads (Figure 3.3b, 3.3d), consistent with the increased stability exhibited 
following polycation addition. The elastic modulus of PLL-coated beads did not decrease 
following liquefaction of the core (Figure 3.3b), indicating that the bulk elastic modulus 
is primarily based on exterior strength and may not accurately reflect the mechanical forces 
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encapsulated cells experience locally within beads. Uncoated High G alginate was 
significantly stiffer (~1.3-fold) compared to the High M alginate, indicating that the cells 
within the High G beads may experience a more constrained microenvironment than those 
in the High M beads. No significant decrease in modulus within the same group was 
observed over two weeks of culture, which was unexpected based on previous reports that 
bead stability decreases with time [156,158,175] and the data presented here regarding 
aggregate escape from the beads (Figure 3.5l).  
The difference between the constant elastic modulus over time and the increasing 
frequency of aggregate escape may be due to the discrepancy between a bulk mechanical 
measure like the Young’s modulus and the incidence of local fissures in the material that 
can create pathways for cell escape. The formation and propagation of local cracks in the 
beads is further supported by the correlation between the extended, ovoid morphology and 
the frequency of escape (Figure 3.5), indicating that the aggregates appear to grow and 
expand along the primary axis of weakness prior to escape. Although some previous reports 
of elongated, “lens-like” morphology of microencapsulated cells have been described 
[151,170], no clear explanation for this phenomenon has been offered. The correlation 
between cell growth and cell escape is likely related to differences in gel mechanics, 
however it is unclear whether stiffer alginate materials impede cell growth (and therefore 
the expansion of aggregates out of the bead) directly, or whether less stress is exerted on 
the stiffer alginate due to less net cell growth, leading to prolonged bead stability. It is also 
possible that local gradients in calcium due to cellular calcium use may contribute to the 
generation of local weak points in the alginate. In general, greater cell numbers and higher 
cell viability were observed in the conditions with more elongated aggregates, indicating 
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that in cases where elongation was not observed, cell growth may have been physically 
impeded. Increased initial cell growth rates (Figure 3.6b) and higher cell viability (Figure 
3.6a) were observed in the PLL-coated capsules, which is consistent with previous studies 
that directly compared PLL-coated and uncoated alginate capsules [156,170]. While the 
direct mechanism behind the differences observed in PLL-coated and non-coated beads is 
unknown, it is possible that the increased barrier to diffusion in the PLL-coated beads [170] 
could result in “trapping” of autocrine growth factors within the bead, leading to increased 
cell proliferation and viability. While others have found that encapsulation within alginate 
can slow cell proliferation [155,173,176], it is not universally observed, indicating that the 
diverse alginate compositions reported in the literature have yielded varying conclusions 
regarding the impact of microencapsulation on cell growth.   
 In addition to proliferative and morphologic changes, differences in phenotype 
were observed for cells from the different encapsulation conditions, implying that the bead 
configuration can impact the differentiation trajectory of the entrapped cells. Generally, the 
longer that cells were entrapped within the beads without escape, the more prolonged the 
expression of pluripotency markers was observed. The High M group, which had the 
highest incidence of aggregate escape, exhibited pluripotency marker expression similar to 
the unencapsulated aggregates, whereas the cells in the High G + PLL group, which 
contained the aggregates for the entire 14 days of culture, had the highest expression of 
both Oct4 and Nanog at day 14. In the High G + PLL group, Nanog expression remained 
relatively unchanged from undifferentiated ESC levels even as Oct4 expression decreased, 
indicating that regulation of Nanog may be occurring separately from the other pluripotent 
transcription factors [177–179]. Persistent OCT-4 signal in encapsulated ESC aggregates 
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was also observed via immunostaining (Figure 3.9f, 3.10b-e). The correlation between 
lower cell growth and high expression of the pluripotency markers appears somewhat 
counterintuitive given that undifferentiated cells are commonly believed to proliferate at a 
faster rate. However, recent work has demonstrated that inhibiting cell division of hESCs 
led to increased NANOG levels [180], implying that a similar mechanism of action may 
be responsible for the high Oct4 and Nanog levels observed in the groups which grew more 
slowly than others. Previous reports have indicated that microencapsulation can be used to 
prevent or delay differentiation of both single ESCs [67,69] and ESC aggregates [70], 
which is interesting given that aggregation of ESCs is often deemed to be an important 
initiating step in many differentiation protocols and indicates that differentiation within 
alginate hydrogels alters the kinetics and trajectory of differentiation. Therefore, when 
directed differentiation within alginate is desired, the presence of additional cues, either 
soluble or co-entrapped within the material matrix, may be critical for efficient ESC 
differentiation. 
 Along with changes in the loss of pluripotency, modulation of differentiation 
lineage commitment was also observed depending on the bead configuration, which is not 
commonly reported. The most striking difference was the increased propensity of cells 
within High M beads to differentiate toward an endodermal lineage, evidenced by alpha-
fetoprotein (AFP) gene (Figure 3.8d) and protein (Figure 3.10i) expression. In some cases, 
the AFP+ cells were localized to regions surrounded by an epithelial-looking layer, similar 
to structures observed via histology (Figure 3.7N). Interestingly, even though 96% of the 
aggregates in the High M condition escaped the bead prematurely and therefore were 
actually unencapsulated at day 14 of differentiation, dramatic differences in AFP were 
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observed between the High M group and the unencapsulated group, indicating that the 
earlier period of encapsulation may have primed or directed the differentiation of the 
entrapped cells toward an endodermal fate. In addition, cells encapsulated in High M 
alginate produced more VEGF and BMP-4 (Figure 3.11), which has been correlated with 
increased mesendoderm differentiation [181]. The other major phenotypic distinction 
observed was the high frequency of spontaneous contractile beating in the unencapsulated 
and High M cultures, and the complete lack of beating in the other conditions, though it is 
possible that entrapment within the alginate limited the detection of beating in other groups. 
MLC-2v levels were elevated in the unencapsulated, High M, and High M + PLL conditions 
(Figure 3.8e), and staining for alpha smooth muscle actin (α-SMA) exhibited strong 
localized expression in the unencapsulated and High M groups (Fig 3.10k, 3.10n). There 
are several hypotheses for the increased incidence of cardiac differentiation which may not 
be directly related to encapsulation parameters. First, culture of EBs under rotary orbital 
suspension has been previously implicated in inducing cardiomyogenic differentiation 
[182], and the unencapsulated condition was directly exposed to the hydrodynamic forces 
throughout the culture period. Due to the early escape of cells from the beads (Figure 3.5l), 
the High M group was also exposed to hydrodynamic forces for a more prolonged duration 
than the other encapsulated conditions that were shielded within the beads for a longer time 
period. A second hypothesis is based on the recent finding that high lactate culture 
environments lead to preferential survival of cardiomyocytes [183]. Since the 
unencapsulated and High M conditions consistently yielded higher cell densities than the 
other conditions (Figure 3.6b), there were possibly higher levels of lactate present in the 
culture media. Finally, while effort was put forth to control for initial aggregate size, the 
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aggregates in the unencapsulated and High M groups resulted in larger diameter EBs. 
Previous work investigating the impact of aggregate size on differentiation has observed 
that larger aggregates have a greater tendency to undergo cardiac differentiation [184–186]. 
Overall, these results suggest that sustained encapsulation impedes cardiomyogenic 
differentiation, which along with sustained expression of pluripotency markers, signifies 
that encapsulation is a capable platform for maintenance and/or expansion of ESCs in a 
less differentiated state. 
3.5 Conclusions 
Overall, this study establishes the significant impacts of alginate bead composition 
on the expansion and phenotype of encapsulated pluripotent stem cells. Alginate beads 
with a high ratio of guluronic acid residues maintain a less differentiated phenotype and 
addition of a PLL coating to the High G alginate prevents cell escape from the bead while 
maintaining cell viability. Additionally, employing alginate with a high ratio of 
mannuronic to guluronic acid residues induced differentiation toward an endodermal 
lineage. Future work with human pluripotent stem cells (hPSCs) may provide further 
insight into the impact of encapsulation parameters on hPSC behavior and determine 
whether alginate microencapsulation is a feasible expansion and/or differentiation platform 
for hPSC bioprocessing or collection of cell secreted factors. Overall, the findings of this 
study suggest that selecting different alginate compositions for PSC expansion or 
differentiation provides a facile approach to control stem cell fate, as distinct phenotypes 




DESIGN OF A PACKED BED PERFUSION BIOREACTOR FOR 
STEM CELL CULTURE AND TROPHIC FACTOR PRODUCTION 
4.1 Introduction 
 Classical bioprocessing approaches revolve around using cells to generate valuable 
products. In standard bacterial fermentation, microorganisms are exploited to produce 
molecules ranging from simple chemicals, such as ethanol or acetic acid, to enzymes, 
including lactase and catalase [187]. Advances in the scalable culture of mammalian cells 
and in recombinant DNA technology led to approval of the first mammalian-derived 
protein therapeutic, human tissue plasminogen activator, in 1986. By 2010, 28 different 
monoclonal antibody therapeutics had been approved by the United States Food and Drug 
Administration, primarily for applications in immune disorders and cancer [188], and 
approximately 60-70% of these proteins were produced in mammalian systems [189], 
likely due to unique ability of mammalian cells to perform post-translational modifications. 
Despite the robust history of producing cell-secreted proteins, often primarily from 
engineering of simple cell types, there has been limited research applying bioprocessing 
principles to harness more complex cell types and the generation of composite protein 
mixtures.  
 Since stem cells have emerged on the scientific scene, most of the direct 
applications have initially focused on exploiting the differentiation capacity of stem cells 
for the replacement of damaged tissues. However, the results of initial in vivo 
transplantation studies indicated that many of the observed functional improvements were 
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due to the transient paracrine actions of the transplanted stem cells, rather than the stem 
cells permanently engrafting and replacing the damaged cellular material [190,191]. Thus, 
research on the identity and potency of paracrine factors secreted by stem cells has become 
an increased area of focus in the regenerative medicine field. The majority of research to 
date has focused on mesenchymal stem/stromal cells (MSCs), as MSCs have been found 
to secrete significant quantities of pro-angiogenic, anti-inflammatory, and anti-apoptotic 
molecules [192,193]. Thus far, the secretory properties of pluripotent stem cells, including 
embryonic stem cells (ESCs), have been largely neglected despite records of improvement 
in embryonic cardiac phenotype [30] and reduced myocardial dysfunction post-ischemia 
[31] due to the presence of ESC paracrine factors. ESCs are thus an underexplored cell 
population with a unique and potent secretome due to their mitogenic and morphogenic 
roles during the early stages of development. Because many of the morphogens and growth 
factors produced by ESCs may be in low individual abundance, engineering a system to 
increase the yield of cell-derived factors may enhance the relative potency. 
 Despite the substantial knowledge base in bioprocess design for obtaining cell-
secreted products, essentially all of the published literature regarding stem cell 
bioprocessing has focused on bioreactor design for cell cultivation rather than for protein 
production, consistent with the initial emphasis on cell therapy applications. There are 
numerous challenges in designing systems in which the cells themselves are the product, 
including the need for more intense process validation and characterization of the cell 
product, which necessitates the development of complex monitoring and control systems 
[136]. In order to facilitate expansion of stem cells to achieve the anticipated high numbers 
required for cell therapies and to remain consistent with standard bioprocessing systems, 
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suspension culture platforms, at least in the macroscale, have been the dominant paradigm. 
Because most stem cells, with the exception of hematopoietic stem cells, are adherent in 
nature, culturing stem cells in a single cell suspension is not typically successful [194]. 
Therefore, the cells are commonly cultured as aggregates, on the surface of microcarriers, 
within bulk hydrogel constructs, or in hydrogel microcapsules. Stirred suspension systems, 
usually in the form of bench-scale spinner flasks, are the most common format due to their 
scalability and ease of integration with monitoring systems [195].  
Encapsulation of stem cells within hydrogel microbeads or microcapsules can be 
employed to provide a defined environment for adherent stem cell populations while 
enabling culture in large scale bioreactor systems [143]. Culture within hydrogels can also 
protect the enclosed cells from experiencing shear forces inherent to stirred bioreactor 
systems, which is particularly important in the case of stem cells due to their phenotypic 
sensitivity to hydrodynamic forces [196]. Spinner flask culture of microencapsulated 
human ESCs (hESCs) found that while encapsulation of single hESCs led to poor viability, 
encapsulation of hESC aggregates and hESCs on microcarriers allowed for maintenance 
of viability and pluripotency for up to two weeks in suspension culture [70]. In addition to 
stirred tank bioreactors, other reactor configurations have been investigated, including the 
high aspect ratio vessel (HARV), a rotary microgravity reactor that operates under the 
laminar flow regime to lessen the impact of mechanical forces. A HARV reactor has been 
used with murine ESC-containing alginate microcapsules to create mineralized constructs 
for bone tissue engineering [74]. 
 Perfusion bioreactors are often used to enhance the yield of cell number through 
continuous provision of nutrients and removal of cell waste products while also providing 
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a relatively homogeneous soluble environment when compared to unmixed static cultures 
[197]. Perfusion culture of stem cells was first reported in the early 1990s as a method to 
expand bone marrow stem and progenitor cell populations [198] and has since been applied 
to the culture of pluripotent stem cells [72,199–201]. The published perfusion bioreactor 
systems for ESCs have been restricted to stirred suspension, HARV, and hollow fiber 
platforms; however using a packed bed reactor configuration offers the additional 
advantage of a high local cell density. Only a handful of studies have implemented packed 
bed perfusion bioreactor systems with encapsulated stem cells. A fixed bed reactor in 
which CellBeads, a commercially available product consisting of human MSC aggregates 
in alginate microcapsules, were packed and perfused with culture medium was able to 
maintain viability and induce adipogenic differentiation [75]. A similar system of alginate 
beads containing human MSCs was assembled into a tube and  perfused with media as a 
method of direct assembly of a tissue-engineered construct [76,77]. Thus far, there have 
been no reports of culturing microencapsulated ESCs within a packed bed system for either 
expansion or collection of ESC-produced factors, despite the ease in which the protein-rich 
perfusate could be easily collected and/or delivered downstream. 
 In order to take advantage of the robust knowledge in bioprocessing and apply it to 
the novel application of harnessing pluripotent stem cells for their unique protein secretion, 
a first generation bioreactor platform for microencapsulated ESCs was designed and 
validated. Specifically, cell viability, proliferation, and growth factor secretion were 
compared between static and perfusion culture. Additionally, the impact of perfusion flow 
rate and multiple passes through the system were assessed to determine whether the 
efficiency of growth factor production could be modulated through adjusting engineering 
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design parameters. Overall, the results of this study demonstrate the design and validation 
of a uniquely engineered system capable of culturing ESCs and concentrating ESC secreted 
factors with applications for delivery to downstream paracrine-factor mediated processes. 
4.2 Materials and methods 
4.2.1 Bioreactor construction  
 The packed bed perfusion bioreactors were assembled using the following materials 
(all purchased from McMaster-Carr): high-temperature soft silicone rubber tubing, 1/4" 
ID, 3/8" OD in semi clear white and cut into 1.5" lengths; high-temperature silicone rubber 
tubing, 1/16" ID, 1/8" OD in semi-clear white and cut into 5" lengths; polyester mesh discs, 
72 x 72 mesh, 0.0091" opening, cut into circles with 1/4" diameter; lightweight quick-turn 
tube couplings with barbed plugs for 1/4" tube ID; lightweight quick-turn tube couplings 
with barbed sockets for 1/16" tube ID; and 4" nylon cable ties. The mesh was inserted 
between the end of the 1/4" barbed plug and the top 3/8" of a 20 µL pipette tip (Rainin), 
removed using a razor blade, and affixed using lab tape (VWR).  The 1.5" of 1/4" ID 
silicone tubing was pushed over the ends of the two barbed plugs to form a bed volume of 
approximately 0.5 mL, with several cable ties securing the connection to prevent leaks. 
The 1/16" quick-turn barbed socket couplings were fitted on either side of the 1/4" barbed 
plug and attached to 5" length 1/16" silicone tubing. The other end of the 1/16" silicone 
tubing was fitted to an additional 1/16" quick-turn barbed socket couplings and secured to 
syringes (BD). All bioreactor parts were sterilized individually via autoclave and 
assembled in a sterile manner in a biosafety cabinet.   
4.2.2 Embryonic stem cell culture 
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Murine ESCs (D3 cell line) were cultured on tissue culture treated polystyrene 
dishes (Corning) adsorbed with 0.1% gelatin (EmbryoMax). Undifferentiated ESC culture 
media consisted of Dulbecco’s modified Eagle’s medium (DMEM) (Mediatech) 
supplemented with 15% fetal bovine serum (Hyclone), 100 U/mL penicillin, 100 μg/mL 
streptomycin, and 0.25 μg/mL amphotericin (Mediatech), 2 mM L-glutamine (Mediatech), 
1x MEM non-essential amino acid solution (Mediatech), 0.1 mM 2-mercaptoethanol 
(Fisher Scientific), and 103 U/mL of leukemia inhibitory factor (LIF) (ESGRO). Cultures 
were replenished with fresh media every other day and passaged prior to reaching 70% 
confluence. 
4.2.3 ESC aggregate formation  
A single cell suspension of undifferentiated ESCs was obtained through 
dissociation of monolayer cultures with 0.05% trypsin-EDTA (Mediatech). Defined, 
serum-free KO N2B27 media (note: formulation is slightly different than what was used in 
Chapter 3) was used for all aggregate cultures and consisted of Knock-Out (KO) DMEM 
(Life Technologies) supplemented with N2 (Gibco), B27 (Gibco), 100 U/mL penicillin, 
100 μg/mL streptomycin, and 0.25 μg/mL amphotericin (Mediatech), 2 mM L-glutamine 
(Mediatech), 1x MEM non-essential amino acid solution (Mediatech), and 0.1 mM 2-
mercaptoethanol (Fisher Scientific). Aggregation of ESCs was achieved by centrifugation 
(200 rcf) of ESCs into 400 μm square polydimethylsiloxane (PDMS) micro-wells 
(AggrewellTM, Stem Cell Technologies) as previously reported [19,152]. The cell seeding 
density yielded approximately 500 cells per individual well. The ESCs were incubated in 
the wells for approximately 24 hours in serum-free KO N2B27 culture media to allow for 
aggregate formation. 
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4.2.4 Cell microencapsulation  
Ultrapure medium viscosity MVG alginate (Pronova), which contains greater than 
60% G residues (High G), was prepared at 1.5 wt% in calcium-free DMEM (Gibco) and 
autoclaved for sterilization no more than one day before use. An electrostatic bead 
generator (Nisco) was utilized for encapsulation. Pre-formed ESC aggregates were 
resuspended in alginate at a density of 12,000 aggregates per mL of alginate, and the cell-
containing alginate solution was extruded through a 400 μm nozzle using a syringe pump 
at a flow rate of 6 mL/hour and a voltage of 10 kV to drop the beads into a stirred hardening 
bath of 100 mM calcium chloride (EMD). The beads were washed three times with serum-
free media prior to downstream culture.  
4.2.5 Static and perfusion culture of encapsulated aggregates 
 Static cultures of encapsulated ESC aggregates were cultured in sterile 100 x 15 
mm bacteriological grade polystyrene Petri dishes (BD) at a typical seeding density of 3 x 
106 cells in 10 mL of KO N2B27 medium, unless otherwise noted. For perfusion cultures, 
encapsulated ESC aggregates were added into the silicone packed bed during bioreactor 
assembly at a typical seeding of 3 x 106 cells, unless otherwise noted. The reactor was 
perfused with KO N2B27 medium using a syringe pump (Cole-Palmer) at a typical rate of 
150 µL/hr, unless otherwise noted, and the perfusate was collected into an output syringe 
(BD). Most experiments were performed for a duration of three days, unless otherwise 
noted. 
4.2.6 Cell viability staining and imaging 
Cell viability was assessed using a LIVE/DEAD kit (Molecular Probes Inc., 
Eugene, OR). Samples were incubated in PBS containing 0.1 μM calcein AM and 8 μM 
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ethidium homodimer-1 at 4°C for 1 hour. The samples were washed with PBS, transferred 
to a glass-bottomed 24-well plate, and immediately imaged using a Zeiss LSM 700-405 
confocal microscope or a Zeiss Axio Observer inverted fluorescence microscope. 
4.2.7 Cell number quantification 
Encapsulated aggregates were released from beads through 5 minute incubation 
with 55 mM sodium citrate (Sigma), as previously described [73]. The cells were 
centrifuged at 200 rcf for 5 minutes and rinsed 3x with PBS. Cells from all conditions were 
pelleted at 375 rcf for 4 minutes followed by supernatant removal and storage at -20°C. A 
CyQUANT Cell Proliferation Assay Kit (Molecular Probes Inc., Eugene, OR) was used to 
determine cell number, with a standard curve created using undifferentiated ESCs that were 
counted using a hemocytometer. The fluorescence (480 nm excitation, 520 nm emission) 
was read using a Synergy H4 plate reader (Biotek) or an i3 plate reader (Molecular 
Devices). 
4.2.8 Conditioned media analysis 
 Spent media was collected from encapsulated ESC aggregates cultured under static 
or perfusion conditions. The conditioned media was centrifuged at 3000 rcf for 5 minutes 
to remove cellular debris, and the supernatant was transferred to a new 15 mL conical tube 
for storage at -20°C. Enzyme-linked immunosorbent assay (ELISA) kits were used to 
quantify the amount of VEGF, (DuoSet, R&D), BMP-4 (DuoSet, R&D), and IGFBP-2 
(PicoKine, Boster Bio) present in the conditioned media. Concisely, capture antibody was 
adsorbed onto 96 well MaxiSorp Immunoplates (Nunc), blocked with 1% BSA in PBS, 
incubated with standards and samples, and bound with detection antibody. The 
concentration of protein was determined using a colorimetric reaction of peroxidase and 
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tetramethylbenxidine and a plate reader to measure the absorbance at 450 nm. The 
absorbance values for the conditioned media samples were compared to a standard curve 
to determine the protein concentration. 
4.2.9 Quantitative real time PCR 
Encapsulated aggregates were released from beads through 5 minute incubation 
with 55 mM sodium citrate (Sigma), as previously described [73]. The cells were 
centrifuged at 200 rcf for 5 minutes and rinsed 3x with PBS. RNA was extracted from the 
aggregates with the RNeasy Mini kit (Qiagen Inc, Valencia, CA). The RNA (300 
ng/sample) was converted to complementary DNA using the iScript cDNA synthesis kit 
(Bio-Rad, Hercules, CA) and analyzed using real time PCR (MyIQ cycler, Bio-Rad). 
Forward and reverse primers for 18s, Oct4, Vegf, and Hif-1α were designed with Beacon 
Designer software (sequences and conditions are given in Table 4.1) and purchased from 
Invitrogen. Gene expression were calculated with respect to undifferentiated ESC 
expression levels as previously described [168]. 
 





All experiments were performed with replicate samples from independent 
conditions. The data is represented as the mean of the independent replicates, and the error 
bars represent the standard error of the mean. Before performing statistical analysis, data 
were normalized using a Box–Cox power transformation to normalize data variance. One-
way ANOVAs were calculated between different conditions as appropriate, followed by 
post hoc Tukey analysis to determine significant differences (p < 0.05). All statistical 
analysis was performed using MatLab and SYSTAT software.  
4.3 Results 
4.3.1 Bioreactor design and construction  
 An initial observation regarding ESC secretion kinetics was made in the context of 
unencapsulated ESC aggregates cultured on a rotary orbital shaker. While the 
concentration of the growth factor bone morphogenetic protein-4 (BMP-4) initially rose 
and subsequently leveled off within a 48 hour culture period, the introduction of fresh 
media into the system at 24 hours led to continued BMP-4 secretion (Figure 4.1). Within 
the 24 hour time period between the first and second day of culture, the ESC aggregates 
cultured in fresh media generated sufficient protein to lead to a 51 pg/mL increase in BMP-
4 concentration, in contrast to the 39 pg/mL increase in BMP-4 concentration observed in 
the cultures which did not receive a media exchange. The results of this study indicated 
that depletion of external growth factors may influence cell secretion dynamics, perhaps 
through negative feedback inhibition mechanisms. Thus, a culture platform capable of  
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Figure 4.1. Media replacement enhances production of ESC secreted growth factor. Analysis 
of conditioned media collected from unencapsulated ESC aggregates cultured in rotary suspension 
for bone morphogenetic protein-4 (BMP-4) concentration indicates that performing a media 
exchange can enhance the yield of BMP-4. 
 
constant depletion of cell-secreted products may be able to enhance overall ESC trophic 
factor production. 
 In order to maximize the concentration of ESC secreted factors, a high density 
culture platform with integrated media perfusion was designed. Three-dimensional culture 
generally enables higher cell densities than two-dimensional monolayer cultures, thus 
ESCs were aggregated into multicellular spheroids. ESC spheroids were maintained within 
alginate microbeads to ensure sufficient separation between aggregates, as multiple 
aggregates often agglomerate into large cell masses, leading to uncontrolled oxygen and 
nutrient gradients,. A classic packed bed reactor design was thus chosen to enable high 
density packing of the ESC aggregates and continuous media perfusion. 
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 Several important design parameters were considered, including that the reactor be 
(1) fully sterilizable via autoclaving or similar method, (2) gas permeable to ensure 
sufficient oxygen transport, (3) closed such that there are no leaks to minimize 
contamination, and (4) have an adjustable bed volume such that the number of encapsulated 
aggregates could be altered as needed. The design consists of medical grade silicone tubing 
(1/4" ID) fitted on either side with barbed Luer locks and polyester mesh with a 0.0091" 
opening (Figure 4.2). Gas permeable silicon tubing was used both for the packed bed itself 
as well as for the tubing used for media delivery to ensure adequate oxygen delivery to the 
cells. For most studies, a bed volume of approximately 0.5 cm3 (height = ½", width = ¼") 
was employed. Assuming a void fraction of 0.39 (poured random packing for spheres), an 
average bead diameter of 600 μm, and an average of two aggregates per bead, the 
approximate capacity is 3600 beads per 0.5 cm3 of bed volume (approximately 7.2 x 106 
cells/mL).  
Using a syringe pump, an initial flow rate of 150 μL/hr was delivered, as this is 
comparable to the exchange rate that is performed in typical batch culture (exchanging 10 
mL of media every 72 hours). To establish whether this flow rate should be sufficient for 
removal of cell-secreted products, the dimensionless Peclet number for the system was 
determined. The Peclet number (Pe) describes the ratio of advective transport to diffusive 















where ρ is the fluid density, v is the superficial velocity, L is the characteristic length 




Figure 4.2. Design of a packed bed perfusion bioreactor for culture of encapsulated ESC 
aggregates. Silicone tubing with a 1/4" inner diameter (ID) was fitted on either end with a polyester 
mesh to contain alginate microbeads within the bed volume. The silicone tubing is gas permeable 
to enable oxygen transport, and all components of the bioreactor are sterilizable via autoclave. The 
bed volume can be modified by altering the length of the 1/4" silicone tubing, with a typical volume 
of 0.5 mL containing approximately 3600 beads (average diameter of 600 μm) and 3.5 x 106 cells. 
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interest in the fluid medium. Given the approximation of the system parameters (v ≈ 1.3 x 
10-4 cm/s, L ≈ 0.64 cm, and D for proteins ≈ 5 x 10-7 cm2/s), a Peclet number of ~168 was 
obtained, indicating that the flow rate used should be sufficient to remove cell-secreted 
proteins. Several assumptions are required in this estimation, including that (1) there is no 
electrostatic force between the negatively-charged alginate and proteins which would 
influence transport, (2) the diffusive transport is dominated by transport through the media 
and not the alginate, (3) production of the proteins is relatively constant and not affected 
by flow, and (4) that the ESCs are consuming (i.e. receptors on the cells binding to the 
ligand) a low proportion of the protein. 
4.3.2 Cell function and secretion within bioreactor 
 To assess whether culture of encapsulated ESC aggregates within the packed bed 
reactor affected basic cell function, the viability, growth, and differentiation of cells 
cultured under perfusion were compared to encapsulated ESC aggregates cultured in static 
suspension. After 24 hours of culture, similar degrees of cell viability were observed in 
aggregates cultured in static and perfusion conditions (Figure 4.3a-b). To determine if the 
position within the bioreactor (i.e. near the entrance or exit) affects cell viability, cell-
containing alginate beads were extracted from approximately the front 10% and back 10% 
of the reactor. Similar levels of viability after 72 hours of culture were observed regardless 
of position (Figure 4.3c-d), implying that adequate transport of nutrients are provided 
throughout the length of the system. The aggregate morphology (Figure 4.3e-j) and cell 
growth curves (Figure 4.3k) were comparable between the encapsulated cells in static and 
perfusion conditions. Similar downregulation of the pluripotency marker Oct4 after 72 




Figure 4.3. Influence of perfusion culture on ESC viability, proliferation, differentiation, and 
secretion. ESCs cultured in a static petri dish or within the perfusion bioreactor (flow rate 150 
μL/hr) exhibited similar viability after 24 hours (A-B) (scale bar = 200 µm), and no differences in 
viability were observed after 72 hours of culture between ESCs cultured at the front and back of 
the bioreactor (C-D) (scale bar = 100 µm). Similar morphology (E-J) (scale bar = 500 µm) and cell 
growth curves (K) were observed in static and perfusion cultures throughout the course of culture. 
The loss of the pluripotency marker Oct4 was unchanged in static and perfusion cultures relative 
to undifferentiated ESCs (red dotted line) (L). Higher concentrations of vascular endothelial growth 
factor (VEGF) were observed in the perfusate than in the conditioned media collected from static 
cultures. Significant (p < 0.05) differences (*) are denoted.  
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 packed bed bioreactor did not significantly influence the transition from the pluripotent 
state. Analysis of the perfusate at the outlet of the bioreactor revealed that the concentration 
of ESC-produced vascular endothelial growth factor (VEGF) was significantly increased 
(4.9-fold increase) in comparison to the conditioned medium collected from the static 
cultures (Figure 4.3m), despite the analogous overall cell densities. 
 It is possible that the increased VEGF production is a byproduct of the culture 
platform, perhaps due to limitations in oxygen transport; therefore a static bioreactor that 
lacked convective transport was examined. Transport of nutrients within the static 
bioreactor was driven entirely by diffusion from the media-containing syringes at either 
end of the reactor (Figure 4.4a).  Reduced cell viability after 72 hours was observed in the 
static bioreactor (Figure 4.4c) in comparison to both the static plate (Figure 4.4b) and the 
perfused bioreactor (Figure 4.4d), and significantly fewer cells were observed in the static 
bioreactor (Figure 4.4e). The medium conditioned by the perfusion reactor once again 
contained the highest concentrations of VEGF (Figure 4.4f), and very little VEGF was 
observed in the medium conditioned in the static reactor. At the gene expression level, 
there were no significant differences between the groups in expression of hypoxia-
inducible factor-1α (HIF-1α) or VEGF (Figure 4.4g-h), indicating that the increased 
production of VEGF was likely being regulated at the protein level. The results of this 
study indicate that the increased VEGF concentration observed was likely not a secondary 
effect of culture within the bioreactor, as the results were not recapitulated in an identically 
configured static bioreactor.  
 To determine if the growth factor concentration could be increased by recycling the 




Figure 4.4. Lack of hypoxic response observed due to bioreactor culture. ESCs were cultured 
in a static petri dish, in a static bioreactor, or within a bioreactor subject to a flow rate of 150 μL/hr 
(A). Lower cell viability was observed in cells cultured in the static bioreactor (C) in comparison 
with the static plate (B) and perfusion reactor for 72 hours (D) (scale bar = 100 µm), with lower 
cell numbers observed in the static reactor (E). The media conditioned by the perfusion reactor 
contained higher concentrations of VEGF (F), though no differences in gene expression of hypoxia-
inducible factor-1α or VEGF were observed between the groups. Significant (p < 0.05) differences 





Figure 4.5. Influence of recycled perfusion on growth factor yield. Encapsulated ESCs were 
perfused for 72 hours at a low flow rate (150 μL/hr), a high flow rate (300 μL/hr), or a high flow 
rate (300 μL/hr) with the media conditioned for the first 36 hours recycled through the reactor for 
the second 36 hours (A), as described in Table 4.2. Similar concentrations of vascular endothelial 
growth factor (VEGF) were observed in the conditioned media from all conditions (B), but higher 
overall quantities of VEGF were yielded in the high flow rate condition (C). Significant (p < 0.05) 
differences (*) are denoted. 
 
compared to a single pass configuration (Figure 4.5a). In order to maintain the same 
overall cell density, the flow rate through the reactor was doubled from 150 μL/hr to 300 
μL/hr; therefore, an additional condition of a single pass approach with the higher flow rate 
of 300 μL/hr was also included to account for any differences based on flow rate (Table 
4.2). The concentration of VEGF was similar for all conditions (Figure 4.5b), indicating 
that recycling the once-conditioned medium through the packed bed of ESCs a second time 
did not lead to increased growth factor concentration. However, because the single-pass, 
high flow rate condition circulated double the total volume of media through the reactor, 
the total amount of VEGF produced by the cells was also approximately doubled in 
comparison to the other conditions (Figure 4.5c).  
Table 4.2. Flow rates and total volumes delivered for double-pass experiment 
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 Based on this observation, the effect of flow rate on ESC secretion dynamics was 
evaluated at a greater range of flow rates/dilution rates (Table 4.3) and for two different 
growth factor species: VEGF and insulin-like growth factor binding protein-2 (IGFBP-2), 
identified as protein produced by ESCs in high levels (Figure 5.3, 5.7). Images of 
encapsulated ESC aggregates cultured under perfusion for 72 hours at 75 μL/hr, 150 μL/hr, 
300 μL/hr, and 600 μL/hr appeared similar in morphology (Figure 4.6a-d), though 
“escape” of aggregates seemed to be more prevalent in the 600 μL/hr condition which may 
indicate that the alginate beads were under more mechanical stress at the higher flow rate  
that led to reduced integrity of the alginate beads. Approximately 3 x 106 cells were seeded 
into each bioreactor, though analysis of cell number following 72 hours of perfusion culture 
indicated that there were differences in cell expansion (Figure 4.6e). The cells cultured 
under the lowest flow rate (75 μL/hr) were present in significantly lower numbers in 
comparison to the higher flow rate conditions (300 μL/hr and 600 μL/hr), conceivably due 
to a lack of sufficient nutrients and/or greater accumulation of cell byproducts. As expected 
based on the experimental design, greater overall cell densities were observed at the lower 
flow rates (Figure 4.6e).  
 






Figure 4.6. Growth of encapsulated ESCs under different perfusion flow rates. Encapsulated 
ESCs were perfused at four different flow rates for 72 hours: 75 μL/hr (A), 150 μL/hr (B), 300 
μL/hr (C), and 600 μL/hr (D). Because different total volumes are being perfused through the 
system, the cell density decreases with increasing flow rate (E). An equivalent number of cells were 
seeded into each bioreactor, but a lower number of cells were observed in the low 75 μL/hr  flow 
rate condition following 72 hours of culture (E). A significant (p < 0.05) difference (*) from the 
300 μL/hr and 600 μL/hr conditions is denoted. 
 
Perfusate from the reactors was collected every 24 hours and analyzed for VEGF and 
IGFBP-2 content, both as a concentration and as an absolute amount based on the volume 
of media that had been conditioned. In general, higher protein concentrations were 
observed at the lower flow rates (Figure 4.7a-b), consistent with the higher cell densities 
in these conditions. However, intermediate flow rates led to higher absolute quantities at 
most time points (Figure 4.6c-d) since higher volumes of media were being conditioned. 
At the higher flow rate conditions (≥150 μL/hr), the concentration and absolute quantity of 
VEGF and IGFBP-2 was relatively constant over time, while the concentration and 
quantity appeared to increase over time in the 75 μL/hr flow rate condition. By calculating 
the overall concentration and quantity of the proteins after 72 hours of perfusion, the 
productivity of each bioreactor flow rate was determined for each protein. Similar to 




Figure 4.7. Influence of perfusion flow rate on ESC secreted growth factor concentration and 
yield. Encapsulated ESCs were perfused at four different flow rates for 72 hours: 75 μL/hr, 150 
μL/hr, 300 μL/hr, and 600 μL/hr. For the higher flow rates, the concentration (A-B) and local 
quantity (C-D) of vascular endothelial growth factor (VEGF) and insulin-like growth factor binding 
protein-2 (IGFBP-2) were fairly constant over time. Compiling the temporal data into an overall 
concentration and amount for the full 72 hours, a higher concentration of VEGF (E) and IGFBP-2 
(F) were observed with lower flow rates. The highest yield of VEGF was obtained at a flow rate of 
300 μL/hr (E), while the highest yield of IGFBP-2 was obtained at a flow rate of 150 μL/hr (F). 
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produced by the ESCs (Figure 4.7e), while a flow rate of 150 μL/hr yielded the highest 
amount of IGFBP-2 (Figure 4.7f).  
4.4 Discussion 
 The design and validation of a novel packed bed perfusion bioreactor for 
encapsulated ESC culture is a novel approach to harness and deliver stem cell secreted 
products. In this work, a bioreactor was constructed using silicone tubing in combination 
with a polyester mesh and luer connections to create a defined environment in which 
culture media can be continuously conditioned by encapsulated ESCs. Cell viability and 
proliferation were not affected over the 72 hour culture period, in comparison to static 
controls at comparable overall cell to media densities, yet an increased yield of ESC-
produced growth factor was observed in the perfused conditioned medium (Figures 4.3, 
4.4).  
  To understand the mechanism behind the increased concentration, several factors 
were interrogated in parallel. The amount of protein present in a system at a given time is 
dependent on several parameters but can be estimated using simple mass balances in which 
protein accumulation (dP/dt) is the sum of protein entering the system (+), protein being 
generated by cells (+), protein being consumed, either through cellular uptake or protein 
degradation (–), and protein leaving the system (–).  In a static system, there is no protein 
entering or leaving the system over the period of culture, while protein is continuously 
leaving the system under a perfusion conditions. Because similar cell growth was observed 
in static and perfusion systems (Figure 4.3k, 4.4e), the consumption term can be assumed 
to be equivalent in both conditions given that the consumption rate is directly related to 
cell number.  
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Based on early studies with static cultures, it was observed that cells provided with 
fresh, unconditioned media secreted more growth factor than cells that did not experience 
a media change (Figure 4.1). In addition, the recycling of conditioned media back through 
the bioreactor for a second pass did not lead to further concentration of the conditioned 
media (Figure 4.5). There are several possible explanations for these observations, 
including that the addition of fresh media provided more energy or material for the 
transcriptional and translational processes required for protein production. Alternatively, 
there may some form of negative feedback inhibition in which the cells slowed their 
production of growth factor in response to the high extracellular growth factor 
concentrations, either due to the accumulation of protein locally in the static condition or 
the re-perfusion of previously conditioned media. Examining a case in which no negative 
feedback inhibition is present, the amount of product present (as well as the concentration 
of product, assuming constant volume) would rise linearly over time, while the rate of 
secretion (first derivative of the amount of product) would be constant with time (Figure 
4.8a). However, under the effects of feedback inhibition, the rate of product secretion 
would slow over time, thus the concentration and amount would cease to increase linearly 
and ultimately level off, similar to what was observed experimentally (Figure 4.1). By 
introducing an exchange of volume into the system, the exogenous concentration of 
product could be modulated to diminish or even negate the effect of negative feedback 
inhibition. At steady state, the average concentration of a cell-secreted product in a 
continually perfused system could be maintained at a semi-constant level, assuming that 
the rate of dilution with fresh media largely prevents feedback inhibition (Figure 4.8b). 




Figure 4.8. Theoretical and experimental trends of growth factor production. Expected 
dynamics for growth factor secretion, concentration, and overall amount in the absence or presence 
of feedback inhibition, assuming a constant volume (A). Expected dynamics for growth factor 
concentration and total amount in the presence of volume exchange, assuming an average spatial 
value (B), aligns with experimental data for static and perfusion culture (C). Expected spatial 
gradient in a perfusion reactor in the presence of feedback inhibition, assuming steady state has 
been achieved (D). 
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fixed volume, the total amount of product yielded in a system with dynamic volume would 
instead be correlated with the integral of the concentration and would thus increase over 
time (Figure 4.8b). Comparing the theoretical relationships of product concentration, 
product amount, media volume, and time with experimental results, very similar trends are 
observed for the theoretical fixed, constant volume condition and the static experimental 
condition, as well as for the theoretical dynamic volume exchange condition with the 
experimental perfusion system (Figure 4.8c). The concentration and absolute amount of 
VEGF in the static condition increased over time but appeared to level off by 72 hours of 
culture. In contrast, the concentration of VEGF was relatively constant over time in the 
perfusion bioreactor (consistent with the results for flow rates ≥150 μL/hr in Figure 4.7a-
b), thus the total VEGF yielded increased with time.  
Assuming that negative feedback inhibition is present in the system also implies 
that spatial differences likely exist within the packed bed bioreactor configuration. In the 
absence of inhibition, the rate of secretion would be constant across the length of the bed, 
leading to an increase in concentration across the x dimension (starting at zero 
concentration and ending at the final concentration of the perfusate) (Figure 4.8d). 
However, in the presence of negative feedback inhibition, the rate of secretion would be 
highest at the packed bed entrance and would decrease with increasing concentration along 
the x direction, still fixed by the boundary conditions of zero concentration at the entrance 
and the final perfusate concentration at the exit. By altering the geometry of the packed 
bed bioreactor (i.e. increasing the ratio of the diameter to the length), the gradient along 
the length of the reactor could theoretically be reduced. In addition to spatial variance along 
the length of the bioreactor, other spatial heterogeneities may exist depending on the 
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packing of the alginate beads in the reactor. In general, if the perfused structure is not 
homogeneous, only partial perfusion is achieved since the fluid flow will likely follow the 
path of least resistance and flow unevenly through specific channels within the packed bed, 
which could lead to local heterogeneities in cell secretion and product concentration [202]. 
To experimentally determine if spatial heterogeneities exist, cells from different regions of 
the bioreactor could be collected for downstream analysis (gene and protein expression); 
alternatively, the entire bioreactor could be fixed in place through snap freezing and 
embedding within a filler medium to enable histological sectioning. 
Quantitative modeling of product formation is possible for defined systems in 
which certain parameters are known. For example, microbial growth to produce simple 
products, such as ethanol, can be predicted using mass balance calculations based on the 
specific rate of product formation product (qp), which can in turn be dependent on the 
product yield coefficient (YP/S) [187]. Products can also be described as growth-associated, 
non-growth associated, or mixed-growth-associated, depending if the product is produced 
concurrent with cell growth or once the cells have achieved a stationary growth phase. 
Extension of simple models to mammalian cell systems has proven to be challenging, and 
several attempts to model cell growth, metabolism, and antibody production from 
hybridoma and chinse hamster ovary (CHO) cells have had to employ complex 
unstructured kinetic models or logistic equations [203,204]. In general, the production of 
antibodies in mammalian cells appears to be non-growth associated, though the mechanism 
is dependent on the culture platform and feeding strategy [204–206]. However, describing 
the production of a recombinant protein, which has been optimized to be a high efficiency 
expression system, is a distinct process from endogenous protein production, and thus it is 
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difficult to correlate published results to the production of multiple growth factors from 
stem cell populations.  
In general, the secretion of protein products from cells is a highly regulated process 
involving the folding and assembly of proteins in the endoplasmic reticulum followed by 
glycosylation and packaging within lipid vesicles in the Golgi apparatus. Through the 
process of exocytosis, the vesicle containing the proteins can be transported through the 
plasma membrane and into the extracellular environment [207]. While most cell-secreted 
proteins follow this classical pathway, others, including fibroblast growth factors 1 and 2 
(FGF-1 and FGF-2), undergo unconventional secretory processes [208–210] in which 
processing by the Golgi is altered or entirely absent. Additionally, cell secretion can be 
broken down into constitutive secretion and regulated secretion mechanisms, particularly 
for cell types with primary endocrine functions [211]. With constitutive secretion, the 
protein is constantly secreted regardless of specific external signals. In contrast, cells with 
regulated secretion processes accumulate secretory vesicles intracellularly and only release 
them when triggered by the appropriate signal, termed the secretagogue. For example, 
epithelial cells lining the gastrointestinal system secrete acid in response to the 
secretagogue hormone gastrin [212]. Feedback mechanisms are known to exist for many 
protein hormones, including growth hormone (GH), as well as growth factors like insulin-
like growth factor-2 (IGF-2) [213,214].  In some cases, high concentrations of the protein 
itself repress gene expression and protein production, such as with IGF-2 which is appears 
to be mediated by the type I IGF receptor. While the mechanism of self-regulation of gene 
expression has not been observed for VEGF, several endogenous proteins which are 
induced by VEGF expression act as feedback inhibitors of angiogenesis [215–217], and it 
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is possible that their co-expression with VEGF may in turn reduce the quantity of VEGF 
produced. 
Based on the flow rate used (and the equivalent dilution rate), different efficiencies 
of protein production were achieved (Figure 4.7). The highest quantity of VEGF was 
produced at a flow rate of 300 µL/hr (dilution rate of 0.6) (Figure 4.7e), while the most 
IGFBP-2 was produced at a flow rate of 150 µL/hr (dilution rate of 0.3) (Figure 4.7f). The 
difference in peak efficiency between the two proteins could be explained by a variety of 
hypotheses, including that IGFBP-2, which is produced in much higher quantities (103-104 
higher concentrations than VEGF), is less sensitive to the feedback inhibition mechanisms 
which might come into play at the lower flow rates. At the higher flow rates, it is also 
possible that the removal of autocrine factors from the cells influences their capacity for 
the production of certain growth factors, as it has been observed that removal of autocrine 
factors from ESC populations affects differentiation and tissue specification [218].  
The bioreactor system designed in this study is similar to several commercial 
products, most of which have been designed for tissue engineering applications. Kiyatec 
produces 3DKUBETM, a three-dimensional cell culture chamber with a volume of 250 µL 
that has an optional co-culture configuration through addition of a permeable membrane 
between the two chambers. On a slightly larger scale, 3D Biotek manufactures three 
dimensional perfusion bioreactor systems that can be fitted with multiple scaffold discs 
composed of polystyrene, polycaprolactone, or tri-calcium phosphate. Instron offers 
OsteoGenTM, a more advanced perfusion stimulation bioreactor system that can be coupled 
with pulsatile flow simulator. All of types of these perfusion systems currently involve the 
use of large scaffolds to maintain the cells in place, which is more relevant for the tissue 
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engineering of large constructs. However, they could be modified to include filters at the 
entrance and exit to restrict microcapsules within the system, thereby enabling the study of 
perfused ESC aggregates in a different geometric configuration. Similar changes in 
dimension could also be achieved with the system designed herein by altering the length 
and diameter of the tubing used for the packed bed. 
4.5 Conclusions 
 Overall, the results of this study demonstrate the utility of a novel perfused packed 
bed bioreactor for the culture of encapsulated embryonic stem cells and for increasing the 
production of stem cell secreted growth factors. While the precise mechanism for the 
increased concentration is unknown, it may stem from stimulation of secretion due to the 
continuous removal of exogenous growth factor. Recycling previously conditioned 
medium through the reactor did not lead to increases in growth factor concentration, though 
higher yields of growth factor could be obtained by determining the flow rate which 
balances high cell secretion with low dilution. Taken together, the bioreactor designed in 
this study will enable several applications, including the continuous delivery of growth 
factor-enriched perfusate to downstream cell and tissue populations.   
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CHAPTER 5 
GLOBAL ANALYSIS OF EMBRYONIC STEM CELL SECRETED 
FACTORS 
5.1 Introduction 
 Pluripotent embryonic stem cells (ESCs) are isolated from the inner cell mass of 
the pre-implantation blastocyst [1,3] and thus simulate mammalian early embryonic 
development [219]. During embryogenesis, the in vivo equivalents of pluripotent stem cells 
act as an autonomous source of morphogenic signals that stimulate histogenesis of 
neighboring cells through paracrine actions, as well as differentiation of the ESCs 
themselves through autocrine signals. Through their secretion of growth factors, cytokines, 
chemokines, and mitogens, ESCs create a microenvironment that stimulates the 
morphogenic events leading to subsequent tissue and organ formation [219,220]. Despite 
their significant paracrine actions, the emphasis of most research in stem cell pluripotency 
and differentiation has been on defining phenotypic markers and signaling pathways rather 
than on coincident expression and/or secretion of morphogenic growth factors. 
 Because of the role of pluripotent stem cells in developmental processes, it is 
anticipated that ESCs may be exceptionally unique in their expression and secretion of 
morphogenic proteins. There are several classes of proteins, such as the fibroblast growth 
factor (FGF), bone morphogenetic protein (BMP), insulin-like growth factor (IGF), and 
Wnt families, which play important roles in developmental processes in addition to acting 
as key regulators of multipotent stem cells and somatic cell populations. The FGF family 
includes 18 proteins that can be broken down into six sub-families, five of which act as 
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paracrine factors that dictate patterning and morphogenesis during embryonic development 
as well as act as mitogenic and cytoprotective agents in mature cellular systems [221]. 
Members of the FGF family have also been implicated as key regulators of both pluripotent 
and multipotent stem cell populations and generally stimulate cell proliferation and self-
renewal while inhibiting cellular senescence [222]. The BMP family is actually a subgroup 
representing approximately 1/3 of the members of the larger transforming growth factor-β 
(TGF-β) superfamily of growth factors, and under the umbrella of the BMP family are 
several other signaling growth factors, including growth differentiation factors (GDFs). 
Though the primary focus of BMPs has been their role in the musculoskeletal system, a 
much larger range of functions has been established including most processes relating to 
epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions [223]. The IGF 
family contains fewer members than the FGF and BMP families, consisting only of two 
IGFs and six IGF-binding proteins (IGFBPs). The IGFBPs have much higher affinities for 
the IGFs than the IGF receptors do and thus play crucial roles in controlling IGF activity 
[224]. During embryonic development, members of the IGF family are involved in critical 
functions during morphogenesis through the control of apoptosis in order to sculpt and 
pattern specific regions [225]. Interestingly, the role of IGFs appears to shift over the 
lifespan of an animal, as the proteins have primarily mitogenic roles during development 
and early in life but are actually observed to augment the aging process later in life 
[226,227]. The Wnt family consists of highly conserved small secreted signaling proteins 
which influence cell proliferation and fate specification through canonical (through 
Frizzled receptors and β-catenin translocation to the nucleus) and non-canonical (not acting 
through β-catenin) pathways [228]. In addition to key roles during development, members 
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of the Wnt family are key signaling molecules involved in the maintenance and self-
renewal of multipotent stem cell populations, including hematopoietic stem cells [229]. 
 Despite the evidence of ESC trophic factors and their paracrine actions, little work 
has been performed to characterize specifically what stem cells produce. A challenge in 
determining the secretome is that secretion is likely dependent on a number of 
environmental factors, such as the type of media or supplements used, the culture format, 
the presence of differentiation stimuli, and the stage of differentiation. Proteomic mass 
spectrometry has been used to identify a number of secreted molecules present during 
undifferentiated culture, including growth factors (e.g. BMPs, FGFs, VEGF, TGF-β) and 
signaling molecules involved in the GSK3β/Wnt/β-catenin, Jak/Stat, Notch/Delta, and 
MAPK/ERK pathways [230–232]. However, mass spectrometry studies are constrained 
due to technical limitations (e.g. presence of contaminants, high background concentration 
of carrier proteins such as albumin, low concentrations of species of interest), and thus 
gene expression analysis has also been performed. Large scale microarray analysis 
[233,234] in addition to more targeted gene expression screens [235,236] have been used 
to discriminate gene expression profiles between undifferentiated and differentiating 
pluripotent stem cells as well as to determine differentially regulated genes based on 
embryoid body (EB) size. However, a focused analysis of secreted morphogens would 
provide insight into the unique profiles of expression that pluripotent stem cells possess in 
comparison to other cell types. 
 Various pre-conditioning approaches have been found to alter the secretion profile 
of stem cells by providing more defined and regulated microenvironments. Reducing the 
oxygen tension of the culture to hypoxic levels (<5%), which more closely resembles the 
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physiologic microenvironment, increases expression of hypoxia-inducible factors [237–
239], which in turn can lead to increased expression of various cytokines and growth 
factors, including VEGF, IGF-2, and TGF-α [240,241]. Additionally, mesoderm 
differentiation of ESCs, the lineage that further differentiates into components of the bone 
marrow compartment (e.g. hematopoietic progenitors, stromal cells, and osteoblasts), may 
lead to secretion of hemogenic-specific factors. Directed mesoderm differentiation can be 
induced through the addition of specific proteins (e.g. BMP-4, VEGF, FGF-2, activin A) 
[146,242,243] or small molecules (e.g. CHIR99021, a GSK3 inhibitor) [244], during early 
stages of differentiation. From previous findings (Chapter 3), it has also been observed that 
varying the alginate composition can induce changes in cell phenotype and the secretion 
of specific growth factors [245]. The type of culture platform employed, such as culture 
under static or perfusion conditions, may also influence the expression of specific proteins 
[246].  
 In order to harness the unique paracrine activities of pluripotent stem cells for 
applications in stimulating adult stem cell populations, further characterization of their 
expression of secreted morphogens is essential. Thus, the objective of this study was to 
perform a global analysis of pluripotent stem cell secreted factors in response to exposure 
to distinct environmental conditions. Specifically, manipulating the oxygen tension, 
alginate composition, culture platform, and induction of mesoderm differentiation provide 
additional engineering approaches to specify and control the secretion of pluripotent stem 
cell-derived trophic factors. A combination of proteomic and gene expression approaches 
were employed to assess the influence of these environmental parameters as well as to 
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distinguish the expression profiles of undifferentiated embryonic stem cells from other cell 
types and from differentiating stem cell populations.  
5.2 Materials and methods 
5.2.1 Embryonic stem cell culture 
Murine ESCs (D3 cell line) were cultured on tissue culture treated polystyrene 
dishes (Corning) adsorbed with 0.1% gelatin (EmbryoMax). Undifferentiated ESC culture 
media consisted of Dulbecco’s modified Eagle’s medium (DMEM) (Mediatech) 
supplemented with 15% fetal bovine serum (Hyclone), 100 U/mL penicillin, 100 μg/mL 
streptomycin, and 0.25 μg/mL amphotericin (Mediatech), 2 mM L-glutamine (Mediatech), 
1x MEM non-essential amino acid solution (Mediatech), 0.1 mM 2-mercaptoethanol 
(Fisher Scientific), and 103 U/mL of leukemia inhibitory factor (LIF) (ESGRO). Cultures 
were replenished with fresh media every other day and passaged prior to reaching 70% 
confluence. 
5.2.2 ESC aggregate formation  
A single cell suspension of undifferentiated ESCs was obtained by dissociation of 
monolayer cultures with 0.05% trypsin-EDTA (Mediatech). Defined, serum-free KO 
N2B27 media (note: formulation is slightly different than what was used in Chapter 3) was 
used for all aggregate cultures and consisted of Knock-Out (KO) DMEM (Life 
Technologies) supplemented with N2 (Gibco), B27 (Gibco), 100 U/mL penicillin, 100 
μg/mL streptomycin, and 0.25 μg/mL amphotericin (Mediatech), 2 mM L-glutamine 
(Mediatech), 1x MEM non-essential amino acid solution (Mediatech), and 0.1 mM 2-
mercaptoethanol (Fisher Scientific). Aggregation of ESCs was achieved by centrifugation 
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(200 rcf) of ESCs into 400 μm square polydimethylsiloxane (PDMS) micro-wells 
(AggrewellTM, Stem Cell Technologies) as previously reported [19,152]. The cell seeding 
density yielded approximately 500 cells per individual well. The ESCs were incubated in 
the wells for approximately 24 hours in serum-free KO N2B27 culture media to allow for 
aggregate formation. 
5.2.3 Cell microencapsulation  
Two different medium viscosity alginates were used: ultrapure MVG (Pronova) 
which contains greater than 60% G residues (High G) and ultrapure MVM (Pronova) which 
contains greater than 50% M residues (High M). Alginate solutions were prepared at 1.5 
wt% in calcium-free DMEM (Gibco) and autoclaved for sterilization no more than one day 
before use. An electrostatic bead generator (Nisco) was utilized for encapsulation. Pre-
formed ESC aggregates were resuspended in alginate at a density of 12,000 aggregates per 
mL of alginate, and the cell-containing alginate solution was extruded through a 400 μm 
nozzle using a syringe pump at a flow rate of 6 mL/hour and a voltage of 10 kV to drop the 
beads into a stirred hardening bath of 100 mM calcium chloride (EMD). The beads were 
washed three times with serum-free media prior to downstream culture. A thin PLL-coating 
was used to prevent aggregate escape for the seven day factorial experiment examining the 
influence of oxygen tension, alginate type, and mesoderm-induction. The beads were 
coated with 0.05% PLL (MW 15,000-30,000; Sigma) for 2 minutes prior to three additional 
media rinses. 
5.2.4 Microencapsulated cell culture and differentiation 
 Microencapsulated ESC aggregates were generally cultured statically in sterile 100 
x 15 mm bacteriological grade polystyrene Petri dishes (BD) in 10 mL serum-free KO 
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N2B27 media (see 5.2.2) at an initial cell density of 3 x 105 cells/mL media. A 90% media 
exchange was performed every three days. For the factorial experiment examining the 
influence of oxygen tension, alginate type, and mesoderm-induction, the encapsulated 
aggregates were cultured statically in 6 well plates in 3 mL culture media at a seeding 
density of 1.5x105 cells/mL media. To induce mesodermal differentiation, recombinant 
human bone morphogenetic protein-4 (BMP-4; R&D) was supplemented at 10 ng/mL at 
each media exchange. Cells were cultured in humidified incubators under either normoxic 
(21% oxygen, 5% carbon dioxide) or hypoxic (3% oxygen, 5% carbon dioxide) conditions. 
Cells cultured under perfusion were placed in a custom packed bed perfusion reactor (3 x 
106 cells/reactor) and received serum-free KO N2B27 media at a rate of 150 µL/hr (see 
Chapter 4). 
5.2.5 Mesenchymal stem cell and mouse embryonic fibroblast culture 
 Murine bone marrow-derived mesenchymal stem cells (MSCs, isolated from 
C57Bl/6J mice) were obtained from the Texas A&M College of Medicine Institute for 
Regenerative Medicine The cryopreserved MSCs were thawed and plated onto a 15-cm 
tissue culture dish in 20 mL MSC complete expansion medium (CEM) which consists of 
Iscove’s Modified Dulbecco’s Medium; Invitrogen/GIBCO) supplemented with 10% fetal 
bovine serum (FBS; Hyclone, Logan, UT), 10% horse serum (Hyclone), 2 mM L-
glutamine (Invitrogen/GIBCO), 100U/mL penicillin, 100 μg/mL streptomycin and 0.25 
μg/mL amphotericin B (Invitrogen/ GIBCO). Following overnight incubation at 37°C, 
adherent MSCs were washed with phosphate-buffered saline (PBS, Invitrogen/GIBCO) 
and detached from the tissue culture plate using 0.25% trypsin and 1 mM EDTA 
(Invitrogen/GIBCO). Cells were plated onto 15-cm tissue culture dishes, at a density of 50 
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cells/cm2 in 20 mL CEM per dish. Cells were fed every 3–4 days with 20 mL of fresh CEM 
and maintained until they reached ∼70% confluence, at which point cells were once again 
trypsinized, counted and either re-plated or collected for downstream quantitative real time 
PCR analysis. Mouse embryonic fibroblasts (mEFs) were isolated from day 14.5 embryos 
using digestion with 0.25% trypsin/EDTA. The equivalent of one embryo was plated per 
15-cm tissue culture dish in 30 mL of mEF complete media which consists high glucose 
DMEM (Gibco) supplemented with 10% fetal bovine serum (Hyclone), 1% 
penicillin/streptomycin (Mediatech), 2 mM l-glutamine (Mediatech), and 1x MEM non-
essential amino acid solution (Mediatech). The isolated cells were cultured for 3-4 days 
until they reached 90% confluence before freezing at 2 x 107 million cells/mL. To collect 
the mEFs for PCR, a vial of approximately 1 x 106 cells was thawed into a 10 cm tissue 
culture dish in 10 mL of mEF complete media, and the cells were collected after 2 days of 
culture. 
5.2.6 Cell number quantification 
Encapsulated aggregates were released from beads through 5 minute incubation 
with 55 mM sodium citrate (Sigma) for all beads, as previously described [73]. The cells 
were centrifuged at 200 rcf for 5 minutes and rinsed 3x with PBS. Cells from all conditions 
were pelleted at 375 rcf for 4 minutes followed by supernatant removal and storage at -
20°C. A CyQUANT Cell Proliferation Assay Kit (Molecular Probes Inc., Eugene, OR) was 
used to determine cell number, with a standard curve created using undifferentiated ESCs 
that were counted using a hemocytometer. The fluorescence (480 nm excitation, 520 nm 
emission) was read using a Synergy H4 plate reader (Biotek). 
5.2.7 Quantitative real time PCR 
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Encapsulated aggregates were released from beads through 10 minute incubation 
with TrypLETM (Invitrogen) to remove the PLL coating, trituration, and 5 minute 
incubation with 55 mM sodium citrate (Sigma) to break down the alginate. The cells were 
centrifuged at 200 rcf and rinsed 3x with PBS to remove residual PLL. RNA was extracted 
from the aggregates with the RNeasy Mini kit (Qiagen Inc, Valencia, CA). The RNA (300 
ng/sample) was converted to complementary DNA using the iScript cDNA synthesis kit 
(Bio-Rad, Hercules, CA) and analyzed using real time PCR (MyIQ cycler, Bio-Rad). 
Forward and reverse primers for 18s, Oct4, Nanog, Vegf, Igf1, Igf2, Fgf2, Bmp4, and Gdf11 
were designed with NCBI’s Primer-BLAST (sequences and conditions are given in Table 
5.1) and purchased from Invitrogen. Gene expression were calculated with respect to 
undifferentiated ESC expression levels as previously described [168].  
 
Table 5.1. Primer sequences for quantitative real time PCR 
 
5.2.8 Cytokine array analysis of conditioned media 
 Spent media was collected from encapsulated ESC aggregates after 72 hours of 
culture. The conditioned media was centrifuged at 3000 rcf for 5 minutes to remove cellular 
debris, and the supernatant was transferred to a new 15 mL conical tube for storage at -
20°C. The presence of 96 cytokines in ESC conditioned media was assessed using two  
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commercially-available cytokine arrays (Mouse Cytokine Antibody Array – 62 targets and 
Mouse Cytokine Antibody Array – 34 targets; Abcam) (species listed in Table 5.2). 
Briefly, the provided membranes were blocked with Blocking Buffer for 30 minutes at 
room temperature, followed by overnight incubation with undiluted conditioned media at 
4ºC. The next day, the membranes were washed in 25 mL of Wash Buffer I for 30 minutes 
under gentle agitation. Three subsequent washes with 2 mL of Wash Buffer I (5 min each) 
were performed, followed by two washes with 2 mL of Wash Buffer II (5 min each). Biotin-
Conjugated Anti-Cytokines were added to the membranes and incubated at 4ºC overnight. 
The three washes with Wash Buffer I and two washes with Wash Buffer II were repeated 
before application of a solution of HRP-Conjugated Streptavidin (2 mL per membrane), 
which was incubated with the membranes overnight at 4ºC. The wash step were repeated, 
and the membranes were then transferred to clean plastic sheets and covered with 500 µL 
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of detection buffer. After 2 minutes of incubation, a second plastic sheet was placed on top 
of the membrane to sandwich it in plastic, and the array was immediately imaged using a 
Li-Cor Odyssey Fc imager equipped with a CCD camera. The arrays were quantified using 
ImageJ (http://imagej.nih.gov/ij/) by (1) converting the image to 8 bit, (2) inverting it so 
that it has a black background, (3) subtracting the background, (4) enabling the “integrated 
density” measurement, (5) drawing a circle around the largest dot and measuring the 
integrated density, and (6) moving the drawn circle to each dot and measuring the 
integrated density. The intensity of each species was averaged between two dots and 
reported as an intensity relative to the average intensity of the six positive control dots on 
each membrane. 
5.2.9 Fluidigm custom PCR array 
 Encapsulated aggregates were released from beads through 5 minute incubation 
with 55 mM sodium citrate (Sigma). RNA was extracted from the aggregates with the 
RNeasy Plus Mini kit (Qiagen Inc, Valencia, CA). The RNA (840 ng/sample) was 
converted to complementary DNA using the iScript cDNA synthesis kit (Bio-Rad, 
Hercules, CA). Forward and reverse primers for 96 genes were designed with NCBI’s 
Primer-BLAST (identities and sequences are given in Table 5.3a-b) and were pooled into 
a single tube (1 µL of each 100 µM primer stock such that the final concentration of each 
primer is 500 nM). The cDNA (1 µL) was combined with the pooled primers and PreAmp 
Master Mix (Fluidigm) (4 µL, 5 µL total volume) prior to pre-amplification (2 minute hold 
at 95ºC, 15 cycles of 15 sec at 95ºC and 4 min at 60ºC) using a SimpliAmp thermal cycler 
(Life Technologies). Exonuclease treatment was then performed to remove unincorporated 
primers by adding Exonuclease I and Exonuclease I Reaction Buffer (New England 
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 BioLabs) to each sample, digesting for 30 min at 37ºC, and inactivating for 15 min at 80ºC. 
The final product at this stage was diluted 5-fold with TE Buffer (Teknova). The samples 
were then combined with 2X SsoFast EvaGreen Supermix with Low ROX (Bio-Rad) and 
20X DNA Binding Dye Sample Loading Reagent (Fluidigm) (2.5 µL EvaGreen Supermix 
and 0.25 µL DNA Binding Dye per 2.25 µL sample) and vortexed thoroughly. The assay 
mix was prepared by combining the forward and reverse primer for each gene (0.25 µL 
total primer volume) with 2.5 µL Assay Loading Reagent (Fludigm) and 1X DNA 
Suspension Buffer (Teknova) and vortexed thoroughly. A 96.96 Dynamic Array IFC 
(Fluidigm) was primed with control line fluid (Fluidigm) and loaded with 5 µL of each 
sample and assay mixture. A BioMark HD system was used to run the chip, and BioMark 
HD Data Collection Software and Fluidigm Real-Time PCR Analysis Software were used 
to run and analyze the chip. For heat map analysis, gene expression values were calculated 
with respect to undifferentiated ESC expression levels, and the data was hierarchically 
clustered and plotted using Genesis software (Institute for Genomics and Bioinformatics, 
Graz University of Technology). 
5.2.10 Ingenuity Pathway Analysis (IPA) 
 Ingenuity Pathway Analysis (IPA, QIAGEN, Redwood City, www.qiagen.com/ 
ingenuity) software was used to analyze biological functions and signaling networks 
associated with proteins and genes expressed by pluripotent stem cells. For the cytokine 
array data, the presence of detected proteins in specific pathways was determined using 
IPA’s database of biological processes. To compare the gene expression profile of 
undifferentiated ESCs to mEF and MSC gene expression profiles, genes were filtered using 
a minimum 10-fold change threshold between the two cell types to create a list of focus 
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genes. Those focus genes were then compared to the reference gene set for functional 
categories, and a right-tailed Fisher Exact Test was used to determine significance by 
identifying over-representation of the focus genes in the specific process. In addition, the 
Benjamini-Hochberg (B-H) multiple testing correction method was applied to account for 
false-positives. The top 10 functions for ESCs vs. mEFs and ESCs vs. MSCs are reported 
in Table 5.4-5.5, with each function having a significance of p < 10-7 and a list of the 
relevant focus genes for each functional pathway recorded.  
5.2.11 Statistics 
All experiments were performed with replicate samples from independent 
conditions, with the exception of the cytokine arrays which were performed with pooled 
samples on a single array. Data is generally represented as the mean of the independent 
replicates, and the error bars represent the standard error of the mean. Before performing 
statistical analysis, data were normalized using a Box–Cox power transformation to 
normalize data variance. A three-way ANOVA was calculated in MatLab to determine the 
influence of alginate composition, external oxygen tension, and the presence of mesoderm 
stimuli, followed by post hoc Tukey analysis to determine significant differences (p < 
0.05). Volcano plots describing differences in gene expression profile between time points 
of differentiation and cells cultured under static and perfusion were calculated through 
paired t-tests between the delta Ct values calculated for each gene and normalized to the 
housekeeping gene 18s.  
5.3 Results 
5.3.1 Influence of microenvironment on ESC growth factor gene expression 
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 To determine the how specific environmental parameters can promote the 
expression of growth factors, encapsulated ESC aggregates cultured statically were studied 
in a three factor, two level (23 factorial design, 8 total conditions) experiment. The three 
factors were (1) alginate composition (Level 1: High G alginate, Level 2: High M alginate; 
both had thin PLL coatings to maintain the aggregates within the beads for 7 days), (2) 
external oxygen tension (Level 1: normoxia – 21% O2, Level 2: hypoxia – 3% O2), and (3) 
presence of the mesoderm stimulating protein bone morphogenetic protein-4 (BMP-4) 
(Level 1: no BMP-4 added, Level 2: 10 ng/mL BMP-4 added) (Figure 5.1a). The 
morphology of the encapsulated aggregates over time (Figure 5.1b-q) was consistent with 
previous findings, with aggregates cultured in the High G alginate maintaining a spherical 
structure while aggregates cultured in the High M alginate became elongated over time 
[245]. No drastic changes in morphology were observed in response to oxygen level or the 
presence of BMP-4, though some of the BMP-4 treated groups appeared to have distinct 
light and dark regions (Figure 5.1m, 5.1q), which can be a sign of morphogenesis and 
differentiation [247,248]. 
 Analysis of gene expression for a pluripotency marker and a number of growth 
factors after seven days indicated that the environmental parameters were capable of 
modulating ESC cell state. Expression of the pluripotency marker Oct4 was decreased in 
comparison to undifferentiated ESCs in all groups, as expected after seven days of 
differentiation (Figure 5.2a). However, culture with BMP-4, particularly under hypoxic 
conditions, promoted increased Oct4 expression in the High M alginate only. Two growth 
factors which have been identified as sensitive to oxygen level, Vegf and Igf2, exhibited 




Figure 5.1. Factorial experiment of environmental parameters. ESCs were encapsulated in 
either High G alginate or High M alginate and cultured in either hypoxic or normoxic oxygen 
concentrations with or without the presence of the mesoderm-stimulating protein BMP-4 (A). Phase 
images of each condition at day 4 and day 7 of differentiation exhibit morphological differences, 
including elongation of the aggregates and the presence of contrasting dark/light morphogenic 





Figure 5.2. Growth factor gene expression profiles resulting from environmental 
conditioning. Gene expression results at day 7 of differentiation for the pluripotency marker Oct4 
(A) and growth factors Vegf (B), Igf1 (C), Igf2 (D), Fgf2 (E), and Bmp4 (F) are displayed relative 
to the expression level of undifferentiated ESCs (denoted by the red dashed line). Significant 
differences (p < 0.05) between paired alginate composition are denoted by an a; significant 
differences between paired oxygen concentrations are denoted by an o; and significant differences 
between paired media conditions, namely the presence or absence of BMP-4, are denoted by an m. 
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increased in response to low oxygen, but this response was only observed in the High M 
alginate (Figure 5.2b). Conversely, the expression of Igf2 was not affected by oxygen level 
but was expressed more highly when cultured in High G alginate or in the presence of 
BMP-4 (Figure 5.2d). The growth factor Igf1 was affected only by alginate composition 
and was significantly more highly expressed in the High G + BMP-4 groups than in the 
High M + BMP-4 groups (Figure 5.2c). In contrast, Fgf2 was expressed more highly by 
cells cultured in High M alginate in the absence of BMP-4 (Figure 5.2e). Finally, the 
expression of Bmp4 was influenced by all three environmental parameters and was 
generally increased in High G alginate, in low oxygen conditions, and the presence of 
external BMP-4 (Figure 5.2f). The results of this study indicate that the growth factor 
expression of ESCs is not exclusively regulated by a single environmental parameter (or 
combination of environmental parameters) but that the defined culture conditions play a 
significant role in controlling expression patterns. 
5.3.2 Global analysis of ESC secreted factors using cytokine arrays 
 To assess the presence of cytokines and growth factors at a more comprehensive 
level, commercially-available antibody arrays were used to determine if certain secreted 
factors were present in the ESC conditioned media. The two arrays used were capable of 
assessing the presence of 96 unique proteins (identified in Table 5.2). Perfusate collected 
from ESC aggregates encapsulated in High G alginate and perfused at 150 µL/hr for 4 days 
(day 1-5 of differentiation; pooled from 6 different reactors) was analyzed using both arrays 
and subsequently quantified to obtain relative abundance. Of the 96 species, 59 were 
present above the threshold of 10% of the intensity of the positive control spot (Figure 




Figure 5.3. Relative intensity of protein species present in ESC conditioned medium. 
Commercial antibody arrays were used to determine the presence of 96 proteins in conditioned 
media collected from perfused ESCs between days 1-5 of differentiation. Ingenuity Pathway 
Analysis (IPA) was used to categorize the proteins into the following categories: (1) Increase 
proliferation of mesenchymal cells; (2) Affect developmental processes of bone marrow cells; (3) 
Decrease cell death of hematopoietic progenitors; (4) Increase proliferation of hematopoietic 
progenitor cells; and (5) Increase the quantity of hematopoietic cells.  
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factor binding protein-2 (IGFBP-2), osteopontin, thymus CK-1 (CXCL7), LIX (CXCL5), 
and insulin-like growth factor binding protein-3 (IGFBP-3). Many of the detected proteins 
play roles in processes related to the bone marrow physiology. Using Ingenuity Pathway 
Analysis (IPA), the presence of detected proteins in five functional categories was 
explored. IGF-1, VEGF-A, and bFGF are documented as “increasing proliferation of 
mesenchymal cells;” IGF-1, M-CSF, SDF-1α, TPO, and SCF “affect developmental 
processes of bone marrow cells;” IGF-1, PF-4, TSLP, TPO, bFGF, Leptin, RANTES, and 
SCF “decrease cell death of hematopoietic progenitors;” Osteopontin, IL-1α, TSLP, IL-
12p70, M-CSF, SDF-1α, IL-1β, IL-4, TPO, VEGF-A, bFGF, SHH-N, and SCF “increase 
proliferation of hematopoietic progenitor cells;” and IGFBP-2, IGF-1, IL-1α, M-CSF, 
SDF-1α, TPO, Leptin, SCF, and IL-3 Rb “increase the quantity of hematopoietic cells.”  
 To determine how the global secretion profiles change with differentiation stage 
and culture under perfusion, ESCs were cultured in either basal or mesoderm-promoting 
conditions and under static or perfusion culture (Figure 5.4). Smaller alginate beads 
composed of High G alginate were used for the early stage of differentiation (Figure 5.4b-
c), while larger alginate beads of High M alginate (Figure 5.4e) were used for the later 
stage, mesoderm-primed cultures so that the larger aggregates (Figure 5.4d) would not be 
subjected to shear stress during the encapsulation process and due to previous findings that 
culture in High M alginate promotes mesoderm differentiation [245]. 
 A global increase in protein concentration was observed in the conditioned media 
collected from the day 4-7 “mesoderm-primed” cultures in comparison to the day 1-4 
“early differentiating” cultures (Figure 5.5a-b). This is likely due to the increase in cell 




Figure 5.4. Comparison of ESC differentiation stage and culture platform. A timeline (A) of 
ESC culture and encapsulation indicating the two stages of differentiation (early-differentiating 
cells cultured in High G alginate from day 1-4 and mesoderm-primed cells cultured unencapsulated 
in the presence of BMP-4 from day 1-4 and subsequently encapsulated in High M alginate and 
cultured for three additional days in the absence of BMP-4). ESC aggregates cultured in static (B) 
and perfusion (C) culture exhibit similar morphology, while unencapsulated ESC aggregates 
primed with BMP-4 (D) are larger after three days of culture. The larger aggregates were 
encapsulated in larger alginate beads composed of High M alginate (E) and did not appear to 
increase in size in the subsequent three days in culture. 
 
there was a general increase in concentration of all proteins, some species were increased 
more or less relative to the average increase (Figure 5.5d). Proteins involved in mesoderm-
related processes, including SDF-1α, VEGF-A, and MMP-2, had a greater relative increase 
than would be expected based on cell number alone, while species involved in more early 
stage development and general mitogenesis, such as IGF-1, IGF-2, and several of the 
IGFBPs, exhibited a lower relative increase than would be expected based on cell number. 
Comparing the static and perfusion culture platforms (Figure 5.6a-b), the perfusate 
collected from the packed bed reactor contained higher concentrations of all but two 
detected protein species, with an overall average increase of 1.6-fold over static (Figure 




Figure 5.5. Secreted profiles of early differentiating and mesoderm induced ESCs. Antibody 
arrays were used to analyze the contents of ESC conditioned media collected from cells in an early 
stage of differentiation (A) and at a late, more directed stage of differentiation (B). More cells were 
present in the mesoderm-induced, later stage differentiation (C), which may be partially responsible 
for the general increase in intensity observed. The intensity of each detected protein was normalized 
to the overall average increase to attempt to account for the influence of cell number, and certain 






Figure 5.6. Secreted profiles of ESCs cultured under static and perfusion conditions. Antibody 
arrays were used to analyze the contents of ESC conditioned media collected from cells in an early 
stage of differentiation cultured either statically (A) or in a custom perfusion bioreactor at a flowrate 
of 150 µL/hr (B). A global increase in intensity was observed in the conditioned media derived 
from the perfusion reactor (D), despite the lower number of cells present in this condition (C). The 
intensity of each detected protein was normalized to the overall average increase to attempt to 
determine if certain species were more or less sensitive to perfusion culture, and certain species 
were found to be present at higher or lower concentrations relative to that average increase (E). 
 
conditions (Figure 5.6c), likely due to uneven initial seeding within the reactor. Though a 
global increase in growth factor and cytokine concentration was observed when the ESCs 
were cultured under perfusion, certain species were upregulated to a greater extent than 
others (Figure 5.6e), indicating that the secretion of specific proteins may regulated to a 
greater extent by changes in culture condition, such as the observations observed with 
VEGF and IGFBP-2 in Chapter 4.  
5.3.3 Comprehensive analysis of ESC morphogen expression 
The limited number of cytokines and lack of developmental morphogens of interest 
present on commercially available arrays prompted a complementary approach to examine 
the proteins expressed by ESCs; thus, a custom 96 gene expression array was designed 
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using the Fluidigm platform. To determine what unique morphogens, growth factors, and 
cytokines are expressed by ESCs in comparison to other common supportive cell 
populations, the gene expression profiles of mouse embryonic fibroblasts (mEFs) (Figure 
5.7a) and mouse bone marrow mesenchymal stem cells (MSCs) (Figure 5.7b) were 
directly compared to undifferentiated mouse ESCs. There were drastic increases (>1000-
fold) in the expression of certain genes uniquely observed in ESCs in comparison to both 
mEFs and moMSCs, including Fgf3, Fgf4, Fgf15, Fgf 17, Nodal, and Igfbp2. Using IPA, 
the top related functions and diseases for each cell type were determined, based on genes 
with a 10-fold or greater difference (Table 5.4 and 5.5). The genes differentially expressed 
by ESCs were primarily related to morphogenic events and processes, while the stromal 
mEFs and MSCs expressed genes associated with more general cell functions, such as 
migration and proliferation. The unique expression profile of ESCs in comparison to these 
two common support cell types indicates that they are a unique cell source for morphogenic 
proteins. 
To evaluate the influence of differentiation stage and culture platform on gene 
expression in addition to protein expression, ESCs were cultured in either basal or 
mesoderm-promoting conditions and under static or perfusion culture as previously 
described (Figure 5.4). Gene expression values were normalized to undifferentiated ESCs 
(collected at day 0 of the experiment), organized via two-dimensional hierarchical 
clustering, and displayed as a heatmap, with red indicating increased expression over 
undifferentiated ESCs and blue signifying decreased expression compared with 
undifferentiated ESCs. When comparing differentiation stages, the day 4 “early 




Figure 5.7. Gene expression profiles of ESCs in comparison to mouse embryonic fibroblasts 
(mEFs) and mesenchymal stem cells (MSCs). A custom PCR array was designed and analyzed 
using the Fluidigm platform, and the expression profile of undifferentiated ESCs was compared to 
that of mEFs (A) and MSCs (B). Several of primers which were found to be highly expressed by 
ESCs in comparison to MSCs did not amplify in the mEF cell population, making direct 
comparison impossible.  
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Table 5.4. Top related functions and diseases for mEFs vs. ESCs 
 
 
Table 5.5. Top related functions and diseases for MSCs vs. ESCs 
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Looking broadly, 17% of the molecules (13 genes) were consistently downregulated when 
compared to day 0, while ~27% (20 genes) were consistently upregulated in comparison 
to day 0 (Figure 5.8a). The remaining ~53% of the genes were either relatively unchanged 
from day 0 (~13%, 10 genes) or differentially expressed between days 4 and 7 (~40%, 30 
genes). To visualize the differences in expression between day 4 and day 7 of 
differentiation, volcano plots were constructed in which the log2 fold difference relative to 
day 4 was plotted with the corresponding p-value describing the statistical significance of 
the difference in gene expression (Figure 5.8b). In comparison to the 1000+ fold changes 
observed when comparing different cell types, modest changes in gene expression (<10-
fold) were observed between the two stages of differentiation (Figure 5.8c). In general, 
genes involved in developmental processes, including several members of the fibroblast 
growth factor (FGF) family as well as leukemia inhibitory factor (LIF), Nodal, and Lefty1, 
were more highly expressed in the early stage of differentiation, while genes involved in 
slightly later developmental and cell processes, such as other members of the transforming 
growth factor-β and bone morphogenetic protein (TGF-β/BMP) family, were expressed 
more highly in the later stage, mesoderm-primed cells. 
Culture of the early differentiating ESCs under static or perfusion conditions also 
led to subtle changes in gene expression, with cells from the two culture platforms 
clustering separately from one another. Relative to the undifferentiated cells collected at 
day 0, ~16% of the molecules (11 genes) were consistently downregulated when compared 
to day 0, while ~42% (28 genes) were consistently upregulated when compared to 
undifferentiated cells (Figure 5.9a). Approximately 34% of the molecules (23 genes) were 




Figure 5.8. Gene expression profiles of ESCs at different stages of differentiation. Using the 
PCR array designed and analyzed using the Fluidigm platform, the expression profile of early-
differentiating ESCs collected at day 4 can be compared to mesoderm-induced ESCs collected at 
day 7. A heatmap organized via two-dimensional hierarchical clustering using Genesis software 
with red indicating increased expression over undifferentiated ESCs and blue signifying decreased 
expression compared with undifferentiated ESCs (A). A volcano plot indicating the log2 fold 
difference relative to day 4 is plotted with the corresponding p-value describing the statistical 
significance of the difference in gene expression (B), and the highlighted genes were are 





Figure 5.9. Gene expression profiles of ESCs cultured under static and perfusion conditions. 
Using the PCR array designed and analyzed using the Fluidigm platform, the expression profile of 
early-differentiating ESCs collected at day 4 cultured under either static or perfusion conditions 
can be compared. A heatmap organized via two-dimensional hierarchical clustering using Genesis 
software with red indicating increased expression over undifferentiated ESCs and blue signifying 
decreased expression compared with undifferentiated ESCs (A). A volcano plot indicating the log2 
fold difference relative to static culture is plotted with the corresponding p-value describing the 
statistical significance of the difference in gene expression (B), and the highlighted genes were are 
statistically significant (p < 0.05) are listed along with the fold change (C).  
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once again subtle in comparison to those observed between cell types (Figure 5.9b-c). A 
striking difference at the global level was the general increase in gene expression observed 
in cells cultured under perfusion, with an overall average fold-increase of 3.3 ± 0.6 across 
all genes (median increase of 2.5-fold change), suggesting that the culture under perfusion 
may be affecting protein expression at the level of transcriptional regulation. 
5.4 Discussion 
 The results of this study identify a profile of unique morphogens, cytokines, and 
growth factors that are expressed by pluripotent stem cells and that can be modulated by 
various parameters, including environmental conditions, bioreactor platform, or 
differentiation stage of the cells. Through a combination of proteomic and gene expression 
analysis, a total of 170 different species (96 via cytokine arrays, 95 via gene expression, 21 
via both protein and gene expression) were examined in order to identify molecules of 
particular interest and to attain a global perspective on the dynamics of expression. Overall, 
the results of this study demonstrate that pluripotent stem cells are unique in their 
expression profiles of morphogens, cytokines, and growth factors in comparison with other 
cell populations frequently used for their paracrine activity and that the expression profile 
can be modulated by altering the environmental and culture parameters. 
 To determine if modulating the external environment of encapsulated ESCs led to 
changes in the expression of growth factors, cells were cultured in combinations of 
normoxic (21%) and hypoxic (3%) oxygen levels, with or without the mesoderm-
stimulating molecule BMP-4, and in alginate with a high (High G) or low (High M) 
percentage of guluronic acid residues (Figure 5.1). Intriguingly, cells cultured within the 
High G alginate had similar gene expression profiles regardless of oxygen tension or the 
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presence of BMP-4, with no significant differences in expression observed for any of the 
six genes evaluated (Figure 5.2). This finding may indicate that signals provided through 
culture in the stiff High G alginate essentially override the other external signals, signifying 
that culture in High G alginate may provide a defined culture environment that is less 
susceptible to variation in environmental parameters. In contrast, cells cultured in the High 
M alginate had varied gene expression depending on all environmental cues, though most 
individual genes were only affected by 1-2 of the parameters. Increased expression of Vegf 
with culture in low-oxygen conditions (Figure 5.2b) is consistent with its established role 
as a hypoxia-induced growth factor [240], though increased expression of Igf2 was not 
observed (Figure 5.2d), indicating that some of the other culture parameters may have 
predominated the response. Indeed, the addition of BMP-4 to the culture media led to 
significant increases in Igf2 (Figure 5.2d) and Bmp4 (Figure 5.2f) expression, which is 
consistent with previous reports [248], and a significant decrease in Fgf2 expression 
(Figure 5.2e). Culture within High M alginate led to decreased expression of three growth 
factors (Igf1, Igf2, and Bmp4) and increased expression of Fgf2, though the differences 
between alginate compositions were typically observed in tandem with one to two other 
culture parameter combinations and not all four of the possible combinations, indicating 
that the influence of other environmental parameters were often the dominant signal. 
 A wider screen of proteins present in the ESC conditioned media was performed 
using commercially available antibody arrays for 96 species, mostly consisting of 
cytokines and chemokines in addition to some growth factors. For an initial screen, 
perfusate collected from ESCs encapsulated in High G alginate and cultured under 
perfusion was found to contain many species which are implicated in the regulation of bone 
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marrow populations (Figure 5.3). Though some indication of relative abundance can be 
drawn from the intensity of each dot blot on the array, it is important to note that they 
provide semi-quantitative results, and thus a higher intensity of one protein does not 
necessarily indicate that it is present in higher abundance than a protein of lower intensity, 
particularly because detection of different proteins via antibody methods should ideally be 
optimized for each species and thus is a general caveat for all protein arrays at present 
[249]. Therefore, greater quantitative information is gained when comparing the same 
protein species across multiple samples obtained from different conditions. Consequently, 
the profile of proteins present in ESC conditioned media was compared between stages of 
ESC differentiation and the type of culture platform (static vs. perfusion) employed 
(Figure 5.4).  
A global increase in protein expression was observed in the day 7 mesoderm-
induced condition in comparison to the day 4 early differentiating condition, likely due to 
the increase in cell number; however, several proteins of interest were identified as 
markedly upregulated with differentiation, including proteins involved in mesoderm-
related processes such as SDF-1α, VEGF-A, and MMP-2, while others were relatively 
decreased in the day 7 condition, including proteins involved in early stage development 
and general mitogenesis, such as IGF-1, IGF-2, and several of the IGFBPs (Figure 5.5). A 
similar signature of molecules was found at the gene expression level through designing 
and analyzing results from a custom 96-gene Fluidigm PCR array (Figure 5.8). Similar to 
previously published results with differentiating mouse embryonic stem cells, comparable 
declines (Fgf17, Nodal, Lefty1, Fgf4, Fgf1, Fgf15, Fgf22, Bmp8a, and Fgf18) and increases 
(Bmp5, Tgf-β2, Bmp2, Tgf-α) of specific molecules over time of differentiation were 
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observed [236]. Reported differences in the secretome of undifferentiated human 
embryonic stem cells (hESCs) in comparison to hESCs which had been spontaneously 
differentiated for 6-8 days exhibited some similarities (Fgf15/19, Igfbp2, Fgf4) and some 
disparities (Bmp6) from the work presented here, which is likely attributed to differences 
in species or in the differentiation protocol used [250]. The shift in secretion and gene 
expression profile with differentiation stage indicates that secretion is dynamically 
regulated during ESC differentiation, as would be expected with the cells undergoing 
morphogenic and phenotypic changes, and that modulation of the differentiation state can 
be used to control the relative abundance of certain secreted proteins. For example, the 
secretion of IGF-2 and VEGF are reported to increase with the differentiation of ESCs as 
embryoid bodies [181]. 
 Subjecting encapsulated ESC aggregates to perfusion culture led to a global 
increase of almost every protein detected by the antibody arrays when compared to static 
cultures (Figure 5.6), in spite of the observation that fewer cells were present in the 
perfusion reactors than were present in the static plates (Figure 5.6c). There are several 
potential explanations to elucidate the observed increase in protein concentration. At the 
cellular level, gene expression or the rate of packaging and secreting proteins out of the 
cell may be increased, either due to changes in cell phenotype, cell proliferation (depending 
if the proteins secreted are growth-associated or are produced independent of cell growth), 
or the absence/presence of feedback inhibition. The gene expression data obtained with the 
Fluidigm PCR array also reflects a global increase in expression for cells cultured under 
perfusion (Figure 5.9), suggesting that the culture platform may be affecting protein 
expression at the level of transcriptional regulation. Though several molecules were more 
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highly expressed in static culture, perfusion culture led to an overall average fold-increase 
of 3.3 ± 0.6 across all genes (median of 2.5 fold-increase) and an average fold-increase of 
4.7 ± 0.8 the subset of genes increased with perfusion culture (median of 4.0 fold-increase).  
 In order to establish the unique proteins expressed by ESCs in comparison to other 
cell types frequently employed for their paracrine actions, the expression profiles of 
undifferentiated ESCs were compared to mouse embryonic fibroblasts (mEFs) and 
mesenchymal stem cells (MSCs). Mouse embryonic fibroblasts were examined because 
they are traditionally used as feeder layers for embryonic stem cell culture due to their 
secretion of factors and extracellular matrix which maintain the pluripotent state. In 
addition, MSCs have been investigated for a number of clinical applications based on their 
paracrine secretion of pro-angiogenic and immunomodulatory cytokines [191,192]. 
Several protein species identified were uniquely expressed in high levels by ESCs, 
including insulin-like growth factor binding protein-2 (Igfbp2) and several members of the 
fibroblast growth factor family (particularly Fgf3, Fgf4, Fgf15, and Fgf 17) (Figure 5.7, 
Tables 5.4-5.5). The protein IGFBP-2, which is generally expressed during development, 
is involved in modulating the activity of the IGFs and also acts independently through 
multiple receptors to regulate cell survival, proliferation, movement, and differentiation of 
many different cell types [251]. In the context of the bone marrow microenvironment, 
IGFBP-2 has been previously used in the ex vivo expansion of mouse and human 
hematopoietic stem cells (HSCs) in combination with angiopoietin-like proteins (Angptls) 
[252,253]. In vivo, IGFBP-2 is reported to act independently of IGF receptors and promote 
HSC repopulation in a non-cell autonomous manner, indicating that cells of the bone 
marrow niche, particularly stromal cell populations, provide the IGFBP-2 required for HSC 
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function [251]. The high expression level of FGF-4 was anticipated given its key 
developmental role as the first member of the FGF family to be expressed, though its 
function is not solely limited to embryogenesis [222,254]. In fact, FGF4 also play key roles 
in regulating bone marrow function through promoting the ex vivo expansion of bone 
marrow mesenchymal stem cells [255–257]. The distinct ability of pluripotent stem cells 
to produce key proteins, like IGFBP-2 and FGF-4, indicates that ESCs may be a novel 
source of important paracrine factors to promote exogenous cell function. 
 Though a large number of proteins were examined in this study with the use of 
antibody and gene expression arrays, a larger-scale proteomics approach would offer 
additional insight through recognition of unknown species of interest. Typical shotgun-
based proteomics using mass spectrometry offer a number of advantages, including the 
lack of bias inherent with target-based approaches. However, mass spectrometry suffers 
from a number of technical shortcomings, including extensive sample preparation which 
can lead to degradation of certain classes of proteins, a limited ability for quantitation, a 
difficulty identifying proteins present in low abundance, and significant rates of false 
positive and false negatives during protein identification [249,258,259]. Even with 
advancement in technologies to identify and quantify individual proteins in complex 
mixtures, effort will still be required to standardize upstream culture protocols and sample 
preparation such that studies across different platforms can be directly compared [191]. 
Ultimately, employing unbiased proteomic approaches may reveal additional unique 





 Overall, the results of this study demonstrate that pluripotent stem cells feature 
expression profiles of morphogens, cytokines, and growth factors that are distinctive from 
other cell populations frequently used for their paracrine activity. The expression profile 
changes with differentiation stage of the ESCs, with proteins involved in early 
developmental process and general mitogenesis expressed more highly in early stages of 
differentiation, whereas proteins involved in tissue specification and cell migration were 
expressed at higher levels at later stages of differentiation. Additionally, by exercising 
control over the cell microenvironment through the type of alginate used for encapsulation, 
exposure to different oxygen tensions or to mesoderm-promoting BMP-4, and culture of 
the cells under perfusion, diverging expression profiles can be attained both at the single 
species and the global level. Specifically, culture in alginate with a higher ratio of guluronic 
acid appears to override the effects of stimuli provided by oxygen level or the presence of 
BMP-4. In addition, culture of the encapsulated cells in a perfusion bioreactor globally 
increases both gene expression and secreted protein concentration. Taken as a whole, this 
study provides new characterization of the morphogenic species expressed by pluripotent 
stem cells and how the expression profile of ESCs can be regulated via systematic control 
over culture parameters.  
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CHAPTER 6 
INFLUENCE OF STEM CELL-DERIVED MORPHOGENS ON 
ADULT STEM AND PROGENITOR CELL POPULATIONS 
6.1 Introduction 
The concept of a stem cell “niche” was first introduced in the late 1970s [78] to 
describe an anatomical location which provides signals to resident stem cells to regulate 
their potency as well as their functional properties [79–81]. The signals that constitute the 
niche come in the form of secreted molecules, extracellular matrix interactions, and cell-
cell interactions, and the recreation of the native stem cell niche has been an active 
approach in tissue engineering as a means to control cell behavior [260]. While the “niche” 
of the in vivo equivalent of embryonic stem cells is transient, multipotent and unipotent 
adult stem cell populations, including those which replenish the blood, skin, intestinal 
epithelium, muscle, and nervous system [79–81], are well established and are maintained 
throughout life. Each niche typically contains a resident stem cell population, progenitor 
cells derived from the stem cells, and supporting cells that produce signals required for the 
resident stem cell to remain quiescent, self-renew, or differentiate, as is appropriate.  
Hematopoietic stem cells (HSCs) give rise to all blood and immune cells and are 
responsible for continually replenishing these cell populations for functions ranging from 
oxygen transport throughout the body to adaptive immune responses. Though the mature 
cells derived from HSCs through the process of hematopoiesis are found throughout 
circulation in the body, adult HSCs reside primarily in the bone marrow cavity. The bone 
marrow niche exists as a semi-solid matrix consisting of various collagens, proteoglycans, 
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glycosaminoglycans, and calcium minerals to house the resident HSCs [10,11,84,85]. 
Many other cell types also reside within the bone marrow niche, including mesenchymal 
stem/stromal cells (MSCs), endothelial progenitor cells, osteoblasts, reticular cells, 
adipocytes, and nerve cells. High levels of regulatory cytokines (e.g. SDF-1, SCF, 
interleukins, TPO) are present within the niche in addition to ligands of the Notch and Wnt 
signaling pathways [82,84,87–89]. Because the bone marrow niche is a vital regulator of 
HSC function, aberrant function of cells within the niche can lead to abnormal HSC 
behavior (e.g. deficient differentiation toward one or all hematopoietic cell types), as has 
been observed in the case of aging [261] and certain pathological disorders [262–264]. For 
example, a mutation in the gene encoding stem cell factor (SCF; also known as Kit-ligand) 
that results in a lack of membrane-bound SCF but maintains soluble SCF secretion leads 
to mice that are incapable of sustaining HSC populations [265–267], indicating that even 
the manner in which signals are physically presented can be vitally important to the 
resulting stem cell behavior.   
In contrast to the billions of blood and immune cells produced every day from 
HSCs, muscle satellite cells tend to remain relatively quiescent until called upon to respond 
to an injury. When skeletal muscle is damaged, a well-orchestrated process occurs in which 
the wounded muscle fibers undergo necrosis, stimulating an inflammatory response, and 
resident satellite stem cells are activated to proliferate and differentiate into a large number 
of myoblast cells [91]. The myoblasts subsequently differentiate and undergo fusion to 
form the mature muscle fibers necessary to replenish the injured tissue [268]. When Pax7+ 
satellite cells are ablated from mice, skeletal muscle is no longer able to regenerate 
following injury [269–271], and transplantation of single myofibers with their associated 
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satellite cells are able to regenerate damaged tissue following transplantation into radiation-
ablated muscles [268]. Similar to HSCs and other adult stem cell populations, satellite cells 
do not act autonomously and require support from their niche in the form of structural and 
biochemical signals. Many soluble cues, including Wnts, FGFs, IGFs, HGF, EGFs, SDF-
1α, and Notch ligand, are exchanged between satellite cells and the surrounding myofibers, 
interstitial cells, and endothelial cells, and the identities and concentrations of the paracrine 
factors are responsible for maintaining quiescence, prompting self-renewal, and instigating 
differentiation [92–97]. The processes regulating satellite cell behavior can become 
dysregulated when aspects of the niche are altered, as is observed with the increased 
sarcopenia and decreased regenerative capacity in aged organisms when the paracrine 
factors secreted by cells of the interstitium, vasculature, and immune system are altered 
[272]. 
 While the self-renewal capacities of adult stem cell populations in vivo are well-
documented, similar success has not been achieved in attempts to expand the cell 
populations ex vivo. Despite decades of research, a striking contradiction persists in 
hematopoietic stem cell biology in that a single HSC transplanted in vivo can expand 
exponentially and eventually repopulate an entire animal, whereas HSCs cultured ex vivo 
exhibit extremely limited expansion potential and rapidly lose the capacity for self-
renewal. The current standard for maintenance of HSCs ex vivo relies upon a cytokine 
cocktail consisting of three to four factors, often some combination of stem cell factor 
(SCF), Flt3 ligand (Flt3L), interleukin-11 (IL-11), and thrombopoietin (TPO). However, 
most attempts at expansion have had limited success [116–118], as HSCs must be 
expanded quickly or risk losing their proliferative and blood lineage potential. Due to 
 134 
insufficient and unreliable HSC expansion with traditional cytokines (SCF, TPO, 
interleukins, Flt3), new emphasis is being placed on the use of developmental factors, such 
as Wnt proteins, Notch ligand, bone morphogenetic proteins (BMPs), and fibroblast growth 
factors (FGFs) as potential mediators of expansion [117,120,127,128]. Similar challenges 
with ex vivo expansion are observed with primary muscle populations, with a decreased 
capacity for re-engraftment and regeneration observed in satellite cell-derived myoblasts 
following expansion ex vivo [129–132]. Current strategies to expand mouse myoblasts 
cultured in vitro include the presentation of Notch-ligand [133] and the use of hydrogel 
culture substrates with a low elastic modulus that better mimics the native physiological 
environment [134], while recent advances in expanding human muscle stem cells have 
been achieved through inhibition of p38 MAPK [135]. Though the development of novel 
approaches has improved the expansion of multipotent stem cell populations, there is still 
significant room for improvement in order to achieve the cell numbers required for 
therapeutic transplantation. 
 Due to the limitations of current methodologies to expand adult stem cell 
populations while maintaining their functional capacity, an increasing emphasis is being 
placed on the use of developmental factors, such as Wnt proteins, Notch ligand, bone 
morphogenetic proteins (BMPs), and fibroblast growth factors (FGFs) [117,120,127,128]. 
Thus, exposing bone marrow and muscle cell populations to developmentally-relevant 
factors durin ex vivo culture could improve the expansion efficiency and function of these 
cells upon transplantation. Cells of the early embryo, the in vivo analog of ESCs, provide 
morphogenic signals during embryogenesis that stimulate histogenesis of neighboring cells 
through paracrine actions and also stimulate their own differentiation through autocrine 
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signals. By secreting growth factors, cytokines, and mitogens, ESCs create a potent 
microenvironment that stimulates morphogenic events leading to tissue and organ 
formation [219,220]. When cultured in vitro, ESCs secrete a similar array of morphogenic 
factors—including Wnts, bone morphogenetic proteins (BMPs), fibroblast growth factors 
(FGFs), and vascular endothelial growth factor (VEGF)—that stimulate the proliferation 
and differentiation of several cell types, as profiled in Chapter 5 [32,181]. Injection of ESCs 
into embryos with multiple cardiac defects has improved the embryonic cardiac phenotype, 
a finding attributed to secretion of insulin-like growth factor 1 (IGF-1) and Wnt5a [30]. 
ESC transplantation has also reduced myocardial dysfunction in a rat model of surgically 
induced global ischemia, presumably by increasing the secretion of VEGF and interleukin-
10 [31]. Additionally, ESC co-culture has been used to expand cardiomyocytes, corneal 
epithelial cells, and fibroblasts in vitro [32–34,181,273], in all cases improving cell 
proliferation and function. Conditioned medium from ESCs increases the proliferation of 
aged satellite cells and myoblasts while inhibiting differentiation [35,250,274], and also 
increases the survival of hematopoietic progenitors [36]. Aside from stem cell–derived 
factors, systemic molecules originating from younger mice improve function in aged mice 
connected via parabiosis, including enhanced wound healing [37,38], improvement in 
muscle satellite cell function [39–41], rejuvenation of neural cells and cognitive function 
[42–45], and reversal of cardiac hypertrophy [46]. Therefore, the paracrine actions of 
trophic factors derived from pluripotent cells may provide analogous signals that enable 
adult stem cells to regain a more “youthful” proliferative or regenerative capability. 
 In order to establish the impact of ESC secreted factors on adult stem cell 
populations ex vivo, three different cell populations were studied in both co-culture and 
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conditioned media configurations. Cultures of bone marrow-derived mesenchymal stem 
cells (MSCs) were examined in addition to more heterogeneous primary cells isolated from 
murine bone marrow and skeletal muscle. In addition to assessing the mitogenic effects of 
pluripotent cell-derived factors on cell proliferation, the differentiation capacity of the adult 
stem and progenitor cell populations was also evaluated to discern the consequence on cell 
function following exposure to the unique soluble milieu. Conditioned media collected 
from ESCs at different stages of differentiation and ESCs cultured under different 
environmental settings were also directly compared to determine the impact of a shifting 
composition of paracrine factors. Overall, this study revealed the impact of the unique 
developmental morphogens produced by pluripotent stem cells on maintaining and 
expanding adult stem cell populations. 
6.2 Materials and methods 
6.2.1 Embryonic stem cell culture 
Murine ESCs (D3 cell line) were cultured on tissue culture treated polystyrene 
dishes (Corning) adsorbed with 0.1% gelatin (EmbryoMax). Undifferentiated ESC culture 
media consisted of Dulbecco’s modified Eagle’s medium (DMEM) (Mediatech) 
supplemented with 15% fetal bovine serum (Hyclone), 100 U/mL penicillin, 100 μg/mL 
streptomycin, and 0.25 μg/mL amphotericin (Mediatech), 2 mM L-glutamine (Mediatech), 
1x MEM non-essential amino acid solution (Mediatech), 0.1 mM 2-mercaptoethanol 
(Fisher Scientific), and 103 U/mL of leukemia inhibitory factor (LIF) (ESGRO). Cultures 
were replenished with fresh media every other day and passaged prior to reaching 70% 
confluence. 
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6.2.2 ESC aggregate formation  
A single cell suspension of undifferentiated ESCs was obtained through 
dissociation of monolayer cultures with 0.05% trypsin-EDTA (Mediatech). Defined, 
serum-free KO N2B27 media (note: formulation is slightly different than what was used in 
Chapter 3) was used for all aggregate cultures and consisted of Knock-Out (KO) DMEM 
(Life Technologies) supplemented with N2 (Gibco), B27 (Gibco), 100 U/mL penicillin, 
100 μg/mL streptomycin, and 0.25 μg/mL amphotericin (Mediatech), 2 mM L-glutamine 
(Mediatech), 1x MEM non-essential amino acid solution (Mediatech), and 0.1 mM 2-
mercaptoethanol (Fisher Scientific). Aggregation of ESCs was achieved by centrifugation 
(200 rcf) of ESCs into 400 μm square polydimethylsiloxane (PDMS) micro-wells 
(AggrewellTM, Stem Cell Technologies) as previously reported [19,152]. The cell seeding 
density yielded approximately 500 cells per individual well. The ESCs were incubated in 
the wells for approximately 24 hours in serum-free KO N2B27 culture media to allow for 
aggregate formation. 
6.2.3 Cell microencapsulation  
Two different medium viscosity alginates were used: ultrapure MVG (Pronova) 
which contains greater than 60% G residues (High G) and ultrapure MVM (Pronova) which 
contains greater than 50% M residues (High M). Alginate solutions were prepared at 1.5 
wt% in calcium-free DMEM (Gibco) and autoclaved for sterilization no more than one day 
before use. An electrostatic bead generator (Nisco) was utilized for encapsulation. Pre-
formed ESC aggregates were resuspended in alginate at a density of 12,000 aggregates per 
mL of alginate, and the cell-containing alginate solution was extruded through a 400 μm 
nozzle using a syringe pump at a flow rate of 6 mL/hour and a voltage of 10 kV to drop the 
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beads into a stirred hardening bath of 100 mM calcium chloride (EMD). The beads were 
washed three times with serum-free media prior to downstream culture. A thin PLL-coating 
was used to prevent aggregate escape for the collection of conditioned media over seven 
days. The beads were coated with 0.05% PLL (MW 15,000-30,000; Sigma) for 2 minutes 
prior to three additional media rinses. 
6.2.4 Microencapsulated cell culture and differentiation 
 Microencapsulated ESC aggregates were generally cultured statically in sterile 100 
x 15 mm bacteriological grade polystyrene Petri dishes (BD) in 10 mL serum-free KO 
N2B27 media (see 6.2.2) at an initial cell density of 3 x 105 cells/mL media. A 90% media 
exchange was performed every three days. Cells were cultured in humidified incubators 
under either normoxic (21% oxygen, 5% carbon dioxide) or hypoxic (3% oxygen, 5% 
carbon dioxide) conditions. Cells cultured under perfusion were placed in a custom packed 
bed perfusion reactor (3 x 106 cells/reactor) and received serum-free KO N2B27 media at 
a rate of 150 µL/hr (see Chapter 4). 
6.2.5 Mesenchymal stem cell culture 
 Murine bone marrow-derived mesenchymal stem cells (MSCs, isolated from 
C57Bl/6J mice) were obtained from the Texas A&M College of Medicine Institute for 
Regenerative Medicine The cryopreserved MSCs were thawed and plated onto a 15-cm 
tissue culture dish in 20 mL MSC complete expansion medium (CEM) which consists of 
Iscove’s Modified Dulbecco’s Medium; Invitrogen/GIBCO) supplemented with 10% fetal 
bovine serum (FBS; Hyclone, Logan, UT), 10% horse serum (Hyclone), 2 mM L-
glutamine (Invitrogen/GIBCO), 100U/mL penicillin, 100 μg/mL streptomycin and 0.25 
μg/mL amphotericin B (Invitrogen/ GIBCO). Following overnight incubation at 37°C, 
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adherent MSCs were washed with phosphate-buffered saline (PBS, Invitrogen/GIBCO) 
and detached from the tissue culture plate using 0.25% trypsin and 1 mM EDTA 
(Invitrogen/GIBCO). Cells were plated onto 15-cm tissue culture dishes, at a density of 50 
cells/cm2 in 20 mL CEM per dish. Cells were fed every 3–4 days with 20 mL of fresh CEM 
and maintained until they reached ∼70% confluence. For co-culture studies with 
ESCs, 1900 MSCs (density of 500 cells/cm3) were seeded into the bottom of tissue cultured 
treated 12 well plates (Corning) with 190,000 or 57,000 encapsulated ESCs (ratio of 100:1 
and 30:1 ESC:MSC) placed in the upper portion of a transwell insert, and the media 
consisted of KO N2B27. For the conditioned media studies, 475 MSCs (density of 500 
cells/cm3) were seeded into the bottom of a 48 well plate (Corning) and cultured with 800 
μL of growth media, 600 μL KO N2B27 with 200 μL growth media, or 600 μL ESC 
conditioned media with 200 μL growth media. 
6.2.6 Murine bone marrow isolation and culture 
Bone marrow (BM) was harvested from 8-12 week male mice (C57BL/6J or male 
C57BL/6 with eGFP constitutively expressed under the beta-actin promotor from Jackson 
Labs) by clipping the epiphysis of the femur and tibia followed by centrifugation at 1,000 
rcf for 5 minutes. BM cells were resuspended in sterile PBS with 3% FBS at ~5 x 107 per 
mL. Lineage cocktail antibodies (BD Pharmingen #558074, CD3e, CD11b, B220, TER-
119, Ly6G, Ly6C) were added to the resuspended BM, and cells were incubated on ice, 
protected from light for 30 minutes. Samples were washed with PBS, centrifuged at 500 
rcf for 5 minutes at 4°C, and then resuspended in 3% FBS/PBS and sorted on a BD FACS 
ARIA II. Lineage negative (Lin-) cells were collected by FACS with gates established 
based on an unstained control BM sample. Lin- cells were seeded into tissue cultured 
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treated 24 well plates at a density of 50,000 cells/well in 1 mL of medium. The standard 
medium used for culture was MyeloCult (Stem Cell Technologies M5300), which contains 
a proprietary blend of Minimum Essential Media Alpha (αMEM) base media, horse serum, 
fetal bovine serum, 2-mercaptoethanol, and other supplements. The use of unconditioned 
KO N2B27 medium, ESC conditioned media, endothelial growth medium (EGM), and 
endothelial cell conditioned media were assessed, and co-cultures with encapsulated ESCs 
were performed using transwell inserts containing 300,000 ESCs. The cells were incubated 
in humidified incubators maintained at 33°C and 5% CO2. 
6.2.7 Endothelial cell culture 
As a paracrine factor-secreting control cell population, murine yolk sac-derived 
endothelial cells (C166, ATCC CRL-2581) were cultured on tissue-cultured polystyrene 
dishes. The endothelial growth medium (EGM) was prepared by mixing 475 mL of 
Endothelial Basal Medium (cAP-03, Angioproteomie) and 25ml of Endothelial Growth 
supplement (cAP-04, Angioproteomie), which contains 5% fetal bovine serum, 
recombinant growth factors, and 1x penicillin and streptomycin. Endothelial cell cultures 
were replenished with fresh media every 2-3 days 
6.2.8 Murine skeletal muscle isolation and culture 
 Muscle tissue was isolated from the hind limbs of 16-20 week male C57Bl/6J mice 
(Jackson Labs) and minced into ~1 mm pieces in PBS using scalpels. The minced tissue 
obtained from four limbs was placed in a 50 mL conical tube and incubated with 10 mL of 
1.5 U/ml collagenase II (Life Technologies) and 2.5 U/ml dispase II (Stem Cell 
Technologies) in 2.5 mM CaCl2 (Sigma) for 30 minutes on a shaker at 37°C, with 
trituration every 10 minutes. After 30 minutes of incubation, the slurry was diluted with 
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PBS not containing calcium and magnesium (Corning), and the supernatant was removed, 
centrifuged at 400 rcf for 5 minutes, and resuspended in PBS. A further 10 mL of the 
collagenase/dispase solution was added to the remaining slurry, and the 30 minute 
incubation was repeated. The resulting cell pellet from the supernatant of the second 
digestion was combined with the first and filtered through 100 µm and 70 µm cell strainers 
(BD) to remove any remaining large tissue pieces, following by centrifugation and 
resuspension of the pellet in growth media. The growth media consisted of Hams F10 basal 
media (Life Technologies) with 20% mL FBS (Hyclone), 100 U/mL penicillin (VWR), 
100 µg/mL streptomycin (VWR), and 2.5 ng/mL basic fibroblast growth factor (Promega). 
The cell suspension was pre-plated on uncoated 100 mm tissue culture treated polystyrene 
dishes (Corning) for 30-60 minutes to preferentially adhere the fibroblast fraction, then the 
supernatant was subsequently transferred to tissue culture treated polystyrene dishes 
adsorbed with 0.1% gelatin (EmbryoMax) and cultured in growth media. A media 
exchange was performed two days post-isolation, and the cells were passaged 
approximately every four days afterward. When exposed to the different growth media, 
cells were seeded into 24 well plates adsorbed with 0.1% gelatin (EmbryoMax) and 
cultured in 1 mL growth media, 0.75 mL KO N2B27 with 0.25 mL growth media, or 0.75 
mL ESC conditioned media (collected from day 1-4 of differentiation under perfusion 
conditions) with 0.25 mL growth media. 
6.2.9 Cell number quantification 
For the MSCs, the collected cells were centrifuged at 200 rcf for 5 minutes, rinsed 
3x with PBS, and pelleted at 375 rcf for 4 minutes followed by supernatant removal and 
storage at -20°C. A CyQUANT Cell Proliferation Assay Kit (Molecular Probes Inc., 
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Eugene, OR) was used to determine cell number, with a standard curve created using MSCs 
that were counted using a hemocytometer. The fluorescence (480 nm excitation, 520 nm 
emission) was read using a Synergy H4 plate reader (Biotek). For the bone marrow cultures 
derived from eGFP mice, the Cytation3 Cell Imaging Multi-Mode plate reader (BioTek) 
was used to determine the number of GFP+ cells one day post-seeding. Assessment of cell 
number at day 4 of culture was performed using a known concentration of AccuCheck 
counting beads (Invitrogen) during flow cytometry analysis (see section 6.2.12). For the 
primary muscle cultures, cell number was determined using image analysis (see section 
6.2.15). 
6.2.10 Quantitative real time PCR 
Encapsulated aggregates were released from beads through 10 minute incubation 
with TrypLETM (Invitrogen), trituration, and 5 minute incubation with 55 mM sodium 
citrate (Sigma). The cells were centrifuged at 200 rcf and rinsed 3x with PBS to remove 
residual PLL. RNA was extracted from the aggregates with the RNeasy Mini kit (Qiagen 
Inc, Valencia, CA). The RNA (300 ng/sample) was converted to complementary DNA 
using the iScript cDNA synthesis kit (Bio-Rad, Hercules, CA) and analyzed using real time 
PCR (MyIQ cycler, Bio-Rad). Forward and reverse primers for 18s, Oct4, Nanog, Vegf, 
Igf1, Igf2, Fgf2, Bmp4, and Gdf11 were designed with NCBI’s Primer-BLAST (sequences 
and conditions are given in Table 6.1) and purchased from Invitrogen. Gene expression 
were calculated with respect to undifferentiated ESC expression levels as previously 
described [168].  
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Table 6.1. Primer sequences for quantitative real time PCR 
 
6.2.11 Conditioned media analysis 
 Spent media was collected from the co-cultures of MSCs and ESCs. The 
conditioned media was centrifuged at 3000 rcf for 5 minutes to remove cellular debris, and 
the supernatant was transferred to a new 15 mL conical tube for storage at -20°C. Enzyme-
linked immunosorbent assay (ELISA) kits was used to quantify the amount of FGF-2 
(Quantikine, R&D) and VEGF (DuoSet, R&D) present in the conditioned media. 
Concisely, capture antibody was adsorbed onto 96 well MaxiSorp Immunoplates (Nunc), 
blocked with 1% BSA in PBS, incubated with standards and samples, and bound with 
detection antibody. The concentration of protein was determined using a colorimetric 
reaction of peroxidase and tetramethylbenxidine and a plate reader to measure the 
absorbance at 450 nm. The absorbance values for the conditioned media samples were 
compared to a standard curve to determine the protein concentration. 
6.2.12 Flow cytometry analysis of surface marker expression  
 Analysis of surface marker expression was performed by collecting the contents of 
each culture well via trypsinization, centrifugation (5 min at 200 rcf) and resuspension in 
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3% FBS/PBS. The cells were fixed with 4% paraformaldehyde for 20 minutes and 
resuspended in 3% FBS/PBS. Counting beads (AccuCheck counting beads; Invitrogen) 
and pre-conjugated antibodies (PerCP/Cy5.5 anti-mouse CD45, APC/Cy7 anti-
mouse/human CD11b, PE anti-mouse/human CD45R/B220, PE/Cy7 anti-mouse CD3ε, 
FITC anti-mouse Ly-6G; all from BioLegend) were added, and cells were incubated on 
ice, protected from light for 30 minutes. Samples were washed with PBS, centrifuged at 
500 rcf for 5 minutes at 4°C, and then resuspended in 3% FBS/PBS prior to analysis on a 
BD LSR II Flow Cytometer.  
6.2.13 Analysis of cell proliferation using CFSE 
Lineage negative cells were labeled with CFSE after sorting (prior to seeding with 
various media types) using the CellTrace CFSE Cell Proliferation Kit for flow cytometry 
(Molecular Probes). The CellTrace stock solution was mixed with DMSO immediately 
prior to use at a concentration of 5 mM. For staining, 2 μL of stock solution was added to 
cells in 1 mL PBS (10 µM final concentration). Cells were incubated for 20 minutes at 
37°C in a cell culture incubator for 20 minutes. Cells were transferred to 5 mL Iscove’s 
Modified Dulbecco’s Medium (IMDM) with 2% FBS, incubated an additional 5 minutes, 
and pelleted by centrifugation (300 rcf for 5 min). Cells were resuspended in MyeloCult 
media and seeded in a 24 well plate at a density of 50,000 cells/well. The plate was 
centrifuged to bring cells to bottom of the plate and the media was removed and replaced 
with the appropriate test media. During flow cytometry analysis, the mean CFSE 
fluorescence intensity for each group was determined. 
6.2.14 Colony-forming unit assays and quantitation 
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 After 4 days of culture with each media type, cells from each condition were 
trypsinized, centrifuged (300 rcf for 5 min), and resuspended in IMDM with 2% FBS. 
MethoCult (Stem Cell Technologies) was added to each cell solution at a 1:10 ratio 
(IMDM:MethoCult) and mixed well. The MethoCult/cell mixture was drawn up into a 
sterile syringe fitted with a 16 gauge blunt-end needle (BD) and dispensed into two 35 mm 
dishes. A third 35 mm dish was filled with PBS, and the three dishes were placed in a larger 
100 mm dish to create a humidified environment. The cells were incubated at 37°C in 5% 
CO2 with ≥ 95% humidity for 12 days and then imaged for analysis using a Zeiss LSM710 
confocal microscope outfitted with an automated stage. The number of colonies present in 
each dish was manually counted from the obtained tiled images. 
6.2.15 Immunostaining and fluorescent imaging 
 Primary muscle cultures which had been exposed to ESC conditioned media (or 
growth media and KO N2B27 controls) were rinsed with PBS, fixed in 4% 
paraformaldehyde for 15 minutes with rotation at room temperature, and rinsed 3x with 
PBS. The fixed cells were blocked and permeabilized for 60 minutes at room temperature 
in PBS containing 5% normal donkey serum (Jackson) and 0.3% Triton X-100 (Sigma). 
The cells were then incubated with a primary antibody against desmin (ThermoFisher, RB-
9014-1p; rabbit polyclonal; 1:200) diluted in a solution of PBS with 1% BSA (Millipore) 
and 0.3% Triton X-100 (Sigma) for 60 minutes at room temperature. The cells were washed 
3x with PBS and incubated with secondary antibody (Life Technologies; 1:1000 Alexa 
Fluor 555 donkey anti-rabbit) and Hoechst (Life Technologies; 1:10,000) for 90 minutes 
at room temperature prior to 3x washes in PBS and imaging on a Zeiss Axio Observer 
equipped with a Hamamatsu camera. Image analysis was performed using ImageJ software 
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(http://imagej.nih.gov/ij/). To discern the nuclei, images from the Hoechst channel were 
converted to 8-bit, thresholded, and inverted, followed by analysis of the number of 
particles 10-500 pixels2. To count the desmin-positive cells, images from the red channel 
were converted to 8-bit, thresholded, and inverted, followed by analysis of the number of 
particles of 50-1000 pixels2 with a circularity >0.7 for the “rounded” cells and particles of 
200-2000 pixels2 with a circularity <0.7 for the “elongated” cells. 
6.2.16 Statistics 
All experiments were performed with replicate samples from independent 
conditions, with the exception of some of the flow cytometry analysis of the bone marrow 
populations due to limited cell number. The data is represented as the mean of the 
independent replicates, and the error bars represent the standard error of the mean. Before 
performing statistical analysis, data were normalized using a Box–Cox power 
transformation to normalize data variance. One–way ANOVAs were calculated between 
different conditions as appropriate, followed by post hoc Tukey analysis to determine 
significant differences (p < 0.05). All statistical analysis was performed using MatLab and 
SYSTAT software.  
6.3 Results 
6.3.1 Influence of ESC secreted factors on mesenchymal stem cell populations 
 To assess whether soluble factors from ESCs affect mesenchymal stem cell (MSC) 
function, encapsulated ESC aggregates were co-cultured with murine MSCs. The 
encapsulated ESCs were placed in the upper level of a transwell insert at a 30:1 or 100:1 
ESC to MSC ratio in serum-free KO N2B27 media such that the culture environment was 
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intentionally dominated by ESC secreted factors. MSC morphology and growth were 
evaluated over 7 days and compared to cells cultured in traditional serum-containing MSC 
growth media, to serum-free KO N2B27 media, and to serum-free KO N2B27 media 
containing empty alginate beads. The MSCs co-cultured with the ESCs took on an altered 
morphology (Figure 6.1j-o), similar to what was observed with MSCs cultured in the KO 
N2B27 (Figure 6.1d-i), in which they appeared much smaller than MSCs in traditional 
growth media (Figure 6.1a-c). However, many more MSCs were observed when cultured 
in the presence of ESC secreted factors than in the KO N2B27 alone, which was 
corroborated through quantification of cell number at the end of 7 days (Figure 6.1p). In 
contrast to KO N2B27 alone, MSCs cultured in the presence of ESCs at either ratio had a 
3.9-fold higher final cell number, indicating that soluble factors from the ESCs had a 
mitogenic effect on the MSCs. To determine if the ESCs were secreting fibroblast growth 
factor-2 (FGF-2), a known mitogen used for MSC expansion, analysis of the spent media 
was performed. However, FGF-2 was not detected (lower limit of detection of 15.6 pg/mL) 
in any condition, including ESCs cultured in the absence of MSCs (Figure 6.1q). Given 
that FGF-2 is present in fetal bovine serum (FBS) at a concentration of approximately 37 
pg/mL (~3.7 pg/mL in 10% FBS containing media), it is possible that sufficient FGF-2 to 
induce a response is present but is below the detection limit of the assay. 
 A limitation of a co-culture format in this case is the two-way communication 
between the ESCs and the MSCs in which the MSCs may be feeding back on the ESCs and 
thus influencing ESC differentiation and subsequent secretion profile. Therefore, the 
influence of ESC conditioned media on MSC growth was also assessed so that the ESC 




Figure 6.1. Mesenchymal stem cell co-culture with encapsulated ESCs. Mesenchymal stem 
cells (MSCs) were cultured in serum-containing MSC media (A-C), in serum-free KO N2B27 (D-
F), in serum-free KO N2B27 with cell-free alginate beads (G-I), and in serum-free KO N2B27 
with encapsulated embryonic stem cells (ESCs) at either a 30:1 ESC:MSC (J-L) or a 100:1 
ESC:MSC ratio (M-O). Quantification of the  final MSC number after 7 days of culture indicates 
that the highest growth was observed in the control MSC media but that co-culture with the ESCs 
led to MSC growth in comparison with the KO N2B27 alone (P). No bFGF was observed in the 
culture media to explain the mitogenic effect (Q). Scale bar = 200 µm. Significant (p < 0.05) 
differences from KO N2B27 only (*) and MSC media (‡) are denoted. N=3 for control groups, 
N=9 for ESC co-culture groups. 
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allows the ESCs to be cultured in distinct environmental conditions from the MSCs, 
including settings that may be advantageous for ESC secretion but may not be ideal for 
MSC culture. Therefore, conditioned media was collected from ESC aggregates 
encapsulated in either High G or High M alginate and cultured under normoxic (21% 
oxygen) or hypoxic (3% oxygen) conditions during early stage differentiation (days 1-4 
post-encapsulation) or during later stage differentiation (days 4-7 post-encapsulation). The 
MSCs were cultured for 7 days in the presence of 75% conditioned media collected from 
ESCs in the described conditions and 25% serum-containing MSC growth media, and the 
final cell number was compared to MSCs cultured in 100% MSC growth media or serum-
free KO N2B27 (75% with 25% MSC growth media). Conditioned media (CM) collected 
from ESCs cultured within High M alginate and under normoxic oxygen conditions led to 
a significant increase in MSC number in comparison with MSC growth media (1.6-fold 
increase for CM collected between day 1-4 of differentiation and 1.9-fold increase for CM 
collected between day 4-7 of differentiation) (Figure 6.2a). Additionally, a significant 
increase in MSC number in comparison to KO N2B27 controls was observed when the 
MSCs were exposed to CM collected from ESCs cultured in High G alginate under 
normoxic conditions, and the final MSC cell number was comparable to what was obtained 
using growth media. In contrast, culture of the MSCs in conditioned media collected from 
ESCs under hypoxic conditions did not increase MSC cell number in comparison to KO 
N2B27 alone.  
 To determine if particular ESC phenotypes enhanced MSC growth, the final MSC 
cell number was correlated to gene and protein expression data of the ESCs from which 




Figure 6.2. Variable ESC conditioned media effects on MSC growth. ESCs were cultured in 
either High G or High M alginate and in either normoxic (21% O2) or hypoxic (3% O2) conditions, 
and the conditioned media was collected at day 4 or day 7 of culture. Conditioned media collected 
from ESCs cultured under normoxic conditions led to improved MSC growth in comparison to 
media collected under hypoxic conditions (A). The corresponding ESC gene expression from the 
cells when conditioned media was collected at day 7 was correlated to MSC growth (B-J) to 
determine what correlations exist between ESC cell state and MSC growth. Significant (p < 0.05) 
increases over growth media (*) and KO N2B27 (+), as well as a lack of significant difference (p 
> 0.05) from growth media (#) are denoted. R2 signifies the Pearson correlation. N=6 for control 
groups, N=3 for ESC conditioned media groups.  
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 at day 7 of differentiation). Increased MSC number was negatively correlated with 
pluripotency marker expression of the ESCs (Figure 6.2b-c), indicating that ESCs in a 
more differentiated state may secrete factors that better promote MSC growth. 
Additionally, expression of the growth factors BMP-4 (Figure 6.2d) and VEGF (Figure 
6.2e) were negatively correlated with MSC number, while expression of the growth factor 
FGF-2 was positively correlated (Figure 6.2f). The gene expression of several other 
growth factors, including GDF-11 (Figure 6.2g), IGF-1 (Figure 6.2h), and IGF-2 (Figure 
6.2i), in addition to the concentration of VEGF present in the conditioned medium (Figure 
6.2j), were not found to be correlated with MSC growth.  
6.3.2 Effect of pluripotent cell-derived factors on bone marrow populations 
 To investigate the effect of ESC-derived factors on a heterogeneous mixture of 
primary stem and progenitor cells, whole bone marrow was isolated from mice and sorted 
to obtain the Lineage-negative (Lin-negative) fraction, excluding cells with mature lineage 
markers. Conditioned media and co-culture approaches to expose the bone marrow 
populations to ESC-derived factors were explored in parallel. To determine whether factors 
secreted during specific stages of differentiation had differential effects or whether the 
timing of and duration between media exchanges created differences, several experimental 
groups were initially explored (Figure 6.3). Prior to the isolation of bone marrow, 
conditioned media was collected from encapsulated ESCs at several stages: (1) at day 2 
following 48 hours of conditioning, (2) at day 4 following 48 of conditioning, and (3) at 
day 4 following 96 hours of conditioning. Groups (1) and (2) were additionally pooled 
together to create (4) a pooled group in order to better mimic one of the co-culture 




Figure 6.3. Scheme and experimental groups for exposure of hematopoietic progenitors to 
ESC secreted factors. Prior to the isolation of bone marrow, conditioned media was collected from 
encapsulated ESCs at several stages: (1) at day 2 following 48 hours of conditioning, (2) at day 4 
following 48 of conditioning, and (3) at day 4 following 96 hours of conditioning. Groups (1) and 
(2) were additionally pooled together to create (4) a pooled group. To mimic the culture regime 
utilized when collecting the conditioned media, two different co-culture schemes were employed, 
(1) with a media exchange after 48 hours and (2) with no media exchange in the 96 hours of culture. 




 media, two different co-culture schemes were employed, (1) with a media exchange after 
48 hours and (2) with no media exchange in the 96 hours of culture. An equivalent density 
of encapsulated ESCs was used in the co-cultures and in the collection of the conditioned 
media. As an additional control for the depletion of nutrients and presence of waste 
products in conditioned media, medium conditioned by endothelial cells and the 
endothelial cell base medium were also utilized. 
 Given the mitogenic response of MSCs to pluripotent cell-derived factors, the total 
number of cells present in the various methods of ESC factor delivery was investigated for 
the isolated bone marrow populations. After 24 hours of culture, the number of cells present 
was assessed using an imaging plate reader to determine the number of fluorescent cells 
(in this case, the whole bone marrow was isolated from eGFP mice). Significantly more 
cells were observed in the groups exposed to endothelial cell conditioned medium (1.8-
fold) and the ESC conditioned media obtained between days 0-2 (2.5-fold) and days 2-4 
(2.1-fold) when compared to the MyeloCult control, a commercially-available serum-
containing media for hematopoietic progenitors (Figure 6.4a). Additionally, all of the ESC 
conditioned media groups, with the exception of the medium collected after 4 days with no 
feed, led to significantly greater bone marrow cell numbers than the basal KO N2B27. The 
final number of cells after 4 days of exposure was evaluated using flow cytometry with 
counting beads, and the greatest number of cells were again observed in the ESC 
conditioned medium collected after 2 days of culture (Figure 6.4b). There was no increase 
in bone marrow cell number observed in the co-culture conditions in comparison to KO 
N2B27 alone, indicating that the co-culture configuration was insufficient to support the 




Figure 6.4. Mitogenic effects of ESC secreted factors on hematopoietic progenitor 
populations. The number of cells one day after seeding was quantified using an imaging plate 
reader (A) and after four days of culture using flow cytometry (B). The cell number was normalized 
to the number of counting beads present and to the MyeloCult control media (dashed line). 
Significant (p < 0.05) increases over growth media (*) and KO N2B27 (+) as well as between 
groups (*) are denoted. N=4 for day 1 cell counts and N=2-3 for day 4 cell counts. 
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 Analysis of the phenotypic composition of the cultures following exposure to the 
different soluble conditions was assessed via flow cytometry analysis of cell surface 
markers. Myeloid cell populations (CD45+CD11b+) were most highly present in the 
MyeloCult media and in the Day 0-2 ESC conditioned media, with lower numbers of 
myeloid cells present in the KO N2B27, co-cultures, and later stage-derived ESC 
conditioned media (Figure 6.5a). In contrast, more lymphoid cells (CD45+CD11b-) were 
observed in all types of the ESC conditioned media than in the MyeloCult media (Figure 
6.5b), though hematopoietic progenitors in co-culture with the ESCs were once again at 
similar numbers of lymphoid cells as the KO N2B27 group. Regarding more specific 
myeloid lineages, monocyte/macrophages (CD45+CD11b+Ly6G-) accounted for ~50% of 
the total cell population in all groups (Figure 6.5c), excluding the KO N2B27 condition. 
Neutrophil populations (CD45+CD11b+Ly6G+), on the other hand, were exclusively 
supported by MyeloCult media and were observed in very low numbers by all other groups 
(Figure 6.5d), indicating that the signals necessary for neutrophil differentiation and/or 
survival were not provided by ESCs. 
 More functional assessments of the isolated bone marrow populations were 
performed to determine the extent of cell proliferation and differentiation capacity. To 
analyze cell proliferation, cells were stained with carboxyfluorescein succinimidyl ester 
(CFSE), with the loss of fluorescence intensity indicating that cell division has occurred 
[275]. A higher intensity was observed in the KO N2B27 group, while all other groups had 
similar intensities, indicating that cell proliferation was occurring at a lower rate in the KO 
N2B27 and at a uniformly higher rate among the other groups (Figure 6.6a). Colony 




Figure 6.5. Phenotypic analysis of hematopoietic progenitors following exposure to ESC 
secreted factors. Flow cytometry was used to determine the composition of the cultures after 4 
days. A similar number of myeloid cells (CD45+CD11b+) were present in the MyeloCult and ESC 
secreted factor groups (A), while increased lymphoid cells (CD45+CD11b-) were observed in the 
cultures exposed to ESC conditioned media (B) but not in ESC co-cultures. Monocyte populations 
(CD45+CD11b+Ly6G-) were supported by all media compositions excluding the KO N2B27 (C), 
while ESC-secreted factors were unable to support neutrophil populations (CD45+CD11b+Ly6G+) 







Figure 6.6. Functional analysis of hematopoietic progenitor proliferation and colony forming 
ability. Staining with carboxyfluorescein succinimidyl ester (CFSE) enabled analysis of cell 
proliferation (A), with cells in all media compositions except the KO N2B27 proliferating at a rate 
similar to the MyeloCult control. After four days of exposure to the different culture configurations, 
the cells were plated for analysis of colony forming units (CFUs). Increased numbers of colonies 
were observed in the MyeloCult and some configurations of the ESC conditioned media in (B-E). 





days of exposure to the different soluble conditions and subsequent culture in 
methylcellulose for 12 days. Significantly more colonies were observed in the MyeloCult 
and ESC conditioned media groups (with the exception of the day 2-4 ESC conditioned 
medium) than in the KO N2B27 (Figure 6.6b). The colonies present in the MyeloCult 
conditions appeared more dark and dense (Figure 6.6c), while the colonies in the ESC 
conditioned media groups were smaller and more sparse (Figure 6.6e), and very few 
colonies were observed in the KO N2B27 condition (Figure 6.6d).  
6.3.3 Impact of ESC derived factors on skeletal muscle populations 
 To investigate if the mitogenic effects of the ESC conditioned media translated to 
a different cell population, primary muscle cells were isolated from mouse hind limbs and 
exposed to ESC conditioned medium collected from encapsulated ESCs cultured within 
the packed bed perfusion reactor at days 1-4 of differentiation. Due to the heterogeneous 
population obtained with the primary cell isolation, a large number of fibroblasts were also 
present in the culture, similar to the composition in the in vivo environment. Following four 
days of culture in either 100% growth media, 75% KO N2B27/25% growth media, or 75% 
ESC conditioned medium/25% growth media, the cells were stained with an antibody 
against desmin, a muscle-specific intermediate filament, to identify the myocytes present 
(Figure 6.7).  While the majority of the cells in the culture were fibroblasts, desmin-
positive cells were observed in all conditions. Smaller, myoblast-like cells were observed 
in the growth media condition (Figure 6.7a, 6.7d), while more differentiated myocytes 
were observed in the KO N2B27 and ESC conditioned medium (Figure 6.7b-c, 6.7e-f), 





Figure 6.7. Exposure of skeletal myocytes to ESC conditioned medium. Mouse myocytes were 
isolated and cultured in serum-containing growth medium (A,D), 75% serum-free KO N2B27 with 
25% growth medium (B,E), or 75% ESC conditioned medium (CM) with 25% growth medium 
(C,F). Greater number of desmin-negative fibroblasts were observed in cells cultured in the growth 
medium and KO N2B27 in comparison to the ESC CM, which appeared to be enriched for desmin-
positive myocytes. Scale bars = 200 µm. 
  
 160 
The proportion of desmin-positive cells relative to total nuclei was determined by 
performing image analysis of a series of fluorescent images (Figure 6.8). The total number 
of nuclei, visualized in Figure 6.8a-c and quantified in Figure 6.8g, indicates that fewer 
total cells were present in the culture after four days of exposure to the ESC conditioned 
medium. In contrast, the total number of desmin-positive cells was similar in all groups 
(Figure 6.8d-f, 6.8h), demonstrating that there were a higher proportion of myocytes 
present in the ESC conditioned media than in the growth media and KO N2B27 controls 
(Figure 6.8i). Though similar numbers of myocytes were observed in all three groups, the 
morphology of the myocytes varied between them, with smaller, more myoblast-like cells 
predominating the culture in growth media and large elongated myocytes and early 
myotubes present in higher abundance in the wells exposed to KO N2B27 and ESC 
conditioned medium (Figure 6.8j). The difference in cell morphology was quantified by 
determining the percentage of desmin-positive cells with a small area (50-1000 pixels2) 
and high circularity (>0.7), which represent a more myoblast-like morphology, from the 
desmin-positive cells with a larger area (200-2000 pixels2) and low circularity (<0.7), 
which represent a more differentiated morphology. The differentiation of myoblasts into 
committed myocytes and myotubes is correlated with reduced serum concentrations, thus 
presence of differentiation is not surprising given that the serum concentration is reduced 
from 20% in the growth media to 5% in the KO N2B27 and ESC conditioned medium. 
However, it is interesting to note that there was a significant decrease in the presence of 
the elongated myocytes (Figure 6.8j) when cells were cultured in ESC conditioned 





Figure 6.8. Analysis of skeletal myocyte number and morphology. Fluorescence images were 
analyzed to determine the total cell number, determined from the number of DAPI-stained nuclei 
(A-C, G) in addition to the number of desmin-positive myocytes (D-F, H). Though similar numbers 
of myocytes were observed in all three conditions, fewer fibroblasts were present in the ESC 
conditioned medium (CM), leading to an overall enrichment of myocytes. A greater percentage of 
the desmin-positive cells in the KO N2B27 and ESC CM groups appeared elongated, indicating 
differentiation (J), though the degree of elongation was reduced in the ESC CM compared with the 
KO N2B27. Significant (p < 0.05) increases from the growth media (*) and the KO N2B27 (+) are 
denoted. N=9 fields for the image analysis.   
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secreted by the ESCs may partially restore the effects of some of the growth factors found 
in serum.  
6.4 Discussion 
 The results of this study suggest that embryonic stem cells (ESCs) produce signals 
that stimulate a mitogenic response in multiple adult stem and progenitor cell populations, 
including mesenchymal stem cells, hematopoietic progenitors, and myocytes. In addition 
to changes in cell growth, the differentiation capacity of several cell types was also altered 
in response to ESC secreted factors. The differentiation stage and microenvironment under 
which the ESCs are cultured prior to collection of the conditioned media also alters the 
downstream cell response, likely due to differences in the secreted milieu based on the 
stage of differentiation and the environmental cues provided to the ESCs (Chapter 5). 
 Exposure of homogeneous populations of bone marrow-derived mesenchymal stem 
cells (MSCs) to ESC secreted factors, either through co-culture (Figure 6.1) or conditioned 
media (Figure 6.2) approaches, led to increases in cell number in comparison to MSCs 
cultured in the basal serum-free media. Although the fold increase in MSC number was 
reduced in the serum-free co-culture compared with the standard serum-containing growth 
medium (1.8-fold higher cell number in comparison to serum-free co-culture) (Figure 
6.1p), a more favorable small, spindle-shaped MSC morphology was observed with 
exposure to pluripotent factors (Figure 6.1j-o). While greater expansion of MSCs was 
observed in response to ESC conditioned media (Figure 6.2a), the reduced MSC expansion 
in the co-culture conditions may be due to the ESCs consuming many of the required 
nutrients and leaving fewer available for MSC consumption, as there were 30-fold or 100-
fold more total cells seeded into the wells in comparison with the MSC growth media 
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condition. The change in MSC growth observed between co-culture and conditioned media 
may also be due to the media composition, of which 25% consisted of unconditioned MSC 
growth media, and the MSCs were thus in a less nutrient-depleted environment. An 
additional hypothesis is that co-culture with the MSCs may have altered the ESC secretion 
profile or kinetics, leading to differences in the paracrine factors produced which may not 
have been as favorable for MSC growth. A previous study using human ESC-conditioned 
media to expand Wharton’s jelly-derived MSCs also reported increased MSC growth in 
comparison with FBS-containing growth media [273], though the ESC medium used had 
been collected from ESCs cultured on fibroblast feeder cells and supplemented with 
fibroblast growth factor, making it difficult to establish which of the specific components 
was responsible for the enhanced MSC growth. 
 Depending on the settings under which the ESC conditioned media was collected, 
differential MSC growth responses were observed. One striking difference in MSC growth 
was observed in media conditioned by ESCs cultured under hypoxic (3% oxygen) 
conditions, which yielded no improvement in MSC number when compared to the serum-
free media alone, unlike the media conditioned by ESCs cultured under normoxic (21% 
oxygen) conditions that promoted MSC growth (Figure 6.2a). Culture of ESCs under 
hypoxia has been observed to increase the production of certain hypoxia-induced growth 
factors, including vascular endothelial growth factor (VEGF) and insulin-like growth 
factor-2 (IGF-2), as well as prevent or delay ESC differentiation [238–240,276]. However, 
the reduction in oxygen may have also limited ESC growth, leading to fewer cells 
producing relevant growth factors. The presence of hypoxia-inducible factor-1α (HIF-1α) 
in the conditioned media may have activated growth-restricting signaling pathways in the 
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MSCs, though culture of MSCs in hypoxic conditions has been previously observed to 
have negligible or even positive impact on MSC growth, likely due to the low oxygen 
tension of the native bone marrow compartment [277,278]. To examine the correlation of 
MSC growth with ESC phenotype, gene expression values for two pluripotency markers 
and six growth factors, in addition to the concentration of VEGF in the conditioned media, 
were compared to MSC number. Many of the negatively-correlated relationships (Figure 
6.2b-c, 6.2e, 6.2j) were associated with the response to the hypoxia-derived conditioned 
media, as higher expression of the pluripotency markers Oct4 and Nanog and the growth 
factor Vegf were observed when the ESCs were cultured under low oxygen. The only 
positively-correlated growth factor was fibroblast growth factor-2 (Fgf2), which is a well-
known mitogen used to promote MSC growth [255,256]. Interestingly, protein levels of 
FGF-2 are generally upregulated by low oxygen conditions through interaction with HIF-
1α, though a decrease in gene expression is observed as the protein concentration rises 
[279]. 
 Moving from the homogeneous population of MSCs to a mixed population of 
primary hematopoietic progenitor cells, similar mitogenic effects were observed in 
response to exposure to ESC conditioned media (Figure 6.4). The highest cell numbers 
were observed in cells cultured in ESC conditioned media obtained from early-stage ESCs 
(day 0-2 post-encapsulation), in comparison to MyeloCult, a commercially-available 
medium used to expand hematopoietic progenitors, to the serum-free KO N2B27 used as 
a base media for ESC culture, and to media conditioned by C166 endothelial cells, which 
are specifically recommended to support proliferation of multipotential hematopoietic stem 
and progenitor cells [280]. However, the mitogenic effect was attenuated in conditioned 
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media obtained from later stage ESCs (day 2-4 post-encapsulation), and no increase in 
growth was observed with ESC co-culture in comparison to basal KO N2B27. The decrease 
in potency with ESC differentiation stage may be due to changes in the secretome, such as 
lower concentrations of specific mitogens or higher concentrations of specific inhibitors. 
The difference could also be the consequence of metabolic differences, as lower 
concentrations of nutrients and higher concentrations of wastes would be present at the 
later stages of ESC culture due to the greater number of cells present. 
 When the data describing overall cell number (Figure 6.4) is combined with the 
results of the CFSE cell proliferation assay (Figure 6.6a), it appears that the hematopoietic 
progenitors are actually proliferating at a similar rate across all conditions, with the 
exception of cells in the KO N2B27 basal medium which are proliferating at a slower rate. 
Thus, the overall differences in cell number are likely due to contrasts in differentiation to 
downstream hematopoietic progenitors rather than in proliferation. This hypothesis is 
supported by the composition and number of lineage-specific cells identified through 
surface marker expression. While the number of myeloid cells (CD45+CD11b+) treated 
with ESC conditioned media (day 0-2) was similar relative to the number of myeloid cells 
in MyeloCult (Figure 6.5a), there were many more lymphoid cells (CD45+CD11b-) in the 
ESC conditioned media groups (Figure 6.5b), which is likely accounting for the increase 
in overall cell number (Figure 6.4b). An interesting observation from the analysis of 
lineage composition is that while the ESC-produced factors were able to support the 
differentiation toward monocyte and macrophage phenotypes (CD45+CD11b+Ly6G-) to 
a similar extent as the MyeloCult medium (Figure 6.5c), the presence of ESC secreted 
factors was not sufficient for differentiation toward or survival of neutrophil populations 
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(CD45+CD11b+Ly6G+) (Figure 6.5d). Alternatively, the ESCs may be producing cues 
that are inhibitory to neutrophil populations. It is likely that the specific cytokines and 
growth factors necessary for support of neutrophils, such as granulocyte-colony 
stimulating factor (G-CSF), stem cell factor (SCF), and interleukin-5 (IL-5), were not 
produced in high enough levels by the ESCs in comparison to the serum concentration 
present in the MyeloCult, while monocyte-colony stimulating factor (M-CSF), which is 
required for the differentiation of monocytes, may have been present in sufficient quantities 
[281,282]. Indeed, examining at the cytokine array analysis of ESC conditioned media in 
Chapter 5, M-CSF was detected in the conditioned media while G-CSF was not (Figure 
5.3). While many of the parameters assessed (cell number, colony formation, number of 
lymphoid cells) were varied based on the manner of delivery, it is of interest that the 
proportion of monocytes and neutrophils present did not appear to be dependent on the 
specific method of delivering the ESC secreted factors, as similar percentages were 
observed in all conditioned media and co-culture groups (Figure 6.5c-d).  
 In general, co-culture of the hematopoietic progenitors with the encapsulated ESCs 
did not lead to the robust increases in cell number (Figure 6.4) or colony-forming units 
(Figure 6.6b) observed in specific ESC conditioned media groups. The decrease in potency 
in the co-culture is consistent with the previous results with MSCs in which conditioned 
media generally led to a greater increase in cell number, though the co-cultures with the 
MSCs still enhanced cell growth in comparison to the KO N2B27 (Figure 6.1p). In 
contrast, the ESC-hematopoietic progenitor co-cultures generally yielded similar results to 
the KO N2B27 alone, indicating that there was little impact of the ESCs over the base 
effect of the media. The one exception is in the proportion of monocytes (Figure 6.5c), in 
 167 
which case co-culture with the ESCs appeared sufficient to promote differentiation toward 
or survival of monocyte populations. It is possible that subjecting the ESCs to co-culture 
with the hematopoietic progenitors led to changes in the ESC secretion profile or secretion 
kinetics, or potentially even to ES cell death, which in turn reduced their capacity to support 
the bone marrow populations. An additional theory is that the diminishing mitogenic effect 
observed in the conditioned media collected from ESCs at later stages (day 2-4) was 
exaggerated in the co-culture conditions, as those cells were present for the entire four day 
duration (Figure 6.3).  
 Transitioning from the bone marrow compartment to the muscle niche, the 
influence of ESC conditioned media on primary myocytes was assessed to determine 
whether the mitogenic effects might translate to another tissue-specific stem and progenitor 
cell population. In addition, existing literature describes the ability of pluripotent cell-
derived factors to “rejuvenate” muscle populations in vitro, with conditioned media from 
undifferentiated human ESCs promoting proliferation of young and old myoblasts, while 
conditioned media from human ESCs differentiated down the neural lineage promoted 
myocyte differentiation and inhibited proliferation [35,274]. Primary myocytes were 
isolated from the hind limbs of mice, and though preferential adhesion steps were 
performed to reduce the number of fibroblasts present in the culture, the composition of 
the culture was still dominated by fibroblasts (~95% fibroblast). While the heterogeneous 
culture makes it challenging to examine the impact of ESC secreted factors on myocytes 
alone, the mixed culture better recapitulates the in vivo muscle niche in which fibroblasts 
play an important supportive role [270], as it has been reported that removing fibroblasts 
from the satellite cell niche promotes premature satellite cell differentiation and an 
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exhaustion of the stem cell pool. Following four days of exposure to a standard FBS-
containing growth medium, to the basal serum-free KO N2B27 (75%, 25% growth 
medium), or to the ESC conditioned medium (75% with KO N2B27 base medium, 25% 
growth medium), the cultures in the ESC conditioned medium appeared to be enriched for 
desmin-positive myocytes (Figure 6.7), and the myocytes present in the both the KO 
N2B27 and ESC conditioned medium groups tended to be more elongated and 
multinucleated, hallmark signs of myogenic differentiation. Image analysis of the mixed 
cultures confirmed that a greater percentage of desmin-positive cells were present when 
cultured in the ESC conditioned medium (Figure 6.8i), although this was due to a decrease 
in the fibroblast number rather than to an increase in the myocyte number (Figure 6.8g-h). 
While conditioned media from ESCs has previously been observed to promote fibroblast 
proliferation [181], the more proliferative fibroblasts may require nutrients present in the 
media in higher abundance than the myocytes, and therefore the myocytes preferentially 
survived.  
 Through the image analysis, it was determined that fewer myocytes exhibited the 
elongated, differentiated morphology when cultured in the ESC conditioned medium 
(48%) in comparison to the KO N2B27 (57%), though the least differentiation was 
observed in the growth media (34%) (Figure 6.8j). Some differentiation is expected in 
both low-serum groups, as serum deprivation inhibits proliferation and promotes 
differentiation and myotube formation [283], and the FGF-2 concentration was also 
reduced to one-quarter of the concentration found in the growth medium. However, the 
decreased extent of differentiation when the cells were cultured with exposure to ESC 
conditioned medium indicates that the paracrine factors produced by the ESCs may be 
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capable of compensating for the lack of growth factor-rich serum. Fetal bovine serum 
contains a multitude of undefined growth factors, some of which seem to be responsible 
for maintaining myocytes in a proliferative state.  Fibroblast growth factor-2 is the most 
commonly attributed factor for maintenance of muscle stem and progenitor cells [284], 
hence its inclusion as a supplemental growth factor in many media compositions, but other 
growth factors, including FGF-1, have also been implicated [285,286]. Conversely, 
insulin-like growth factors (IGFs) have been found to promote both the proliferation and 
the differentiation of myoblasts [287,288]. As both FGFs and IGFs have been found to be 
expressed/produced by ESCs (Chapter 5), competing roles of the different growth factors 
are possible.  
 For all three cell populations examined in this study, further functional assessment 
would clarify the specific effects of the ESC-derived factors. In cases where greater cell 
numbers were observed, it is unclear if the overall increase in cell number was due to an 
increase in cell proliferation or an increase in cell survival. A previous study found that 
exposure of bone marrow-derived hematopoietic progenitors to ESC conditioned medium 
increased the number of granulocyte-monocyte colony forming units likely by increasing 
cell survival, as the number of cells undergoing apoptosis was reduced with culture in ESC 
conditioned medium [36]. For the skeletal muscle cells, it will be important to determine 
if the cells exposed to the ESC secreted factors retain the ability to engraft in vivo, as it has 
been determined that ex vivo expansion of mouse satellite cells for only three days led to a 
10-fold decrease in the efficiency of engraftment [129], a reduction that has also been 
observed between freshly isolated and ex vivo cultured canine muscle progenitor cells 
[133]. Similar engraftment studies could also be performed with the hematopoietic 
 170 
progenitors, as ex vivo expansion of hematopoietic stem cells generally results in decreased 
engraftment efficiency and repopulation activity [117].  
6.5 Conclusions 
 Overall, the results of this study suggest that ESCs are a potent source of mitogens 
and growth factors capable of stimulating the growth of multiple stem and progenitor cell 
types. Populations of bone marrow-derived mesenchymal stem cells exhibited increased 
growth in response to ESC co-culture or exposure to ESC conditioned media. Furthermore, 
the application of ESC conditioned media to a heterogeneous population of hematopoietic 
progenitors led to increased proliferation and colony-forming ability, though the mitogenic 
effect decreased with more differentiated ESCs and was not recapitulated with a co-culture 
configuration. Exposure to ESC-secreted factors generally supported both lymphoid and 
myeloid differentiation, with the exception of neutrophils. When applied to skeletal 
myocytes, the growth factors present in the ESC conditioned medium enriched for 
myocytes over fibroblasts while reducing the differentiation of the myocytes to 
multinucleated myotubes. Taken together, the results demonstrate the potent mitogenic role 






 Taken together, the data presented in this dissertation establish pluripotent stem 
cells as a unique source of potent growth factors and cytokines which can be regulated and 
concentrated using engineering design parameters to stimulate the proliferation and 
differentiation of adult stem and progenitor cell populations. As with most avenues of 
research, many of the findings motivate additional investigation which may lead to further 
advances in the realms of material and bioreactor design as well as identification of unique 
molecules produced by pluripotent stem cells and their subsequent influence on adult stem 
cell populations. 
 The development of an alginate microencapsulation-based platform for ESC 
culture described herein was not the first instance of such an approach [66,69,70,149]; 
however, it was the first report of the phenotypic influences of the alginate material 
employed (Chapter 3). Correlations were established between the composition of alginate 
used and the phenotype of the enclosed ESCs, with mechanically stiffer alginate fostering 
a pluripotent state and a mechanically softer alginate priming the ESCs for mesendodermal 
differentiation. A wide body of work has examined the influence of mechanical stiffness 
on stem cell differentiation and phenotype, with the majority of these studies conducted by 
culturing cells in 2D on different hydrogel substrates [289]. Mechanotransductive 
pathways that cause the observed phenotypic changes are not yet completely understood, 
though recent work indicates that the transcriptional coactivators YAP (Yes-associated 
protein) and TAZ (transcriptional coactivator with PDZ-binding motif), both part of the 
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Hippo pathway, may be key regulators that can sense cytoskeletal tension [290]. There are 
significant challenges in deciphering the specific role(s) of matrix mechanics on cell fate, 
including the difficulty in separating changes in mechanical stiffness from inherently 
linked changes in hydrogel porosity and solute permeability. The mechanical assessment 
performed in Chapter 3 was also a bulk measure and did not represent local interactions, 
which may better relate to the subsequent stem cell behavior. 
Microencapsulation of ESCs within alginate beads facilitated the creation of a high 
density perfusion bioreactor that enabled increased production of ESC-secreted products 
(Chapter 4). The increased concentration achieved with perfusion in addition to the 
dependence of protein production on flow rate prompted the hypothesis that a negative 
feedback mechanism may be involved. In order to further investigate the validity of this 
hypothesis, exogenous protein could be added to the culture media to act as a prospective 
negative feedback regulator. Using standard techniques to determine the concentration of 
proteins in the culture media (such as ELISAs), it would be impossible to distinguish the 
exogenously added protein from endogenously secreted protein. However, changes could 
be examined at the gene expression level if the feedback is affecting protein expression at 
the level of transcriptional regulation. Alternatively, assuming the protein is being secreted 
through classical secretion pathways, an inhibitor of protein transport (such as 
GolgiPlug™) may enable intracellular buildup of the protein for subsequent analysis of the 
cell lysate rather than the media supernatant.  
In the initial development and validation of the bioreactor platform, only two 
protein species (VEGF and IGFBP-2) known to be produced by ESCs were examined as 
indicators of protein production and concentration. Additional characterization in Chapter 
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5 using antibody arrays indicated that protein expression was globally increased with 
perfusion culture. However, a more global indicator of cell secretion would enable stronger 
claims regarding the ability of the perfusion bioreactor to increase cell secretion at a 
comprehensive level. The genetic engineering of ESCs to express secreted alkaline 
phosphatase (SEAP) or Gaussia luciferase may be enable those secreted factors to act as a 
surrogate for the general processes of protein synthesis and secretion [291,292]. While the 
global investigation of ESC secreted protein expression in Chapter 5 demonstrated profiles 
of morphogens, cytokines, and growth factors that are distinctive from other cell 
populations, there are likely additional unique species produced by pluripotent stem cells. 
A larger-scale proteomics approach using mass spectrometry would offer additional insight 
through recognition of unknown species of interest. In addition, non-biased genetic 
approaches such as RNA sequencing (RNA-seq) may be useful to identify mRNAs and 
proteins differentially regulated in specific culture configurations, whether it be the stage 
of ESC differentiation, the presences of perfusion flow, or another environmental stimuli. 
The application of pluripotent stem cell-derived factors to stem and progenitor cell 
populations in Chapter 6 demonstrated their mitogenic effect as well as their ability to 
modulate differentiation, as was observed with hematopoietic progenitor and myoblast 
populations. In the initial studies described in this dissertation, the ESC conditioned media 
was provided as a bolus; however, integration of the downstream cell culture directly with 
the perfusion reactor upstream could be employed to enable continuous delivery such that 
the ESC paracrine factors would not be depleted through cellular uptake or degradation. A 
fed batch culture such as this has already been reported to be favorable for HSC culture 
due to the dilution of inhibitory feedback signals [246]. Depending on the length of the 
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culture period, the ESCs in the upstream reactor may need to be replaced with fresh 
“cartridges” of encapsulated ESCs to maintain the ESCs at the proper differentiation state. 
To determine whether the observed effects are reversible or sustained, the adult stem and 
progenitor populations could be reverted back to standard culture conditions following a 
set period of exposure to ESC secreted factors. Given the development of a robust in vitro 
platform, further examination of the functionality of adult stem cell populations post-
transplantation, such as the ability for homing, engraftment, differentiation, and re-
population, should be performed.  
 In contrast to the approaches discussed above in which the pluripotent cell-derived 
factors are used to expand and/or rejuvenate adult stem cell populations prior to their re-
transplantation, the effect of delivering ESC-derived factors directly in vivo could also be 
explored. For example, a radioprotection assay could be performed to determine whether 
pluripotent cell-derived factors exhibit radioprotective properties on sublethally irradiated 
bone marrow. Exposure to ionizing radiation induces DNA damage in the bone marrow, 
leading to anemia, hemorrhage, and infection due to low numbers of circulating blood cells 
caused by the inability of bone marrow progenitors to effectively repopulate the 
hematopoietic system [30,31]. The search for radioprotective agents, molecules which 
reduce the lethality of radiation following a medical procedure or accidental exposure, has 
focused primarily on synthetic thiol compounds, antioxidants, and cytokines, either 
delivered individually or in combination [32,33]. However, approaches that more 
holistically regenerate the hematopoietic compartment by improving HSC function may 
have reduced toxicity and therefore diminish undesired side effects common to current 
therapies [34]. Therefore, positive outcomes of a radioprotection assay in which ESC 
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secreted factors are injected subcutaneously prior to or concurrent with radiation may be 
more broadly interpreted as evidence that pluripotent cell-derived factors can interact with 
bone marrow populations in an in vivo setting.   
The results of this dissertation provide a basis for future exploration of a number of 
unique opportunities in the realm of regenerative medicine. The application of pluripotent 
stem cell-derived factors specifically to aged cell populations may be useful as a 
“rejuvenative” treatment to reverse the age-related dysfunction present in stem cell niches. 
The translation of the packed bed perfusion bioreactor system into a re-conception as an 
extracorporeal device would enable investigation of pluripotent cell-derived factors in a 
continuous in vivo context. In addition, enhanced material design approaches may be used 
for better upstream control of the encapsulated ESCs and their secreted proteins. Finally, 
additional characterization of other forms of secreted products, specifically the contents 
and role of ESC-derived exosomes and microvesicles, may provide additional information 
regarding the mechanisms of ESC stimulation and inhibition of other cell populations. 
7.1 Application of pluripotent cell-derived factors to aged cell 
populations 
One of the hallmarks of aging is a reduced capacity for regeneration which can be 
attributed to diminished function of adult stem cell populations [293]. At this point, it is 
unclear the extent to which the reduced function of aged stem cells is intrinsically linked 
to replicative or chronological age, or is instead associated with extrinsic changes in the 
surrounding environment [294]. There are many components that might be altered in an 
aged stem cell niche, including the soluble paracrine factors secreted by neighboring cells, 
the constitution of the surrounding extracellular matrix, or the direct contacts with specific 
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membrane-bound proteins and lipids. In a whole organism view, aging is not occurring 
only in the immediate niche but also at the scale of entire tissues and organ systems; thus, 
changes in the composition of systemic factors also plays a role and may be interacting 
with the transformations experienced at all physiological levels. Therefore, the decline in 
ability of aged stem cell populations to maintain deteriorating tissues seems to reflect 
inadequate support from the surrounding aged environment.  
The extent to which a given multipotent stem cell population is affected by aging 
may be directly linked to its role in maintaining its derived tissue population. For example, 
hematopoietic stem cells (HSCs) are responsible for constantly replenishing the blood and 
immune systems and are thus defined as having both high cellular turnover and high 
regenerative potential [294]. In contrast, satellite cells (SCs) of the skeletal muscle are able 
to rapidly respond to injury in order to regenerate damaged muscle but are preserved in a 
quiescent state for the majority of time. On the opposite end of the spectrum are neural 
stem cells (NSCs), which are capable of limited neurogenesis but generally exhibit both 
low cellular turnover and low regenerative potential [295]. Based on the distinct 
functionalities of these multipotent populations throughout life, different responses to and 
impacts of aging can be anticipated. 
Aging of HSCs is typically manifested by anemia, impairment of adaptive immune 
function due to a reduced lymphoid differentiation, and expansion of myeloid cells and 
HSCs in the bone marrow [261,296–301]. The decline in functionality was initially thought 
to reflect intrinsic changes to the HSCs themselves; however, recent studies suggest that 
signals from the aged bone marrow microenvironment are at least partially responsible 
[295,302–304]. For example, the increased local concentration of the inflammatory 
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cytokine Rantes/CCL5 promotes a bias toward myeloid differentiation [305], and the 
decreased plasma concentration of SDF-1/CXCL12 has been implicated in the increased 
turnover of HSCs [306]. When aged HSCs are cultured in vitro, there is no apparent 
difference in cell proliferation or colony-formation [307], and aged HSCs are still able to 
reconstitute all lineages when transplanted to a young donor [308–310]. However, 
decreased capacities for homing and engraftment are observed with aged HSCs [307], 
though some deficiencies can be reversed through exposure to an appropriate 
microenvironment [311].  
The primary indication of aging in skeletal muscle is the decreased ability to 
regenerate following injury, with recovery taking longer and the regenerated muscle fibers 
exhibiting smaller diameters with an increased presence of fibrosis [40,312]. When 
cultured in vitro, aged satellite cells also display an increased propensity to differentiate 
toward adipocyte [313] or fibroblast phenotypes instead of to a myoblast phenotype [103]. 
The increased conversion from a myogenic to a fibrogenic lineage has been attributed to 
activation of canonical Wnt signaling, which may stem from an increased presence of 
Frizzled-binding proteins found in the aged serum [103]. Additionally, the niches of aged 
satellite cell populations with limited self-renewal capacity contain elevated levels of 
fibroblast growth factor-2 (FGF-2). In aged satellite cells which have retained the 
capability for self-renewal, the FGF-inhibitor Sprouty1 is expressed at high levels, with 
exogenous inhibition of FGF signaling also found to prevent the exhaustion of satellite 
cells [314].  
In contrast to the unchanging quantity of hematopoietic stem cells and satellite 
cells, the raw numbers of neural stem cells decline with age, which is likely responsible for 
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the difference in physiological function [315–317]. In aged rodents, decreases in olfactory 
and cognitive function are observed, likely linked to the decreased numbers of NSCs in 
both the subventricular zone and the hippocampus, respectively [318–320]. When cultured 
in vitro as neurospheres, aged NSCs also demonstrate a decreased capacity for self-renewal 
[317]. The paracrine secretion of Wnt3 by astrocytes is essential for NSCs to retain their 
capacity for neurogenesis, and a reduced number of Wnt3-secreting astrocytes and a lower 
overall concentration of Wnt3 in the brain are observed with aging [321]. Overall, changes 
in the extrinsic environments lead to decreased functionality of all three stem cell 
populations, though the way in which the dysfunctionality manifests itself differs.   
To counteract the unsupportive environment found in aged tissues, several 
approaches have been investigated to rejuvenate stem cell populations. There are several 
bodies of work that suggest that factors or materials from “younger” sources are capable 
of improving cell function. Parabiosis, a century-old technique that involves the union of 
the circulatory systems of two animals [322,323], has reemerged as a powerful technique 
to interrogate  the influence of young and aged systemic milieus on cell and tissue function 
[324]. Systemic molecules present in younger mice improve function in aged mice 
connected via heterochronic parabiosis, including enhanced wound healing [37,38], 
improvement in muscle satellite cell function [39–41], rejuvenation of neural cells and 
cognitive function [42–45], and reversal of cardiac hypertrophy [46]. An additional 
approach to rejuvenate cell populations has been to expose them to extracellular matrix 
(ECM) components derived from younger cells. The decreased capacity for self-renewal 
and osteogenic differentiation observed in MSCs derived from older (18 month) mice was 
reversed by culturing the MSCs ex vivo on ECM produced by young (3 month) femoral 
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marrow cells [325], and the culture of adult MSCs on ECM produced by fetal MSCs 
promoted increased proliferation in comparison to ECM produced by adult MSCs [326]. 
Similar to several previous approaches to rejuvenation, the paracrine actions of 
trophic factors derived from pluripotent cells may provide analogous signals that enable 
dysfunctional adult stem cells to regain a more “youthful” proliferative or regenerative 
capability. In preliminary studies with conditioned media obtained from undifferentiated 
human embryonic stem cells, promotion of proliferation was observed in myoblasts 
isolated from aged mice [35,250,274]. In an additional report, media conditioned by 
induced pluripotent stem cells prevented stress-induced senescence of rat cardiomyocyte-
derived H9C2 cells [327], which may translate to an aged system. In a slightly more 
eccentric vein, a recently clinical study in South Korea injected conditioned media obtained 
from hESC-derived endothelial progenitor cells into one side of the face using microneedle 
rollers, while the other side was injected with saline [328]. After 10 weeks of biweekly 
treatment, significant improvements in the presence of pigmentation and wrinkles were 
observed in the side of the face given the stem cell-derived growth factors. 
 There are several specific ESC-produced factors identified in Chapter 5 that have 
been implicated in aging. The serum concentration of insulin-like growth factor-1 declines 
with age [329]; however it has also been observed that IGF-1 signaling can potentiate the 
aging process, as mice with reduced IGF-1 levels in the serum exhibit reduced growth but 
extended lifespan [227,330–332]. IGF-1 also plays a critical role in muscle regeneration, 
and expression of IGF-1 in aged muscle supports skeletal muscle repair [333,334]. Insulin-
like growth factor binding proteins (IGFBPs) are high affinity binders of IGF-1 and IGF-2 
and act primarily to transport IGFs in the serum and to regulate IGF activity. High levels 
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of IGFBP-2 were found to be expressed and secreted by ESCs (Chapter 5), and IGFBP-2 
is the primary IGFBP found in the mammalian brain and cerebral spinal fluid. IGFBP-2, 
which is also the major fetal binding protein, has a much higher affinity for IGF-2 than 
IGF-1 [335]. IGFBP-3 is the primary binder of IGF-1, and the decreased serum 
concentrations of IGFBP-3 with age may be causally linked to the decreased amounts of 
IGF-1 [336,337]. Though the complex interplay of IGFBPs with IGFs and the role of the 
system with aging are still under active investigation [330], the family of growth factors 
appears to play a critical role in many processes related to aging. Other proteins expressed 
and/or produced by ESCs that have been implicated in aging include SDF-1, which is 
present in lower serum concentration with age and has been associated with the increased 
turnover and decreased function of HSCs [306]. ESCs also express Wnt3, and decreased 
concentrations of Wnt3 in the brain with age have been linked to decreased neurogenic 
function [321]. Growth differentiation factor-11 (GDF-11) has been identified in several 
heterochronic parabiosis studies [41,43,46] to mediate age-related phenotypes, including 
cardiac hypertrophy, the decreased capacity for skeletal muscle regeneration, and reduced 
neurogenesis. While GDF-11 was expressed more highly by embryonic fibroblasts and 
mesenchymal stem cells (Figure 5.7), GDF-11 was also present in ESC lysates (data not 
shown). Overall, the paracrine actions of trophic factors derived from pluripotent cells may 
provide signals to enable dysfunctional adult stem cells to regain a more “youthful” 
regenerative capability. 
7.2 Extension to extracorporeal devices 
The design of a continuously perfusable system for delivering stem cell secreted 
factors conjures up images of a platform which directly integrates into the circulation. 
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Dialysis, a common medical procedure used in patients with kidney failure, functions by 
exposing circulating blood to a semi-permeable membrane to facilitate diffusion of highly 
concentrated waste products out of the blood. A similar paradigm could be employed to 
deliver beneficial paracrine factors secreted by cell populations, analogous in some ways 
to the parabiosis studies in which an inadequate systemic composition is supplemented 
with beneficial factors. The development of an extracorporeal device based on the packed-
bed design (Chapter 4) to deliver cell-secreted products would allow for sustained delivery 
and release of factors without complications of directly transplanting cells, such as immune 
rejection or, in the case of stem cell populations, teratoma formation. 
 A similar approach to this envisioned paradigm has been previously investigated 
for bioartificial liver-assist devices. The goal of bioartificial liver devices is to assist with 
the detoxification functionality of the liver for patients transitioning to a transplant or in 
need of temporary support [338]. Hepatocytes have been cultured within the device as 
single cells anchored onto microcarriers [339] and hollow fibers [340,341] or 
microencapsulated within hydrogel beads [342,343]. Aggregated hepatospheres have also 
been encapsulated in hydrogel matrices [344], and the three-dimensional spheroid culture 
of the hepatocytes led to a two-fold increase in metabolic activity in comparison to 
encapsulated single hepatocytes [345], demonstrating the advantages to using platforms 
which enable 3D culture. Ultrafiltration membranes are used in the bioartificial liver 
devices to isolate the enclosed hepatocytes from patient immune cells and molecules [338]. 
Several blood flow configurations through the devices have been explored. For hollow 
fiber reactors, the hepatocytes have been cultured within the fibers in collagen gels while 
the blood moves through the extracapillary space [346], or the hepatocytes have been 
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grown on the outer surface of the fibers while the blood flows through the hollow fibers 
[340]. Fluidized bed configurations consisting of microencapsulated hepatocytes have also 
been explored [347–349], thus there is precedent for the use of packed bed perfusion 
systems as successful extracorporeal devices. 
7.3 Material design parameters to control and enable trophic factor 
delivery 
 In the context of this dissertation, alginate was selected as the material for 
encapsulation for a number of reasons, including its historical prevalence and its 
biocompatible and gentle cross-linking procedure. However, more advanced materials 
exist and/or are capable of being synthesized which may enhance the production and 
delivery of stem cell secreted factors. While it was determined that the composition of 
alginate employed could shift the phenotype of the enclosed ESCs (Chapter 3), more direct 
material modifications could be made to control cell fate and thus regulate the identity and 
quantity of secreted factors. Additionally, the way in which the encapsulation material 
interacts with the secreted factors could be useful for modulating the composition of 
molecules delivered downstream. 
 Modifying the material properties of microbeads and microcapsules can influence 
stem cell differentiation by mimicking elements of the native microenvironment and/or 
through specific functionalization with relevant protein molecules. For example, alginate-
gelatin microcapsules with functional properties more akin to the native adipogenic 
microenvironment led to higher proliferation and more efficient adipogenic differentiation 
of entrapped adipose-derived stem cells (ADSCs) when compared to those encapsulated in 
alginate without gelatin [364]. Additionally, functionalizing agarose with vascular 
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endothelial growth factor (VEGF) yielded more efficient differentiation of 
microencapsulated mESCs to blood progenitors than soluble treatment with VEGF [146], 
and increasing collagen concentrations and/or initial cell seeding density of hMSCs 
encapsulated in collagen beads enhanced chondrogenesis [365]. By functionalizing the 
material used to encapsulated the enclosed stem cells, more direct control over the 
downstream composition of secreted factors could be achieved. 
 In addition to using material properties to control cell phenotype, the physical 
interactions of the material with the secreted species could be used as a sort of filtration 
system. The charge of the hydrogel polymer can be used to selectively bind and sequester 
molecules of the opposing charge, thus limiting their diffusion and delivery downstream. 
For example, glycosaminoglycan-based materials are negatively charged and can therefore 
be used to sequester positively-charged growth factors, such as bone morphogenetic 
protein-2 (BMP-2), fibroblast growth factor-2 (FGF-2), and vascular endothelial growth 
factor (VEGF) [366,367]. Alginate is also a negatively charged polymer and likely reduced 
the diffusion of these positively-charged proteins out of the microbeads. An additional 
material property which can be modulated to restrict the diffusion of certain molecules is 
the pore size, which has been taken advantage of in microencapsulation systems to prevent 
access of immune molecules to the enclosed cells. To prevent the release of large molecules 
from the hydrogel, increasing the cross-linking density and polymer weight percentage 
generally decrease the pore size, or a surface coating such as poly-L-lysine can be applied 
to provide a tighter diffusive barrier [368]. To allow for diffusion of large structures, such 
as microvesicles, several approaches have been applied to increase hydrogel pore size, 
including electrospinning, gas foaming, lyophilization, solvent casting with particle 
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leaching, and the creation of hydrophilic–hydrophobic hybrid hydrogels [369]. Increasing 
the pore size with these methods can also facilitate cellular processes, such as proliferation 
and migration. 
7.4 Microvesicles as paracrine mediators 
 While the focus of this dissertation has been on soluble paracrine factors, there is 
increasing evidence regarding the role of extracellular vesicles as intercellular delivery 
vehicles of proteins, lipids, and nucleic acids. Though microvesicles were identified in 
human plasma almost 50 years ago [350], they were widely regarded as insignificant 
membranous debris until recently. Extracellular vesicles are comprised of many 
subcategories of vesicles ranging from 20 nm to 1 μm in diameter, including nanoparticles, 
exosomes, microparticles, microvesicles, and apoptotic blebs [351]. Exosomes, which are 
in the smaller range of 40-100 nm, are derived from endosomal membranes that have been 
expelled from the membrane of activated cells, while microvesicles (100 nm to 1 μm) are 
shed from the plasma membrane through a budding process [352,353]. Microvesicles 
enable cell-cell communication and represent a unique endogenous approach for horizontal 
gene transfer, as most microvesicles contain both messenger RNAs (mRNAs) and non-
coding RNAs like microRNAs (miRNAs) [354].  
 Microvesicles are produced by most cell populations, including pluripotent and 
multipotent stem cells. The microvesicles derived from adult stem cell populations, 
including hematopoietic stem and progenitor cells, mesenchymal stem cells, and neural 
stem cells, have stimulated pro-regenerative responses in many contexts by increasing cell 
survival and proliferation while promoting vascularization [355–357]. Analyses of the 
contents within the microvesicles have found many species of mRNA and miRNA 
 185 
(including mir126 and mir130 which have been implicated in cell survival and angiogenic 
mechanisms), bioactive lipids (including sphingosine-1-phosphate and ceramide-1-
phosphate), and proteins (including many cytokines and growth factors like stem cell factor 
and vascular endothelial growth factor) [358].  
 With most of the focus on multipotent stem cells populations, only a handful of 
studies have been performed to identify the presence, contents, and functions of pluripotent 
cell-derived microvesicles. The first report of ESC-derived microvesicles was less than a 
decade ago based on the hypothesis that the robust self-renewal capacity of ESCs may 
induce a similar proliferative response in a population of hematopoietic progenitor cells 
[359]. Indeed, improved survival and increased expansion was observed with the addition 
of microvesicles isolated from undifferentiated ESC cultures. High concentrations of the 
Wnt3 protein along with mRNA for pluripotent transcription factors (Oct-4, Gata-2, Gata-
4, Scl/Tal1, Nanog, Rex-1, HoxB4), cytokines (Sdf-1, Kit-L, Vegf, Cxcr4, c-Met, Lif, IL-
8, Fgf-2, Epo), cell cycle and apoptosis proteins (Cyclin D1, Bcl-xl, Cyclin a2, Bcl-2), 
structural proteins (Wnt3, Myogenin, VE-cadherin, Cathepsin, Nestin, P-selectin, β-2 
microglobulin), and proteolytic enzymes (Mmp-2, Timp-1, Timp-2). Following exposure 
to the ESC-derived microvesicles, expression of many of these unique genes was observed 
in the hematopoietic progenitor cells, indicating that the horizontal transfer of genetic 
information may have prompted the changes in survival and proliferation. The contents of 
ESC microvesicles were further characterized in a second study, and despite some 
similarities in the mRNA and protein content between ESCs and their shed microvesicles, 
certain proteins and RNAs are significantly enriched in the microvesicles [360]. The 
presence and identity of several miRNAs was also established, in addition to evidence of 
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ESC microvesicle fusing with and transferring contents to other ESCs and embryonic 
fibroblasts. The most recent report applied ESC-derived microvesicles to retinal progenitor 
Müller cells, which exhibited increased expression of genes and miRNAs related to 
pluripotency, proliferation, early ocular phenotypes, and retinal regeneration and decreased 
expression of genes and miRNAs associated with differentiation and cell cycle arrest [361]. 
Taken together, the results of previous studies indicate that microvesicles shed from ESCs 
play significant roles in regulating the phenotypes of surrounding cells and that a 
significant portion of their overall paracrine activity may be through extracellular vesicles 
rather than through the secretion of soluble factors.  
 Due to the large size of extracellular vesicles in comparison to individual proteins 
(10 to 1000-fold larger), enabling transport of the vesicles through hydrogel matrices 
becomes a greater challenge in material design. Typical alginate hydrogels have a pore size 
of 10-30 nm, significantly smaller than most microvesicles [175,362]. Specialized alginate 
sponges with larger pore sizes can be produced [363], though the problem of cell 
containment increases as the size of the microvesicle approaches the size of an individual 
cell. Based on the alginate hydrogels used for ESC encapsulation in this dissertation, it is 
unlikely that significant transport of microvesicles to the downstream perfusate of the 
packed bed reactor was achieved. It is interesting that a similar trend in increased 
proliferation of hematopoietic progenitor cells (in comparison to the results of [359]) was 
achieved despite the lack of microvesicles, which indicates that a significant paracrine 
response can be achieved based on the delivery of soluble proteins alone. The culture of 
cells in hydrogels with molecular weight cut-offs (MWCOs) lower than the average 
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SINGLE-CELL ANALYSIS OF EMBRYOID BODY 
HETEROGENEITY USING MICROFLUIDIC TRAPPING ARRAY4 
 
A.1 Introduction 
Pluripotent embryonic stem cells (ESCs) have many potential applications as a cell 
source for regenerative medicine and as a vehicle to attain new insights into embryonic 
development. Though ESCs are clonal and therefore are often assumed to exist as a 
homogenous cell population, there are subtle discrepancies in cell phenotype even in the 
undifferentiated state prior to the induction of differentiation [370,371]. It has been 
suggested that undifferentiated stem cells exist as a heterogeneous population so they can 
be simultaneously influenced to differentiate while also maintaining their ability for self-
renewal [372]. Heterogeneity may result from the ability of a single cell type to interconvert 
stochastically between different pluripotent states, as it has been observed that ESCs can 
occupy a continuum of cell states, each with their own distinct phenotypic characteristics 
[373]. Examples of in vivo heterogeneity of pluripotent cells, such as the “salt-and-pepper” 
expression of transcription factors in the inner cell mass [374], imply that such diversity is 
not simply a product of in vitro culture; in fact, the diversity may confer an innate response 
to environmental or physiological stress [375] via cells existing in a bivalent state in which 
they are primed for differentiation while retaining self-renewal capacity [376]. In addition 
                                                 
 
 
4Modified from: Wilson JL, Suri S, Singh A, Rivet CA, Lu H, McDevitt TC. Single-cell analysis of 
embryoid body heterogeneity using microfluidic trapping array. Biomed Microdevices 2014; 16:79-90. 
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to heterogeneity of the pluripotent state of ESC populations, often some level of 
spontaneous differentiation exists within the undifferentiated population of cells [377]. 
Attempts to direct the differentiation of an initially heterogeneous population of stem cells 
is likely to compromise the overall yield and efficiency, as cells in different states may 
respond differentially to the same stimuli. Thus, in order to efficiently proceed with stem 
cell applications and directed differentiation methods, it is necessary to understand and 
account for the presence of multiple cell states within a population of stem cells. 
Embryonic stem cells are often differentiated as three-dimensional multicellular 
aggregates referred to as “embryoid bodies” (EBs) due to their ability to spontaneous yield 
derivatives of the three germ lineages simultaneously [154]. EB differentiation is 
commonly used to model morphogenesis in addition to differentiation since analogous 
structures and patterns are observed within EBs that mimic the morphogenic events of early 
embryonic development [20,21,23,378–380]. Significant research has been conducted to 
examine the ability of different biochemical and environmental factors to direct EB 
differentiation [17,18], and EB formation remains a critical step in many differentiation 
protocols [154,381–386]. Differentiation of cells as three-dimensional multicellular 
aggregates inherently adds the complication of spatial gradients that can differentially 
impact cell phenotypes between the center and exterior of EBs [387]. Consequently, the 
size of EBs used has been found to impact the differentiation propensity [388–392]; for 
example, larger EBs tend to have a greater tendency toward cardiac differentiation than 
smaller EBs [184–186] . However, it is difficult to directly compare studies since EB 
formation methods and size ranges differ from study to study, thus definitive correlations 
between size and differentiated phenotypes have been mixed. Furthermore, aggregate size 
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alone does not account for all the variance in EB phenotype, as heterogeneity between EBs 
of the same size is often observed [17], even when all other parameters are seemingly taken 
into account. 
One of the challenges of investigating the cellular composition of EBs is the 
deficiency of current analytical methods to determine the phenotype of all of the individual 
cells that comprise a single aggregate. Examining phenotypic properties on a single cell 
level provides more information than population averaging-based methods, as one can 
discern whether a small subpopulation is solely responsible for the change in expression or 
if all cells in the population are undergoing similar changes [393]. Previous research has 
demonstrated that ESC gene expression results differ greatly when examined at a single 
cell, rather than a population, level [394], further motivating the development of high 
throughput methods for investigating single stem cell fate. Existing methods, such as flow 
cytometry, provide a high-throughput means to analyze phenotypic characteristics of a cell 
population, but typically require cell quantities (105-6) that are much greater than the 
number of cells comprising a single multicellular aggregate (103-4). Confocal microscopy, 
another common analytical method, is a low-throughput process that has a limited capacity 
to image three-dimensional tissues [395–397]. Due to the high cell density of EBs [17], 
which do not exhibit a large degree of extracellular matrix at early stages of differentiation 
[236], imaging greater than 50 μm into an EB has been challenging due to optical 
limitations.  
Analytical techniques that enable increased understanding of when and where 
heterogeneity is occurring in a cell population could lead to better assessments of directed 
differentiation techniques. Therefore, the objective of this study was to develop an 
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approach to analyze the individual phenotypes of cells not only from populations of EBs, 
but single EBs as well. To achieve this, a microfluidic cell trap device originally designed 
to examine calcium dynamics in Jurkat cells [398] was adapted and validated to examine 
expression of the pluripotent transcription factor OCT-4 in single cells from EBs of 
different sizes (defined by the initial number of cells per aggregate) and at different stages 
of differentiation. Additionally, single cells from dissociated pooled EBs or individual EBs 
were examined separately to discern potential differences in the value or variance of 
expression between the different methods of analysis. The results of this study indicate that 
examining single cell phenotype using a microfluidic approach can provide previously 
unidentified information about heterogeneity of EBs and may act as a complementary 
analysis method that provides more specific information regarding single stem cell fate(s) 
within complex multicellular aggregates.   
A.2  Methods 
A.2.1 Microfluidic device fabrication 
Polydimethylsiloxane (PDMS) devices were fabricated via soft lithography rapid 
prototyping and replica molding, followed by plasma-bonding onto glass slides [398]. 
Briefly, negative molds were fabricated on silicon wafers using photoresist (SU8-2010, 
14–16 μm, and SU8-2002, 1.5–3 μm thickness) (Microchem) and treated with 
tridecafluoro-1,1,2,2-tetrahydrooctyl-1-trichlorosilane vapor (United Chemical 
Technologies, Bristol, PA). PDMS with base polymer to crosslinker ratio of 10:1 was 
molded onto wafers and cured at 70°C for 2 hours. Individual devices were cut, access 
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holes were punched and devices were bonded in an air plasma. Devices were stored at room 
temperature until further use. 
A.2.2 Embryonic stem cell culture 
Murine ESCs (D3 cell line) were cultured on tissue culture-treated polystyrene 
dishes (Corning Inc., Corning, NY) adsorbed with 0.1% gelatin (Millipore, EmbryoMax). 
Undifferentiated ESC culture media consisted of Dulbecco’s modified Eagle’s medium 
(DMEM) (Mediatech) supplemented with 15% fetal bovine serum (Hyclone, Logan, UT), 
100 U/mL penicillin, 100 μg/mL streptomycin, and 0.25 μg/mL amphotericin (Mediatech, 
Herndon, VA), 2 mM L-glutamine (Mediatech), 1x MEM non-essential amino acid 
solution (Mediatech), 0.1 mM 2- mercaptoethanol (Fisher Scientific, Fairlawn, NJ), and 
103 U/mL of leukemia inhibitory factor (LIF) (ESGRO, Chemicon, Temecula, CA). 
Cultures were replenished with fresh media every other day and passaged at approximately 
70% confluence. 
A.2.3 Embryoid body (EB) formation and culture 
A single cell suspension of undifferentiated ESCs was obtained through 
dissociation of monolayer cultures with 0.05% trypsin-EDTA (Mediatech). Aggregation 
of ESCs was achieved by centrifugation (200 rcf) of ESCs into 400 μm diameter 
polydimethylsiloxane (PDMS) micro-wells (AggrewellTM, Stem Cell Technologies, 
Vancouver, Canada), as previously reported [19,152]. The cell seeding density was varied 
to achieve approximately 250 or 1000 cells per individual well. The ESCs were incubated 
in the wells for approximately 20 hours in undifferentiated ESC culture media without LIF 
to allow for EB formation. The resulting EB population was transferred to suspension 
culture (approximately 1500 EBs in 10 mL of undifferentiated ESC culture media without 
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LIF) in sterile 100 x 15 mm bacteriological grade polystyrene Petri dishes (BD, Franklin 
Lakes, NJ) and maintained on rotary orbital shakers [166] at a frequency of approximately 
65 rpm. A 90% media exchange was performed every other day following gravity-induced 
sedimentation of the EBs in 15 mL conical tubes. Suspension cultures were maintained for 
up to 10 days of differentiation. 
A.2.4 Cell loading into microfluidic devices 
At days 5 and 10 of differentiation, EBs were collected and dissociated into a single 
cell suspension by incubation in 0.25% trypsin-EDTA and trituration every 5 minutes for 
20 minutes. After 10 days of differentiation, individual EBs were manually removed from 
the plate, imaged, and similarly dissociated using 0.25% trypsin. The resulting cell 
suspensions were centrifuged (200 rcf, 5 minutes) and resuspended in culture media 
supplemented with 3 mM EGTA for a 30 minute incubation (37°C) to inhibit intercellular 
adhesion and reduce clogging in the microfluidic device. A LIVE/DEAD cell assay 
(Invitrogen) was performed to evaluate cell viability post-loading. Prior to cell loading, the 
devices were perfused with a 2% solution of bovine serum albumin (Millipore). Single 
cells were loaded into the devices by pipetting the cell suspension into an inlet made with 
a 19-gauge needle. The cells were loaded into the device by gravity-driven flow. Once 
loaded, the device was perfused with a 4% paraformaldehyde solution (Alfa Aesar) for 10 
minutes to fix cells. Cells were also collected at day 0 (prior to EB formation) and similarly 
loaded into the devices. Cell-laden devices were stored with PBS at 4°C until 
immunofluorescent staining was performed for parallel samples at the same time. 
A.2.5 On-chip immunofluorescent staining 
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Immunofluorescent staining was performed in the devices by attaching a pipette tip 
containing the solution into the inlet and attaching 2.5 ft of polyethylene tubing (PE3, 
Scientific Commodities) to the outlet to induce gravity-driven flow. The cells were 
permeabilized with 0.05% Triton X and 2% donkey serum in PBS for 45 minutes at room 
temperature prior to overnight incubation at 4°C with the primary antibody against OCT-
4 (Santa Cruz Biotechnology sc-8628; 1:100 in 2% donkey serum in PBS). The devices 
were perfused with PBS for 15 minutes to wash the cells prior to 1 hour incubation with 
the secondary antibody solution (1:200 AlexaFluor®488 donkey anti-goat in 2% donkey 
serum in PBS). The devices were perfused with PBS for 15 minutes to wash the cells prior 
to 10 minute incubation with blue whole cell stain (HCS CellMaskTM, Invitrogen). A final 
15 minute perfusion with PBS was performed prior to imaging. 
A.2.6 Cell trap imaging and image analysis 
The devices were imaged using a Nikon TE 2000 inverted microscope equipped 
with a SPOT Flex camera (Diagnostic Instruments). Each chamber in the device was 
imaged on three channels (phase, Hoechst, and FITC). Image analysis was performed using 
ImageJ software (http://rsbweb.nih.gov/ij/). A threshold was applied to the whole cell stain 
image (blue channel) to determine the cell area. Subsequently, the fluorescent intensity of 
OCT-4 staining (green channel) was determined for individual cells and normalized to the 
cell area. Area and intensity values were exported to Microsoft Excel for further analysis. 
A.2.7 Flow cytometry 
EBs were collected and dissociated into a single cell suspension through incubation 
in 0.25% trypsin-EDTA and trituration every 5 minutes for 30 minutes. Cells were also 
collected at day 0 prior to EB formation. The cell suspension was centrifuged (200 rcf, 5 
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minutes) and resuspended in culture media supplemented with 3 mM EGTA for 30 minute 
incubation (37°C), as was performed prior to loading in the microfluidic devices. Cells 
were fixed in 4% paraformaldehyde, washed 3x with PBS, and stored at 4°C until staining 
was performed. Cells were permeabilized in 0.05% Triton X-100 in blocking buffer (1 
mg/ml BSA and 0.1% Tween20 in PBS) for 30 minutes, then washed in blocking buffer 
for 15 minutes. Cells were incubated at room temperature with the primary antibody 
against OCT-4 (Santa Cruz Biotechnology sc-101462; 1μg/million cells) for 1 hour. Cells 
were washed with blocking buffer, then incubated with the secondary antibody 
(AlexaFluor®488 donkey anti-goat at 1μg/million cells) for 30 minutes at room 
temperature. The cells were resuspended in 300 μL blocking buffer, filtered through the 
35μm cell-strainer cap of a 5 mL polystyrene round-bottom tube (BD Biosciences, San 
Jose, CA), and analyzed with an Accuri C6 flow cytometer for a minimum of 10,000 
events. Normal goat IgG was used in place of primary antibody incubation as an isotype 
control, with positive gates set above 2% of the IgG isotype control population. Analysis 
was performed using FlowJo software (Tree Star, Inc., Ashland, OR). 
A.2.8 Whole mount staining and imaging 
EBs were washed in PBS, fixed for 30 minutes in 4% paraformaldehyde, and 
washed 3x with PBS. EBs were stored in PBS at 4°C until staining was performed. EBs 
were permeabilized for 30 minutes in 1.5% Triton X-100, re-fixed in 4% paraformaldehyde 
for 15 minutes, and blocked in wash buffer (2% donkey serum, 0.1% Tween-20 in PBS) 
for 3 hours. Samples were incubated in OCT-4 primary antibody (Santa Cruz 
Biotechnology sc-8628; 1:100) overnight at 4°C, rinsed with wash buffer (3 times, 15 min), 
and incubated with the secondary antibody solution (1:200 AlexaFluor®488 donkey anti-
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goat in wash buffer) and Hoechst (1:100) for 4 hours at 4°C. To image, samples were re-
suspended in a low volume of wash buffer and imaged with a Zeiss LSM 700-405 confocal 
microscope (Carl Zeiss Inc.). 
A.2.9 Statistics 
All population-based experiments were performed with triplicate samples from 
independent conditions (n=3). The data is represented as the mean of the independent 
replicates, and the error bars represent the standard error of the mean. Before performing 
statistical analysis, data were normalized using a Box–Cox power transformation to 
equalize variance. A two-way ANOVA was calculated between the analysis method (cell 
trap and flow cytometry) and experimental groups, with post hoc Tukey analysis to 
determine significant differences (p < 0.05) between the different analysis methods and 
experimental groups. A one-way ANOVA was calculated between the individual groups 
(population and single EB), with a post hoc Tukey analysis to determine significant 
differences (p < 0.05) between the groups. 
A.3 Results 
A.3.1 Embryonic stem cell (ESC) on-chip analysis 
 To assess heterogeneity in the cell populations comprising embryoid bodies (EBs), 
murine embryonic stem cells were aggregated within PDMS microwells at two different 
seeding densities to form distinct EB sizes, transferred to suspension culture, and allowed 
to differentiate for up to 10 days (Figure A.1). After five days of differentiation, EBs of 
each size were dissociated into single cell suspensions, and the population from each plate 





Figure. A.1. Overview of experimental approach for cell trap device. Embryoid bodies (EBs) 
of 250 or 1000 cells were formed via forced centrifugation in PDMS microwells and cultured for 
up to 10 days of differentiation. After 5 or 10 days of suspension culture, single cells were obtained 
from either from a dissociated population of EBs (~1500 total) or from hand-picked individual 




whole mount immunostaining analysis. The single cell suspensions designated for cell trap 
analysis were loaded into the microfluidic device using gravity-driven flow as previously 
described [398]. Populations of EBs were similarly processed after 10 days of 
differentiation, and single EBs were individually removed manually from the cultures, 
imaged, and dissociated prior to loading into cell trap devices. 
 Prior to EB formation, the ESC population used to form the EBs (Figure A.2a) was 
dissociated into single cells and loaded into cell trap devices or reserved for flow 
cytometric analysis. After five days of EB differentiation, differences in diameter were 
visually observed between the EBs initially seeded at a ratio of 250 cells per EB (Figure 
A.2b) and the EBs seeded at 1000 cells per EB (Figure A.2c). By day 10 of differentiation 
(Figure A.2d, A.2e), the presence of distinct EB sizes was no longer prevalent, though 
minor variability in size was observed in both cultures. Single cells derived from the 
different populations exhibited efficient cell loading into the device (Figure A.2f-o), with 
a low incidence of both empty traps and multiple cells per trap (<10%). The cells were 
stained on-chip using a whole cell stain (blue), with the intensity remaining consistent 
throughout all groups (Figure A.2f-j). On-chip immunofluorescent staining for the 
pluripotent transcription factor OCT-4 was performed just prior to whole cell staining. The 
undifferentiated ESC population used for EB formation exhibited high intensity staining 
for OCT-4 at day 0 (Figure A.2k), and the intensity was reduced as the cells differentiated 
as EBs (Figure A.2l-o). After five days of differentiation, fewer cells expressed OCT-4 
with an intensity as great as those observed with cells on day 0 (Figure A.2l, A.2m) and 
majority of the cells had a faint antibody signal. At day 10 of differentiation, the cells from 




Figure A.2. Image time course and representative cell trap chamber images. Undifferentiated 
ESCs (A) were aggregated to form EBs comprised initially of 250 cells (B,D) or 1000 cells (C,E). 
The dissociated EBs were loaded into the cell traps at days 5 and 10 of differentiation and stained 
with HCS CellMaskTM (F-J) and an antibody against the pluripotent transcription factor OCT-4 
(K-O). The initial undifferentiated ESC population exhibited bright staining for OCT-4 at day 0 




intensity (Figure A.2n). In comparison, qualitative analysis of the cells from the 1000 cell 
EBs indicated that a sub-set of the population of cells retained high levels of OCT-4 
expression, while most cells exhibited low to no expression of OCT-4 (Figure A.2o). 
A.3.2 Examining populations of embryoid bodies (EBs) with cell traps and flow 
cytometry 
 In order to validate the cell trap analytical method, flow cytometry analysis was 
performed on cells dissociated from a population of EBs. Overall, both forms of analysis 
detected a similar decrease in OCT-4 expression (Figure A.3) as the cells differentiated. 
Based upon cell trap analysis, the 250 cell EB population exhibited an average intensity of 
38% ± 3% and 16% ± 3% at days 5 and 10, respectively and relative to the day 0 ESCs. In 
comparison, analysis of the 1000 cell EB population in the cell trap device displayed 44% 
± 22% and 42% ± 17% of the day 0 intensity at days 5 and 10, respectively. The minor 
disparities between the cell trap and flow cytometry methods were not statistically 
significant (p = 1.000, 0.561, 0.198, 0.974).  
 A benefit of single cell analysis methods is the ability to examine the variance and 
heterogeneity of a cell population in addition to calculating simply population average 
information. Therefore, the OCT-4 intensity values were plotted as histograms in order to 
examine the variance of OCT-4 expression in the different groups. In general, OCT-4 
expression was broadly expressed in the starting ESC population at day 0 (Figure A.4a, 
A.4d), though several peaks were observed at higher intensities (10-20 units). While most 
devices exhibited a similar trend, some had a peak at a slightly lower intensity value that 
was not observed in the corresponding flow cytometry histogram (Figure A.4a inset). 




Figure A.3. Comparison of microfluidic trapping array and flow cytometry mean fluorescent 
intensities. The mean fluorescent intensities were calculated by averaging the intensity of 
individual cells within the cell trap devices or from the mean intensity values obtained by flow 
cytomery with a 533/30 nm filter and positive gates set at 2% of the IgG isotype control population. 
No statistically significant differences were found between the two analytical methods (p < 0.05) 
at any of the time points examined.   
 
 
population samples (Figure A.4b), whereas the 1000 cell EBs appeared to have more 
variability between different populations at day 5 (Figure A.4e). After 10 days of 
differentiation, the variability of OCT-4 expression in the 250 cell EBs remained low 
(Figure A.4c), with decreased OCT-4 expression reflected by the narrowed peak of the 
intensity value and leftward shift. In the 1000 cell EBs at day 10 (Figure A.4f), the 
expression pattern was similar to that at day 5, with more cells exhibiting greater OCT-4 
intensity compared to the 250 cell EBs. In general, the shapes of the histograms of the cell 
trap analysis were in agreement with the flow cytometry results (Figure A.4 insets). For 
example, the flow cytometry histograms for the 1000 cell EBs at day 5 (Figure A.4e) also 




Figure A.4. Histogram analysis of OCT-4 heterogeneity. The percentage of the population with 
a given OCT-4 intensity (log scale) was plotted to display the value of the peak intensity as well as 
the width  of the peak for the day 0 undifferentiated starting population (A,D), the 250 cell (B) and 
1000 cell (E) EBs at day 5 of differentiation, and the 250 cell (C) and 1000 cell (F) EBs at day 10 
of differentiation. The histogram outputs of the corresponding flow cytometry analysis (cell count 
vs. OCT-4 intensity) are displayed as insets. 
  
A.3.3 Comparing expression and heterogeneity of single EBs to population values  
 The microfluidic cell trap device has the unique ability to efficiently and rapidly 
trap cells from a single EB, thus enabling the analysis of inter-EB variability that could be 
masked in more common population-based methods. Confocal microscopy techniques 
allow for examination of the cellularity of single EBs; however, imaging is a low-
throughput method that is limited by the lack of complete optical sectioning through 
densely packed multicellular tissues [396], restricting the information obtained for all the 
cells in a tissue or EB. For comparison with the single EB results from the cell trap, 
immunostaining for OCT-4 was performed on intact 250 cell and 1000 cell EBs at days 5 
and 10 differentiation, followed by confocal imaging in which optical sections were 
acquired (depth of 30 μm presented in Figure A.5). Decreasing expression of OCT-4 was 
observed in both sizes between days 5 and 10 of differentiation. After five days of 
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differentiation, the 250 cell EBs (Figure A.5a) generally had similar OCT-4 expression, 
indicating low inter-EB variability, whereas increased variation was observed between EBs 
in the 1000 cell EBs at day 5 (Figure A.5c). After 10 days of differentiation, spatially-
constrained “pockets” of high and low OCT-4 expression were observed in both groups, 
though cells highly expressing OCT-4 appeared more frequently in the 1000 cell EBs 
(Figure A.5d) than in the 250 cell EBs (Figure A.5b). These results clearly indicate an 
increased variability of OCT-4 expression within single EBs in comparison with the more 





Figure A.5. Whole mount immunostaining for OCT-4 in intact EBs. EBs were collected at the 
same time points for which single cell expression was analyzed and stained for OCT-4 expression. 
Images represent optical sections at a 30 μm depth into the EB. The merged images (right panels) 
signify OCT-4 staining in addition to nuclear counterstaining with Hoechst. Relatively strong 
expression of OCT-4 was observed in both groups at day 5 (A,C). After 10 days of differentiation, 
OCT-4 expression decreased in both groups, though it appeared cells with high expression appear 
more frequently higher in the 1000 cell EBs (D) than in the 250 cell EBs (B). 
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 The differences in the intensity and spatial variance of OCT-4 expression within 
EBs of different sizes over time prompted further investigation into the single cell OCT-4 
expression between individual EBs as compared to a population of EBs. Thus, single EBs 
were manually removed and dissociated individually prior to their loading into the cell trap 
devices, with approximately 45% of the individual cells from a single EB successfully 
captured within a device. The reduced capture efficiency could be primarily attributed to 
the difficulty of dissociating a single EB and the subsequent transfer steps where many 
cells were lost. The ability to capture many cells from a single EB indicates the power of 
cell-trap devices despite the difficulty of working with such low cell populations.  
 The mean OCT-4 intensity values were compared for cells from populations and 
single EBs at day 10 of differentiation within the cell trap devices. Representative analyses 
of single EBs are presented in Figure A.6b (250 cells/EB) and Figure A.6c (1000 
cells/EB). In general, the single EBs exhibited lower OCT-4 expression levels than the 
population-averaged value (Figure A.6a), though this difference was not significant (p = 
0.939 for 250 cell EBs; p = 0.137 for 1000 cell EBs). A decrease (p < 0.05) in OCT-4 
expression relative to the day 0 ESC starting population was observed for three of the four 
experimental groups at day 10 of differentiation (250 cell EB population, averaged 250 cell 
single EBs, and averaged 1000 cell single EBs), indicating that most experimental 
conditions had significantly decreased pluripotent transcription factor expression by day 
10 of EB culture. The 1000 cell EBs assessed at the population level did not exhibit a 
significant decrease in expression, which may indicate that the cells within the larger EBs 





Figure A.6. Population and single EB OCT-4 expression. The mean intensity obtained from the 
cell trap device was assessed for each condition, including the single EBs (A). The single EBs of 
both sizes were imaged (B,C) immediately prior to their dissociation and loading at day 10 of 
differentiation. In general, single EBs exhibited lower OCT-4 expression than the population-
averaged values (A), though the differences were not statistically significant (p = 0.939 for 250 cell 
EBs; p = 0.137 for 1000 cell EBs). * indicates significant decrease in OCT-4 intensity compared to 
the day 0 starting population (p < 0.05).  
 
 In an attempt to elucidate whether inter-EB or intra-EB heterogeneity was dominant 
in the different sizes, the values for each cell analyzed at day 10 of differentiation were 
arrayed with regard to intensity and cell size/area. Although the flow cytometry scatter 
plots for the population samples were similar for the two EB sizes (Figure A.7a, A.7d), 
the cell trap population scatter plots demonstrated that the 1000 cell EB population (Figure 
A.7e) appeared more heterogeneous than the 250 cell EB population (Figure A.7b). The 
scatter plot for the 250 cell single EBs (Figure A.7c) had a similar appearance to the 
corresponding population scatter plot (Figure A.7b), suggesting that the heterogeneity of 
phenotypes within individual EBs was more prevalent than the overall heterogeneity 





Figure A.7. Heterogeneity of OCT-4 expression in EB populations versus single EBs. Values 
of OCT-4 intensity vs. forward scatter (or cell size) were graphed as scatter plots for both 
population and single EB analysis of both sizes at day 10. Corresponding flow cytometry scatter 
plots for 250 cell EBs (A) and 1000 cell EBs (D) are displayed for comparison. Similar shapes are 
observed between the 250 cell population (B) and single EBs (C) but differential patterns are 
observed in the 1000 cell population (E) and single EBs (F). 
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heterogeneity than the EB population analysis (Figure A.7f), which indicates that inter-EB 
heterogeneity was more prevalent for larger EBs of this size.  
A.4  Discussion 
 The differentiation of pluripotent stem cells as embryoid bodies (EBs) remains a 
common method for inducing differentiation toward many lineages, including cardiac 
[384,399], hematopoietic [154,385], and neural [383,400]. However, differentiation via EB 
methods typically gives rise to heterogeneity in the cell population, as most cells 
differentiate in parallel toward multiple lineages while some may remain undifferentiated. 
In addition to different media compositions, physical parameters, such as the size of the 
EBs, can contribute to phenotypic variation through the establishment of nutrient and 
oxygen gradients [387]. Therefore, the objective of this work was to examine EB 
heterogeneity on the single-cell level, which was accomplished using a microfluidic cell 
trap device in combination with on-chip staining and imaging. Information regarding the 
degree and heterogeneity of single cell OCT-4 expression was obtained for both a 
population of EBs and for single EBs. The results from the cell trap device were compared 
with flow cytometry and whole mount immunostaining to compare the overall OCT-4 
expression as well as the heterogeneity of expression observed with each approach. 
Overall, assessing the variability of OCT-4 expression in single EBs in comparison with 
the variability in a population of EBs represents a novel approach for evaluating how 
heterogeneity is manifested in EB cultures.  
 Microfluidic systems are being increasingly used as instruments for sorting stem 
cells [401–403] and for deciphering stem cell function owing to their capacity to array cells 
in a high-throughput fashion, to precisely deliver solutions in well-controlled spatial and 
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temporal manner, and to enable real-time imaging. Several studies have examined 
microfluidic methods to control EB culture and differentiation on-chip [404,405], although 
the devices previously developed do not include any downstream analysis of the single 
cells within the aggregates. Other studies have described devices which enable trapping of 
single-cell populations [406–408] for cell pairing and real-time monitoring, some of which 
have examined stem cell populations. Studies with hematopoietic stem cells (HSCs) have 
been most often described, likely due to their non-adherent phenotype, and include 
investigations into the differences in proliferation and survival of normal [409] and 
diseased HSCs [410], as well as the percentage of HSCs in different stages of the cell cycle 
[411]. Other microfluidic platforms capable of performing on-chip staining and imaging 
similar to flow cytometry have been described for a number of cell types as a means to 
decrease reagent volumes and the required cell sample size [412,413], similar to 
advantages achieved with the device described in this paper. However, there has been a 
deficiency of microfluidic approaches describing the analysis of small tissue constructs, 
like EBs, that are difficult to evaluate using typical analytical tools owing to the high cell 
density and small cell numbers of individual aggregates. The ability to quantitatively 
examine the protein expression of the single cells that comprise individual EBs, as achieved 
with the hydrodynamic cell trap in this paper, could provide new information while also 
complementing emerging strategies offered by microfluidic-based single cell PCR systems 
[394,414,415] as a means to examine differential gene and protein expression patterns.  
 In order to substantiate the results obtained with the microfluidic cell trap, the 
outcomes were compared to those obtained via flow cytometry and whole mount 
immunostaining. Flow cytometry is perhaps the most common tool for examining single 
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cell phenotype, and the results from the cell trap generally agreed with those obtained with 
flow cytometry (Figure A.3). However, some differences were observed for certain groups 
and time periods (i.e. Figure A.3, 250 cell EBs at day 10). Some divergence is to be 
expected due to the number of cells being sampled in each case. For flow cytometry, a 
minimum of 10,000 events were collected, and the contribution of non-specific binding 
could be removed with gates using an isotype control. In contrast, only approximately 2000 
cells were examined per microfluidic device. The fact that 20% fewer cells were used for 
the cell traps compared to flow cytometry may account for some of the variability seen, 
although it is interesting to note that both analytical tools assessed only a fraction of the 
cells (< 0.5%) present in an experimental replicate (approximately 2 million cells total). 
The other method used to compare the results of the cell trap was immunostaining and 
whole mount imaging using confocal microscopy (Figure A.5). While confocal 
microscopy is relatively low-throughput, it is useful in that it provides spatial information; 
however, the technique is technically limited due to poor optical penetration into embryoid 
bodies greater than 50 μm in diameter. Nevertheless, EBs imaged by confocal microscopy 
exhibited OCT-4 expression patterns that were consistent with the quantitative data 
obtained from the cell traps. For example, areas of bright and dim OCT-4 expression were 
observed in the 1000 cell EBs at day 10 (Figure A.5d), which corresponded to the cell trap 
images (Figure A.2o) and histograms demonstrating the relative proportion of OCT-4 
intensities of individual cells (Figure A.4f).  
 While flow cytometry can be used to evaluate the phenotypic state of a population 
of EB-derived cells, there is no current method that can easily be used to quantify the 
phenotypic diversity of single EBs because of the small numbers of cells in single EBs. 
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Therefore, flow cytometry is unable to aid in the confirmation and deciphering of the lower 
OCT-4 expression detected in single EBs compared to the average population values 
(Figure A.6a). One caveat is that the fraction of the sampled population is very small (< 
1% of the EBs from a plate of 1500); therefore any observed differences may be based on 
the limited sampling due to the low throughput nature of the current method. When the 
variability in OCT-4 expression was inspected for the population and single EBs (Figure 
A.7), similar patterns were observed in the 250 cell EB population and single EBs, 
indicating that the individual EBs sampled were representative of the population and/or 
that variability between EBs (inter-EB variability) was less significant for the 250 cell 
aggregates and the variance of phenotypes within a single EB (intra-EB variability) 
governed heterogeneity. In contrast, the divergent patterns of OCT-4 expression observed 
between the population of 1000 cell EBs and single EBs may indicate that the single EBs 
examined were not characteristic of the population, or it may signify that the variance of 
cell phenotypes between individual EBs (inter-EB variability) is greater for larger sized 
EBs.  
The implications of greater inter-EB variability than intra-EB heterogeneity may 
be that that a culture process is impacting different aggregates in a divergent manner, which 
may indicate that some EBs are experiencing appreciably different environmental 
influences than others. On the other hand, if high intra-EB variability is present, this may 
imply that internal nutrient/oxygen gradients or contrasting local cell-cell interactions are 
the primary contributor(s) to the observed heterogeneity of cell phenotypes [387,416]. In 
general, the subtle differences observed in OCT-4 expression between different EB sizes 
are consistent with previous literature which has demonstrated that larger 1000 cell EBs 
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tend to exhibit a delayed temporal decrease of OCT-4 expression compared to smaller 250 
cell EBs [417], as was found with all of the methods of analysis used in this study (Figure 
A.2, A.4, A.5).  
A.5 Conclusions 
Overall, the development and subsequent validation of an approach to 
quantitatively assess information about individual EBs at a single cell resolution was 
established, leading to notable findings regarding the variance of OCT-4 expression within 
single EBs. In the future, coupling of single-cell analysis with long-term live cell imaging 
could provide additional information regarding the dynamics of protein expression and 
could lead to an improved understanding about the underlying cause of heterogeneity in 
stem cell populations. Nevertheless, the approach described will be beneficial in evaluating 
the variability encountered during stem cell differentiation and can provide more specific 
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